WO2024204521A1 - Liquid crystal aligning agent, liquid crystal alignment film, liquid crystal display element, and methods for manufacturing same - Google Patents
Liquid crystal aligning agent, liquid crystal alignment film, liquid crystal display element, and methods for manufacturing same Download PDFInfo
- Publication number
- WO2024204521A1 WO2024204521A1 PCT/JP2024/012607 JP2024012607W WO2024204521A1 WO 2024204521 A1 WO2024204521 A1 WO 2024204521A1 JP 2024012607 W JP2024012607 W JP 2024012607W WO 2024204521 A1 WO2024204521 A1 WO 2024204521A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- liquid crystal
- organic group
- polymer
- crystal alignment
- Prior art date
Links
- 239000004973 liquid crystal related substance Substances 0.000 title claims abstract description 274
- 239000003795 chemical substances by application Substances 0.000 title claims abstract description 103
- 238000000034 method Methods 0.000 title claims abstract description 63
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 16
- 229920000642 polymer Polymers 0.000 claims abstract description 138
- 125000000962 organic group Chemical group 0.000 claims abstract description 129
- 229920001721 polyimide Polymers 0.000 claims abstract description 101
- 239000004642 Polyimide Substances 0.000 claims abstract description 97
- 239000002243 precursor Substances 0.000 claims abstract description 85
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 81
- 150000001875 compounds Chemical class 0.000 claims abstract description 71
- 239000000758 substrate Substances 0.000 claims description 53
- 125000003118 aryl group Chemical group 0.000 claims description 32
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 28
- 229910052757 nitrogen Inorganic materials 0.000 claims description 26
- 125000000217 alkyl group Chemical group 0.000 claims description 18
- 125000003277 amino group Chemical group 0.000 claims description 17
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 16
- 125000005843 halogen group Chemical group 0.000 claims description 12
- 125000000623 heterocyclic group Chemical group 0.000 claims description 11
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 11
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 11
- 125000003342 alkenyl group Chemical group 0.000 claims description 9
- 229910052731 fluorine Inorganic materials 0.000 claims description 9
- 125000001153 fluoro group Chemical group F* 0.000 claims description 9
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 9
- 125000000304 alkynyl group Chemical group 0.000 claims description 8
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 6
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 4
- 125000003396 thiol group Chemical group [H]S* 0.000 claims description 4
- 125000001140 1,4-phenylene group Chemical group [H]C1=C([H])C([*:2])=C([H])C([H])=C1[*:1] 0.000 claims description 3
- 239000004202 carbamide Substances 0.000 claims description 3
- BVXOPEOQUQWRHQ-UHFFFAOYSA-N dibutyl phosphite Chemical compound CCCCOP([O-])OCCCC BVXOPEOQUQWRHQ-UHFFFAOYSA-N 0.000 claims description 3
- 238000010304 firing Methods 0.000 claims description 3
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 claims description 3
- 125000000467 secondary amino group Chemical group [H]N([*:1])[*:2] 0.000 claims description 3
- 125000001302 tertiary amino group Chemical group 0.000 claims description 3
- UFFAFBPZFGAMJJ-UHFFFAOYSA-N (2-methoxy-4,6-dimethylphenyl)boronic acid Chemical compound COC1=CC(C)=CC(C)=C1B(O)O UFFAFBPZFGAMJJ-UHFFFAOYSA-N 0.000 claims description 2
- OOSPDKSZPPFOBR-UHFFFAOYSA-N butyl dihydrogen phosphite Chemical compound CCCCOP(O)O OOSPDKSZPPFOBR-UHFFFAOYSA-N 0.000 claims description 2
- LXCYSACZTOKNNS-UHFFFAOYSA-N diethoxy(oxo)phosphanium Chemical compound CCO[P+](=O)OCC LXCYSACZTOKNNS-UHFFFAOYSA-N 0.000 claims description 2
- XFUSKHPBJXJFRA-UHFFFAOYSA-N dihexyl hydrogen phosphite Chemical compound CCCCCCOP(O)OCCCCCC XFUSKHPBJXJFRA-UHFFFAOYSA-N 0.000 claims description 2
- CZHYKKAKFWLGJO-UHFFFAOYSA-N dimethyl phosphite Chemical compound COP([O-])OC CZHYKKAKFWLGJO-UHFFFAOYSA-N 0.000 claims description 2
- KUMNEOGIHFCNQW-UHFFFAOYSA-N diphenyl phosphite Chemical compound C=1C=CC=CC=1OP([O-])OC1=CC=CC=C1 KUMNEOGIHFCNQW-UHFFFAOYSA-N 0.000 claims description 2
- ZUNGGJHBMLMRFJ-UHFFFAOYSA-O ethoxy-hydroxy-oxophosphanium Chemical compound CCO[P+](O)=O ZUNGGJHBMLMRFJ-UHFFFAOYSA-O 0.000 claims description 2
- QXLBKTGZGPVJOO-UHFFFAOYSA-N hexyl dihydrogen phosphite Chemical compound CCCCCCOP(O)O QXLBKTGZGPVJOO-UHFFFAOYSA-N 0.000 claims description 2
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 claims description 2
- PRAHMDIEZMWIRW-UHFFFAOYSA-N propyl dihydrogen phosphite Chemical compound CCCOP(O)O PRAHMDIEZMWIRW-UHFFFAOYSA-N 0.000 claims description 2
- CYTQBVOFDCPGCX-UHFFFAOYSA-N trimethyl phosphite Chemical compound COP(OC)OC CYTQBVOFDCPGCX-UHFFFAOYSA-N 0.000 claims description 2
- HVLLSGMXQDNUAL-UHFFFAOYSA-N triphenyl phosphite Chemical compound C=1C=CC=CC=1OP(OC=1C=CC=CC=1)OC1=CC=CC=C1 HVLLSGMXQDNUAL-UHFFFAOYSA-N 0.000 claims description 2
- 206010047571 Visual impairment Diseases 0.000 abstract description 11
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 144
- 239000010408 film Substances 0.000 description 88
- 239000000243 solution Substances 0.000 description 68
- 239000000203 mixture Substances 0.000 description 45
- 150000004985 diamines Chemical class 0.000 description 37
- 150000002430 hydrocarbons Chemical group 0.000 description 37
- 238000003786 synthesis reaction Methods 0.000 description 36
- 230000015572 biosynthetic process Effects 0.000 description 34
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 33
- -1 phosphite ester compound Chemical class 0.000 description 31
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 30
- SWXVUIWOUIDPGS-UHFFFAOYSA-N diacetone alcohol Chemical compound CC(=O)CC(C)(C)O SWXVUIWOUIDPGS-UHFFFAOYSA-N 0.000 description 30
- 239000002904 solvent Substances 0.000 description 29
- ZFPGARUNNKGOBB-UHFFFAOYSA-N 1-Ethyl-2-pyrrolidinone Chemical compound CCN1CCCC1=O ZFPGARUNNKGOBB-UHFFFAOYSA-N 0.000 description 24
- GTDPSWPPOUPBNX-UHFFFAOYSA-N ac1mqpva Chemical compound CC12C(=O)OC(=O)C1(C)C1(C)C2(C)C(=O)OC1=O GTDPSWPPOUPBNX-UHFFFAOYSA-N 0.000 description 24
- 150000000000 tetracarboxylic acids Chemical group 0.000 description 24
- 230000000694 effects Effects 0.000 description 22
- 239000011248 coating agent Substances 0.000 description 20
- 238000000576 coating method Methods 0.000 description 20
- 210000002858 crystal cell Anatomy 0.000 description 20
- 239000010410 layer Substances 0.000 description 16
- RWNUSVWFHDHRCJ-UHFFFAOYSA-N 1-butoxypropan-2-ol Chemical compound CCCCOCC(C)O RWNUSVWFHDHRCJ-UHFFFAOYSA-N 0.000 description 15
- 239000007787 solid Substances 0.000 description 15
- 125000002723 alicyclic group Chemical group 0.000 description 14
- 230000000052 comparative effect Effects 0.000 description 14
- 239000000463 material Substances 0.000 description 12
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 11
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 11
- 125000006158 tetracarboxylic acid group Chemical group 0.000 description 11
- 238000010438 heat treatment Methods 0.000 description 10
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 9
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 239000002253 acid Substances 0.000 description 9
- 230000008569 process Effects 0.000 description 9
- 238000003756 stirring Methods 0.000 description 9
- AVQQQNCBBIEMEU-UHFFFAOYSA-N 1,1,3,3-tetramethylurea Chemical compound CN(C)C(=O)N(C)C AVQQQNCBBIEMEU-UHFFFAOYSA-N 0.000 description 8
- PTTPXKJBFFKCEK-UHFFFAOYSA-N 2-Methyl-4-heptanone Chemical compound CC(C)CC(=O)CC(C)C PTTPXKJBFFKCEK-UHFFFAOYSA-N 0.000 description 8
- NQBXSWAWVZHKBZ-UHFFFAOYSA-N 2-butoxyethyl acetate Chemical compound CCCCOCCOC(C)=O NQBXSWAWVZHKBZ-UHFFFAOYSA-N 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- UYAAVKFHBMJOJZ-UHFFFAOYSA-N diimidazo[1,3-b:1',3'-e]pyrazine-5,10-dione Chemical compound O=C1C2=CN=CN2C(=O)C2=CN=CN12 UYAAVKFHBMJOJZ-UHFFFAOYSA-N 0.000 description 8
- 239000003822 epoxy resin Substances 0.000 description 8
- BHXIWUJLHYHGSJ-UHFFFAOYSA-N ethyl 3-ethoxypropanoate Chemical compound CCOCCC(=O)OCC BHXIWUJLHYHGSJ-UHFFFAOYSA-N 0.000 description 8
- 229920000647 polyepoxide Polymers 0.000 description 8
- 229940116423 propylene glycol diacetate Drugs 0.000 description 8
- 125000006239 protecting group Chemical group 0.000 description 8
- 230000005855 radiation Effects 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- VATRWWPJWVCZTA-UHFFFAOYSA-N 3-oxo-n-[2-(trifluoromethyl)phenyl]butanamide Chemical compound CC(=O)CC(=O)NC1=CC=CC=C1C(F)(F)F VATRWWPJWVCZTA-UHFFFAOYSA-N 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 7
- 239000000565 sealant Substances 0.000 description 7
- RRQYJINTUHWNHW-UHFFFAOYSA-N 1-ethoxy-2-(2-ethoxyethoxy)ethane Chemical compound CCOCCOCCOCC RRQYJINTUHWNHW-UHFFFAOYSA-N 0.000 description 6
- YEBLAXBYYVCOLT-UHFFFAOYSA-N 2-hydroxy-n,n-dimethylpropanamide Chemical compound CC(O)C(=O)N(C)C YEBLAXBYYVCOLT-UHFFFAOYSA-N 0.000 description 6
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
- 244000126211 Hericium coralloides Species 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- 229910052581 Si3N4 Inorganic materials 0.000 description 6
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 6
- 229940019778 diethylene glycol diethyl ether Drugs 0.000 description 6
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical group C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 230000001678 irradiating effect Effects 0.000 description 6
- 230000014759 maintenance of location Effects 0.000 description 6
- YKOQQFDCCBKROY-UHFFFAOYSA-N n,n-diethylpropanamide Chemical compound CCN(CC)C(=O)CC YKOQQFDCCBKROY-UHFFFAOYSA-N 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- HQVNEWCFYHHQES-UHFFFAOYSA-N silicon nitride Chemical compound N12[Si]34N5[Si]62N3[Si]51N64 HQVNEWCFYHHQES-UHFFFAOYSA-N 0.000 description 6
- QCAHUFWKIQLBNB-UHFFFAOYSA-N 3-(3-methoxypropoxy)propan-1-ol Chemical compound COCCCOCCCO QCAHUFWKIQLBNB-UHFFFAOYSA-N 0.000 description 5
- 125000003545 alkoxy group Chemical group 0.000 description 5
- 125000002947 alkylene group Chemical group 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- 230000007774 longterm Effects 0.000 description 5
- 229920005575 poly(amic acid) Polymers 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- ARXJGSRGQADJSQ-UHFFFAOYSA-N 1-methoxypropan-2-ol Chemical compound COCC(C)O ARXJGSRGQADJSQ-UHFFFAOYSA-N 0.000 description 4
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 239000004372 Polyvinyl alcohol Substances 0.000 description 4
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical group C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 4
- 125000004018 acid anhydride group Chemical group 0.000 description 4
- 125000002015 acyclic group Chemical group 0.000 description 4
- 125000001931 aliphatic group Chemical group 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 235000010290 biphenyl Nutrition 0.000 description 4
- BGTOWKSIORTVQH-UHFFFAOYSA-N cyclopentanone Chemical compound O=C1CCCC1 BGTOWKSIORTVQH-UHFFFAOYSA-N 0.000 description 4
- 230000018044 dehydration Effects 0.000 description 4
- 238000006297 dehydration reaction Methods 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 4
- 229910052753 mercury Inorganic materials 0.000 description 4
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 4
- 125000001624 naphthyl group Chemical group 0.000 description 4
- 239000012299 nitrogen atmosphere Substances 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 239000009719 polyimide resin Substances 0.000 description 4
- 229920002451 polyvinyl alcohol Polymers 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- DJCYDDALXPHSHR-UHFFFAOYSA-N 2-(2-propoxyethoxy)ethanol Chemical compound CCCOCCOCCO DJCYDDALXPHSHR-UHFFFAOYSA-N 0.000 description 3
- UENRXLSRMCSUSN-UHFFFAOYSA-M 3,5-diaminobenzoate Chemical compound NC1=CC(N)=CC(C([O-])=O)=C1 UENRXLSRMCSUSN-UHFFFAOYSA-M 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 101000652482 Homo sapiens TBC1 domain family member 8 Proteins 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 238000005481 NMR spectroscopy Methods 0.000 description 3
- 239000004793 Polystyrene Substances 0.000 description 3
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 3
- 102100030302 TBC1 domain family member 8 Human genes 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 230000008033 biological extinction Effects 0.000 description 3
- 239000004305 biphenyl Substances 0.000 description 3
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical compound C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 description 3
- DKPFZGUDAPQIHT-UHFFFAOYSA-N butyl acetate Chemical compound CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 3
- 150000001721 carbon Chemical group 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 125000004093 cyano group Chemical group *C#N 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 3
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 3
- 230000005684 electric field Effects 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 230000001747 exhibiting effect Effects 0.000 description 3
- 238000005227 gel permeation chromatography Methods 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- IQPQWNKOIGAROB-UHFFFAOYSA-N isocyanate group Chemical group [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- 229920002223 polystyrene Polymers 0.000 description 3
- 238000007639 printing Methods 0.000 description 3
- 125000006850 spacer group Chemical group 0.000 description 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 3
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 3
- WYTZZXDRDKSJID-UHFFFAOYSA-N (3-aminopropyl)triethoxysilane Chemical compound CCO[Si](OCC)(OCC)CCCN WYTZZXDRDKSJID-UHFFFAOYSA-N 0.000 description 2
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 2
- CYSGHNMQYZDMIA-UHFFFAOYSA-N 1,3-Dimethyl-2-imidazolidinon Chemical compound CN1CCN(C)C1=O CYSGHNMQYZDMIA-UHFFFAOYSA-N 0.000 description 2
- 125000004972 1-butynyl group Chemical group [H]C([H])([H])C([H])([H])C#C* 0.000 description 2
- 125000000530 1-propynyl group Chemical group [H]C([H])([H])C#C* 0.000 description 2
- LDQMZKBIBRAZEA-UHFFFAOYSA-N 2,4-diaminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C(N)=C1 LDQMZKBIBRAZEA-UHFFFAOYSA-N 0.000 description 2
- FPZWZCWUIYYYBU-UHFFFAOYSA-N 2-(2-ethoxyethoxy)ethyl acetate Chemical compound CCOCCOCCOC(C)=O FPZWZCWUIYYYBU-UHFFFAOYSA-N 0.000 description 2
- SBASXUCJHJRPEV-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethanol Chemical compound COCCOCCO SBASXUCJHJRPEV-UHFFFAOYSA-N 0.000 description 2
- AOBIOSPNXBMOAT-UHFFFAOYSA-N 2-[2-(oxiran-2-ylmethoxy)ethoxymethyl]oxirane Chemical compound C1OC1COCCOCC1CO1 AOBIOSPNXBMOAT-UHFFFAOYSA-N 0.000 description 2
- CDAWCLOXVUBKRW-UHFFFAOYSA-N 2-aminophenol Chemical compound NC1=CC=CC=C1O CDAWCLOXVUBKRW-UHFFFAOYSA-N 0.000 description 2
- 125000000069 2-butynyl group Chemical group [H]C([H])([H])C#CC([H])([H])* 0.000 description 2
- SZNYYWIUQFZLLT-UHFFFAOYSA-N 2-methyl-1-(2-methylpropoxy)propane Chemical compound CC(C)COCC(C)C SZNYYWIUQFZLLT-UHFFFAOYSA-N 0.000 description 2
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 2
- LVYXPOCADCXMLP-UHFFFAOYSA-N 3-butoxy-n,n-dimethylpropanamide Chemical compound CCCCOCCC(=O)N(C)C LVYXPOCADCXMLP-UHFFFAOYSA-N 0.000 description 2
- 125000000474 3-butynyl group Chemical group [H]C#CC([H])([H])C([H])([H])* 0.000 description 2
- CPIVYSAVIPTCCX-UHFFFAOYSA-N 4-methylpentan-2-yl acetate Chemical compound CC(C)CC(C)OC(C)=O CPIVYSAVIPTCCX-UHFFFAOYSA-N 0.000 description 2
- QZHXKQKKEBXYRG-UHFFFAOYSA-N 4-n-(4-aminophenyl)benzene-1,4-diamine Chemical compound C1=CC(N)=CC=C1NC1=CC=C(N)C=C1 QZHXKQKKEBXYRG-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- VYQYKCAZJQOVJO-UHFFFAOYSA-N 9-ethylcarbazole-3,6-diamine Chemical compound NC1=CC=C2N(CC)C3=CC=C(N)C=C3C2=C1 VYQYKCAZJQOVJO-UHFFFAOYSA-N 0.000 description 2
- KPIAHQAOODFLBZ-UHFFFAOYSA-N 9-methylcarbazole-3,6-diamine Chemical compound NC1=CC=C2N(C)C3=CC=C(N)C=C3C2=C1 KPIAHQAOODFLBZ-UHFFFAOYSA-N 0.000 description 2
- NKSQIEJTEVJKKB-UHFFFAOYSA-N 9-phenylcarbazole-3,6-diamine Chemical compound C12=CC=C(N)C=C2C2=CC(N)=CC=C2N1C1=CC=CC=C1 NKSQIEJTEVJKKB-UHFFFAOYSA-N 0.000 description 2
- YCZUWQOJQGCZKG-UHFFFAOYSA-N 9h-carbazole-3,6-diamine Chemical compound C1=C(N)C=C2C3=CC(N)=CC=C3NC2=C1 YCZUWQOJQGCZKG-UHFFFAOYSA-N 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 2
- YYLLIJHXUHJATK-UHFFFAOYSA-N Cyclohexyl acetate Chemical compound CC(=O)OC1CCCCC1 YYLLIJHXUHJATK-UHFFFAOYSA-N 0.000 description 2
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 2
- HXQPUEQDBSPXTE-UHFFFAOYSA-N Diisobutylcarbinol Chemical compound CC(C)CC(O)CC(C)C HXQPUEQDBSPXTE-UHFFFAOYSA-N 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical group C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 2
- 239000004988 Nematic liquid crystal Substances 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- WDVSHHCDHLJJJR-UHFFFAOYSA-N Proflavine Chemical compound C1=CC(N)=CC2=NC3=CC(N)=CC=C3C=C21 WDVSHHCDHLJJJR-UHFFFAOYSA-N 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 125000005370 alkoxysilyl group Chemical group 0.000 description 2
- 125000005103 alkyl silyl group Chemical group 0.000 description 2
- ZOJBYZNEUISWFT-UHFFFAOYSA-N allyl isothiocyanate Chemical compound C=CCN=C=S ZOJBYZNEUISWFT-UHFFFAOYSA-N 0.000 description 2
- OYTKINVCDFNREN-UHFFFAOYSA-N amifampridine Chemical compound NC1=CC=NC=C1N OYTKINVCDFNREN-UHFFFAOYSA-N 0.000 description 2
- 229960004012 amifampridine Drugs 0.000 description 2
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- PXKLMJQFEQBVLD-UHFFFAOYSA-N bisphenol F Chemical compound C1=CC(O)=CC=C1CC1=CC=C(O)C=C1 PXKLMJQFEQBVLD-UHFFFAOYSA-N 0.000 description 2
- 239000002981 blocking agent Substances 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 125000004369 butenyl group Chemical group C(=CCC)* 0.000 description 2
- VHRGRCVQAFMJIZ-UHFFFAOYSA-N cadaverine Chemical compound NCCCCCN VHRGRCVQAFMJIZ-UHFFFAOYSA-N 0.000 description 2
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 2
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 229910052805 deuterium Inorganic materials 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- LZCLXQDLBQLTDK-UHFFFAOYSA-N ethyl 2-hydroxypropanoate Chemical compound CCOC(=O)C(C)O LZCLXQDLBQLTDK-UHFFFAOYSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- HBNYJWAFDZLWRS-UHFFFAOYSA-N ethyl isothiocyanate Chemical compound CCN=C=S HBNYJWAFDZLWRS-UHFFFAOYSA-N 0.000 description 2
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 description 2
- UPBDXRPQPOWRKR-UHFFFAOYSA-N furan-2,5-dione;methoxyethene Chemical compound COC=C.O=C1OC(=O)C=C1 UPBDXRPQPOWRKR-UHFFFAOYSA-N 0.000 description 2
- GAEKPEKOJKCEMS-UHFFFAOYSA-N gamma-valerolactone Chemical compound CC1CCC(=O)O1 GAEKPEKOJKCEMS-UHFFFAOYSA-N 0.000 description 2
- 125000005842 heteroatom Chemical group 0.000 description 2
- NAQMVNRVTILPCV-UHFFFAOYSA-N hexane-1,6-diamine Chemical compound NCCCCCCN NAQMVNRVTILPCV-UHFFFAOYSA-N 0.000 description 2
- 125000002883 imidazolyl group Chemical group 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
- 239000012948 isocyanate Substances 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229910001507 metal halide Inorganic materials 0.000 description 2
- 150000005309 metal halides Chemical class 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- BDJSOPWXYLFTNW-UHFFFAOYSA-N methyl 3-methoxypropanoate Chemical compound COCCC(=O)OC BDJSOPWXYLFTNW-UHFFFAOYSA-N 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000000018 nitroso group Chemical group N(=O)* 0.000 description 2
- 229920003986 novolac Polymers 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 125000003566 oxetanyl group Chemical group 0.000 description 2
- 125000006340 pentafluoro ethyl group Chemical group FC(F)(F)C(F)(F)* 0.000 description 2
- DPBLXKKOBLCELK-UHFFFAOYSA-N pentan-1-amine Chemical compound CCCCCN DPBLXKKOBLCELK-UHFFFAOYSA-N 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 description 2
- VHNQIURBCCNWDN-UHFFFAOYSA-N pyridine-2,6-diamine Chemical compound NC1=CC=CC(N)=N1 VHNQIURBCCNWDN-UHFFFAOYSA-N 0.000 description 2
- YAAWASYJIRZXSZ-UHFFFAOYSA-N pyrimidine-2,4-diamine Chemical compound NC1=CC=NC(N)=N1 YAAWASYJIRZXSZ-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 229910000077 silane Inorganic materials 0.000 description 2
- 150000004756 silanes Chemical class 0.000 description 2
- 125000005372 silanol group Chemical group 0.000 description 2
- 238000004528 spin coating Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 125000000213 sulfino group Chemical group [H]OS(*)=O 0.000 description 2
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 2
- JXUKBNICSRJFAP-UHFFFAOYSA-N triethoxy-[3-(oxiran-2-ylmethoxy)propyl]silane Chemical compound CCO[Si](OCC)(OCC)CCCOCC1CO1 JXUKBNICSRJFAP-UHFFFAOYSA-N 0.000 description 2
- XFNJVJPLKCPIBV-UHFFFAOYSA-N trimethylenediamine Chemical compound NCCCN XFNJVJPLKCPIBV-UHFFFAOYSA-N 0.000 description 2
- 229910052724 xenon Inorganic materials 0.000 description 2
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 2
- DDCJHFYXAPQYLA-UHFFFAOYSA-N (3-chlorophenyl)-phenylmethanol Chemical compound C=1C=CC(Cl)=CC=1C(O)C1=CC=CC=C1 DDCJHFYXAPQYLA-UHFFFAOYSA-N 0.000 description 1
- KNDQHSIWLOJIGP-UMRXKNAASA-N (3ar,4s,7r,7as)-rel-3a,4,7,7a-tetrahydro-4,7-methanoisobenzofuran-1,3-dione Chemical compound O=C1OC(=O)[C@@H]2[C@H]1[C@]1([H])C=C[C@@]2([H])C1 KNDQHSIWLOJIGP-UMRXKNAASA-N 0.000 description 1
- LTQBNYCMVZQRSD-UHFFFAOYSA-N (4-ethenylphenyl)-trimethoxysilane Chemical compound CO[Si](OC)(OC)C1=CC=C(C=C)C=C1 LTQBNYCMVZQRSD-UHFFFAOYSA-N 0.000 description 1
- LZDKZFUFMNSQCJ-UHFFFAOYSA-N 1,2-diethoxyethane Chemical compound CCOCCOCC LZDKZFUFMNSQCJ-UHFFFAOYSA-N 0.000 description 1
- LEEANUDEDHYDTG-UHFFFAOYSA-N 1,2-dimethoxypropane Chemical compound COCC(C)OC LEEANUDEDHYDTG-UHFFFAOYSA-N 0.000 description 1
- QWOVEJBDMKHZQK-UHFFFAOYSA-N 1,3,5-tris(3-trimethoxysilylpropyl)-1,3,5-triazinane-2,4,6-trione Chemical compound CO[Si](OC)(OC)CCCN1C(=O)N(CCC[Si](OC)(OC)OC)C(=O)N(CCC[Si](OC)(OC)OC)C1=O QWOVEJBDMKHZQK-UHFFFAOYSA-N 0.000 description 1
- YJTKZCDBKVTVBY-UHFFFAOYSA-N 1,3-Diphenylbenzene Chemical group C1=CC=CC=C1C1=CC=CC(C=2C=CC=CC=2)=C1 YJTKZCDBKVTVBY-UHFFFAOYSA-N 0.000 description 1
- RTTZISZSHSCFRH-UHFFFAOYSA-N 1,3-bis(isocyanatomethyl)benzene Chemical compound O=C=NCC1=CC=CC(CN=C=O)=C1 RTTZISZSHSCFRH-UHFFFAOYSA-N 0.000 description 1
- DQVRVXRIKVWXQH-UHFFFAOYSA-N 1,8-bis(oxiran-2-yl)-4,6-bis(oxiran-2-ylmethyl)octane-3,5-diol Chemical compound C1OC1CC(C(O)C(CCC1OC1)CC1OC1)C(O)CCC1CO1 DQVRVXRIKVWXQH-UHFFFAOYSA-N 0.000 description 1
- UWFRVQVNYNPBEF-UHFFFAOYSA-N 1-(2,4-dimethylphenyl)propan-1-one Chemical compound CCC(=O)C1=CC=C(C)C=C1C UWFRVQVNYNPBEF-UHFFFAOYSA-N 0.000 description 1
- GDXHBFHOEYVPED-UHFFFAOYSA-N 1-(2-butoxyethoxy)butane Chemical compound CCCCOCCOCCCC GDXHBFHOEYVPED-UHFFFAOYSA-N 0.000 description 1
- NPMRPDRLIHYOBW-UHFFFAOYSA-N 1-(2-butoxyethoxy)propan-2-ol Chemical compound CCCCOCCOCC(C)O NPMRPDRLIHYOBW-UHFFFAOYSA-N 0.000 description 1
- HUZSCDCNYLZCQH-UHFFFAOYSA-N 1-(2-ethoxyethyl)pyrrolidin-2-one Chemical compound CCOCCN1CCCC1=O HUZSCDCNYLZCQH-UHFFFAOYSA-N 0.000 description 1
- QWOZZTWBWQMEPD-UHFFFAOYSA-N 1-(2-ethoxypropoxy)propan-2-ol Chemical compound CCOC(C)COCC(C)O QWOZZTWBWQMEPD-UHFFFAOYSA-N 0.000 description 1
- OIKFIOGYFGWPAB-UHFFFAOYSA-N 1-(3-methoxypropyl)pyrrolidin-2-one Chemical compound COCCCN1CCCC1=O OIKFIOGYFGWPAB-UHFFFAOYSA-N 0.000 description 1
- BNXZHVUCNYMNOS-UHFFFAOYSA-N 1-butylpyrrolidin-2-one Chemical compound CCCCN1CCCC1=O BNXZHVUCNYMNOS-UHFFFAOYSA-N 0.000 description 1
- CNJRPYFBORAQAU-UHFFFAOYSA-N 1-ethoxy-2-(2-methoxyethoxy)ethane Chemical compound CCOCCOCCOC CNJRPYFBORAQAU-UHFFFAOYSA-N 0.000 description 1
- LIPRQQHINVWJCH-UHFFFAOYSA-N 1-ethoxypropan-2-yl acetate Chemical compound CCOCC(C)OC(C)=O LIPRQQHINVWJCH-UHFFFAOYSA-N 0.000 description 1
- ATLYKOUEGIGBCN-UHFFFAOYSA-N 1-ethylpyrrolidin-2-one 1-methylpyrrolidin-2-one Chemical compound C(C)N1C(CCC1)=O.CN1C(CCC1)=O ATLYKOUEGIGBCN-UHFFFAOYSA-N 0.000 description 1
- BMVXCPBXGZKUPN-UHFFFAOYSA-N 1-hexanamine Chemical compound CCCCCCN BMVXCPBXGZKUPN-UHFFFAOYSA-N 0.000 description 1
- BDQNKCYCTYYMAA-UHFFFAOYSA-N 1-isocyanatonaphthalene Chemical compound C1=CC=C2C(N=C=O)=CC=CC2=C1 BDQNKCYCTYYMAA-UHFFFAOYSA-N 0.000 description 1
- NNFAFRAQHBRBCQ-UHFFFAOYSA-N 1-pentylpyrrolidin-2-one Chemical compound CCCCCN1CCCC1=O NNFAFRAQHBRBCQ-UHFFFAOYSA-N 0.000 description 1
- GHELJWBGTIKZQW-UHFFFAOYSA-N 1-propan-2-ylpyrrolidin-2-one Chemical compound CC(C)N1CCCC1=O GHELJWBGTIKZQW-UHFFFAOYSA-N 0.000 description 1
- DCALJVULAGICIX-UHFFFAOYSA-N 1-propylpyrrolidin-2-one Chemical compound CCCN1CCCC1=O DCALJVULAGICIX-UHFFFAOYSA-N 0.000 description 1
- LUVQSCCABURXJL-UHFFFAOYSA-N 1-tert-butylpyrrolidin-2-one Chemical compound CC(C)(C)N1CCCC1=O LUVQSCCABURXJL-UHFFFAOYSA-N 0.000 description 1
- HXJZEGBVQCRLOD-UHFFFAOYSA-N 1-triethoxysilylpropan-2-amine Chemical compound CCO[Si](CC(C)N)(OCC)OCC HXJZEGBVQCRLOD-UHFFFAOYSA-N 0.000 description 1
- KBRVQAUYZUFKAJ-UHFFFAOYSA-N 1-trimethoxysilylpropan-2-amine Chemical compound CO[Si](OC)(OC)CC(C)N KBRVQAUYZUFKAJ-UHFFFAOYSA-N 0.000 description 1
- IVIDDMGBRCPGLJ-UHFFFAOYSA-N 2,3-bis(oxiran-2-ylmethoxy)propan-1-ol Chemical compound C1OC1COC(CO)COCC1CO1 IVIDDMGBRCPGLJ-UHFFFAOYSA-N 0.000 description 1
- UONVFNLDGRWLKF-UHFFFAOYSA-N 2,5-diaminobenzoic acid Chemical compound NC1=CC=C(N)C(C(O)=O)=C1 UONVFNLDGRWLKF-UHFFFAOYSA-N 0.000 description 1
- FDKIPLUTIFGOQS-UHFFFAOYSA-N 2,6-dimethylheptan-4-ol Chemical compound CC(C)CC(CC(C)C)O.C(C(C)C)C(O)CC(C)C FDKIPLUTIFGOQS-UHFFFAOYSA-N 0.000 description 1
- ACUGAGLDFIVSBR-UHFFFAOYSA-N 2,6-dimethylheptan-4-one Chemical compound CC(C)CC(=O)CC(C)C.CC(C)CC(=O)CC(C)C ACUGAGLDFIVSBR-UHFFFAOYSA-N 0.000 description 1
- VXQBJTKSVGFQOL-UHFFFAOYSA-N 2-(2-butoxyethoxy)ethyl acetate Chemical compound CCCCOCCOCCOC(C)=O VXQBJTKSVGFQOL-UHFFFAOYSA-N 0.000 description 1
- XGSQEQCOQAAOHE-UHFFFAOYSA-N 2-(2-butoxyethoxy)propan-1-ol Chemical compound CCCCOCCOC(C)CO XGSQEQCOQAAOHE-UHFFFAOYSA-N 0.000 description 1
- NCHBYORVPVDWBJ-UHFFFAOYSA-N 2-(3-methylbutoxy)ethanol Chemical compound CC(C)CCOCCO NCHBYORVPVDWBJ-UHFFFAOYSA-N 0.000 description 1
- KKKKCPPTESQGQH-UHFFFAOYSA-N 2-(4,5-dihydro-1,3-oxazol-2-yl)-4,5-dihydro-1,3-oxazole Chemical compound O1CCN=C1C1=NCCO1 KKKKCPPTESQGQH-UHFFFAOYSA-N 0.000 description 1
- HQLKZWRSOHTERR-UHFFFAOYSA-N 2-Ethylbutyl acetate Chemical compound CCC(CC)COC(C)=O HQLKZWRSOHTERR-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- HDPLHDGYGLENEI-UHFFFAOYSA-N 2-[1-(oxiran-2-ylmethoxy)propan-2-yloxymethyl]oxirane Chemical compound C1OC1COC(C)COCC1CO1 HDPLHDGYGLENEI-UHFFFAOYSA-N 0.000 description 1
- FVCHRIQAIOHAIC-UHFFFAOYSA-N 2-[1-[1-[1-(oxiran-2-ylmethoxy)propan-2-yloxy]propan-2-yloxy]propan-2-yloxymethyl]oxirane Chemical compound C1OC1COC(C)COC(C)COC(C)COCC1CO1 FVCHRIQAIOHAIC-UHFFFAOYSA-N 0.000 description 1
- GKSXCJNGSBANFA-UHFFFAOYSA-N 2-[2,5-bis(4,5-dihydro-1,3-oxazol-2-yl)phenyl]-4,5-dihydro-1,3-oxazole Chemical compound O1CCN=C1C(C=C1C=2OCCN=2)=CC=C1C1=NCCO1 GKSXCJNGSBANFA-UHFFFAOYSA-N 0.000 description 1
- WTYYGFLRBWMFRY-UHFFFAOYSA-N 2-[6-(oxiran-2-ylmethoxy)hexoxymethyl]oxirane Chemical compound C1OC1COCCCCCCOCC1CO1 WTYYGFLRBWMFRY-UHFFFAOYSA-N 0.000 description 1
- PRJQBLZFLQSJOM-UHFFFAOYSA-N 2-[[1,3-dibromo-2,2-dimethyl-3-(oxiran-2-ylmethoxy)propoxy]methyl]oxirane Chemical compound C(C1CO1)OC(C(C)(C(OCC1CO1)Br)C)Br PRJQBLZFLQSJOM-UHFFFAOYSA-N 0.000 description 1
- KUAUJXBLDYVELT-UHFFFAOYSA-N 2-[[2,2-dimethyl-3-(oxiran-2-ylmethoxy)propoxy]methyl]oxirane Chemical compound C1OC1COCC(C)(C)COCC1CO1 KUAUJXBLDYVELT-UHFFFAOYSA-N 0.000 description 1
- PLDLPVSQYMQDBL-UHFFFAOYSA-N 2-[[3-(oxiran-2-ylmethoxy)-2,2-bis(oxiran-2-ylmethoxymethyl)propoxy]methyl]oxirane Chemical compound C1OC1COCC(COCC1OC1)(COCC1OC1)COCC1CO1 PLDLPVSQYMQDBL-UHFFFAOYSA-N 0.000 description 1
- JTXMVXSTHSMVQF-UHFFFAOYSA-N 2-acetyloxyethyl acetate Chemical compound CC(=O)OCCOC(C)=O JTXMVXSTHSMVQF-UHFFFAOYSA-N 0.000 description 1
- YYHRJJWMKQMOFN-UHFFFAOYSA-N 2-amino-4-(3-amino-4-carboxyphenyl)benzoic acid Chemical compound C1=C(C(O)=O)C(N)=CC(C=2C=C(N)C(C(O)=O)=CC=2)=C1 YYHRJJWMKQMOFN-UHFFFAOYSA-N 0.000 description 1
- IIQLVLWFQUUZII-UHFFFAOYSA-N 2-amino-5-(4-amino-3-carboxyphenyl)benzoic acid Chemical compound C1=C(C(O)=O)C(N)=CC=C1C1=CC=C(N)C(C(O)=O)=C1 IIQLVLWFQUUZII-UHFFFAOYSA-N 0.000 description 1
- DITSSQRHPQIAGL-UHFFFAOYSA-N 2-amino-5-(4-aminophenyl)benzoic acid Chemical compound C1=CC(N)=CC=C1C1=CC=C(N)C(C(O)=O)=C1 DITSSQRHPQIAGL-UHFFFAOYSA-N 0.000 description 1
- QZZNDWGCUFSPKQ-UHFFFAOYSA-N 2-amino-6-(3-amino-4-carboxyphenyl)benzoic acid Chemical compound C1=C(C(O)=O)C(N)=CC(C=2C(=C(N)C=CC=2)C(O)=O)=C1 QZZNDWGCUFSPKQ-UHFFFAOYSA-N 0.000 description 1
- UZSDRHVOBLQYCX-UHFFFAOYSA-N 2-amino-6-hydroxybenzoic acid Chemical compound NC1=CC=CC(O)=C1C(O)=O UZSDRHVOBLQYCX-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- WOYWLLHHWAMFCB-UHFFFAOYSA-N 2-ethylhexyl acetate Chemical compound CCCCC(CC)COC(C)=O WOYWLLHHWAMFCB-UHFFFAOYSA-N 0.000 description 1
- UPGSWASWQBLSKZ-UHFFFAOYSA-N 2-hexoxyethanol Chemical compound CCCCCCOCCO UPGSWASWQBLSKZ-UHFFFAOYSA-N 0.000 description 1
- DPNXHTDWGGVXID-UHFFFAOYSA-N 2-isocyanatoethyl prop-2-enoate Chemical compound C=CC(=O)OCCN=C=O DPNXHTDWGGVXID-UHFFFAOYSA-N 0.000 description 1
- CRWNQZTZTZWPOF-UHFFFAOYSA-N 2-methyl-4-phenylpyridine Chemical compound C1=NC(C)=CC(C=2C=CC=CC=2)=C1 CRWNQZTZTZWPOF-UHFFFAOYSA-N 0.000 description 1
- QTWJRLJHJPIABL-UHFFFAOYSA-N 2-methylphenol;3-methylphenol;4-methylphenol Chemical compound CC1=CC=C(O)C=C1.CC1=CC=CC(O)=C1.CC1=CC=CC=C1O QTWJRLJHJPIABL-UHFFFAOYSA-N 0.000 description 1
- HHCHLHOEAKKCAB-UHFFFAOYSA-N 2-oxaspiro[3.5]nonane-1,3-dione Chemical compound O=C1OC(=O)C11CCCCC1 HHCHLHOEAKKCAB-UHFFFAOYSA-N 0.000 description 1
- 125000003504 2-oxazolinyl group Chemical group O1C(=NCC1)* 0.000 description 1
- YEYKMVJDLWJFOA-UHFFFAOYSA-N 2-propoxyethanol Chemical compound CCCOCCO YEYKMVJDLWJFOA-UHFFFAOYSA-N 0.000 description 1
- UENRXLSRMCSUSN-UHFFFAOYSA-N 3,5-diaminobenzoic acid Chemical compound NC1=CC(N)=CC(C(O)=O)=C1 UENRXLSRMCSUSN-UHFFFAOYSA-N 0.000 description 1
- AJHPGXZOIAYYDW-UHFFFAOYSA-N 3-(2-cyanophenyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid Chemical compound CC(C)(C)OC(=O)NC(C(O)=O)CC1=CC=CC=C1C#N AJHPGXZOIAYYDW-UHFFFAOYSA-N 0.000 description 1
- LXJLFVRAWOOQDR-UHFFFAOYSA-N 3-(3-aminophenoxy)aniline Chemical compound NC1=CC=CC(OC=2C=C(N)C=CC=2)=C1 LXJLFVRAWOOQDR-UHFFFAOYSA-N 0.000 description 1
- ZBMISJGHVWNWTE-UHFFFAOYSA-N 3-(4-aminophenoxy)aniline Chemical compound C1=CC(N)=CC=C1OC1=CC=CC(N)=C1 ZBMISJGHVWNWTE-UHFFFAOYSA-N 0.000 description 1
- GDGWSSXWLLHGGV-UHFFFAOYSA-N 3-(4-aminophenyl)-1,1,3-trimethyl-2h-inden-5-amine Chemical compound C12=CC(N)=CC=C2C(C)(C)CC1(C)C1=CC=C(N)C=C1 GDGWSSXWLLHGGV-UHFFFAOYSA-N 0.000 description 1
- CKOFBUUFHALZGK-UHFFFAOYSA-N 3-[(3-aminophenyl)methyl]aniline Chemical compound NC1=CC=CC(CC=2C=C(N)C=CC=2)=C1 CKOFBUUFHALZGK-UHFFFAOYSA-N 0.000 description 1
- FGWQCROGAHMWSU-UHFFFAOYSA-N 3-[(4-aminophenyl)methyl]aniline Chemical compound C1=CC(N)=CC=C1CC1=CC=CC(N)=C1 FGWQCROGAHMWSU-UHFFFAOYSA-N 0.000 description 1
- GPXCORHXFPYJEH-UHFFFAOYSA-N 3-[[3-aminopropyl(dimethyl)silyl]oxy-dimethylsilyl]propan-1-amine Chemical compound NCCC[Si](C)(C)O[Si](C)(C)CCCN GPXCORHXFPYJEH-UHFFFAOYSA-N 0.000 description 1
- HXLAEGYMDGUSBD-UHFFFAOYSA-N 3-[diethoxy(methyl)silyl]propan-1-amine Chemical compound CCO[Si](C)(OCC)CCCN HXLAEGYMDGUSBD-UHFFFAOYSA-N 0.000 description 1
- DOYKFSOCSXVQAN-UHFFFAOYSA-N 3-[diethoxy(methyl)silyl]propyl 2-methylprop-2-enoate Chemical compound CCO[Si](C)(OCC)CCCOC(=O)C(C)=C DOYKFSOCSXVQAN-UHFFFAOYSA-N 0.000 description 1
- IKYAJDOSWUATPI-UHFFFAOYSA-N 3-[dimethoxy(methyl)silyl]propane-1-thiol Chemical compound CO[Si](C)(OC)CCCS IKYAJDOSWUATPI-UHFFFAOYSA-N 0.000 description 1
- LZMNXXQIQIHFGC-UHFFFAOYSA-N 3-[dimethoxy(methyl)silyl]propyl 2-methylprop-2-enoate Chemical compound CO[Si](C)(OC)CCCOC(=O)C(C)=C LZMNXXQIQIHFGC-UHFFFAOYSA-N 0.000 description 1
- CWLKGDAVCFYWJK-UHFFFAOYSA-N 3-aminophenol Chemical compound NC1=CC=CC(O)=C1 CWLKGDAVCFYWJK-UHFFFAOYSA-N 0.000 description 1
- 229940018563 3-aminophenol Drugs 0.000 description 1
- GALUFHRFAYTRDG-UHFFFAOYSA-N 3-ethoxybutyl acetate Chemical compound CCOC(C)CCOC(C)=O GALUFHRFAYTRDG-UHFFFAOYSA-N 0.000 description 1
- LBVMWHCOFMFPEG-UHFFFAOYSA-N 3-methoxy-n,n-dimethylpropanamide Chemical compound COCCC(=O)N(C)C LBVMWHCOFMFPEG-UHFFFAOYSA-N 0.000 description 1
- CRORGGSWAKIXSA-UHFFFAOYSA-N 3-methylbutyl 2-hydroxypropanoate Chemical compound CC(C)CCOC(=O)C(C)O CRORGGSWAKIXSA-UHFFFAOYSA-N 0.000 description 1
- OFNISBHGPNMTMS-UHFFFAOYSA-N 3-methylideneoxolane-2,5-dione Chemical compound C=C1CC(=O)OC1=O OFNISBHGPNMTMS-UHFFFAOYSA-N 0.000 description 1
- RAMLHCQVJWEUAO-UHFFFAOYSA-N 3-phenylpyrrole-2,5-dione;styrene Chemical class C=CC1=CC=CC=C1.O=C1NC(=O)C(C=2C=CC=CC=2)=C1 RAMLHCQVJWEUAO-UHFFFAOYSA-N 0.000 description 1
- URDOJQUSEUXVRP-UHFFFAOYSA-N 3-triethoxysilylpropyl 2-methylprop-2-enoate Chemical compound CCO[Si](OCC)(OCC)CCCOC(=O)C(C)=C URDOJQUSEUXVRP-UHFFFAOYSA-N 0.000 description 1
- LVNLBBGBASVLLI-UHFFFAOYSA-N 3-triethoxysilylpropylurea Chemical compound CCO[Si](OCC)(OCC)CCCNC(N)=O LVNLBBGBASVLLI-UHFFFAOYSA-N 0.000 description 1
- SJECZPVISLOESU-UHFFFAOYSA-N 3-trimethoxysilylpropan-1-amine Chemical compound CO[Si](OC)(OC)CCCN SJECZPVISLOESU-UHFFFAOYSA-N 0.000 description 1
- UUEWCQRISZBELL-UHFFFAOYSA-N 3-trimethoxysilylpropane-1-thiol Chemical compound CO[Si](OC)(OC)CCCS UUEWCQRISZBELL-UHFFFAOYSA-N 0.000 description 1
- XDLMVUHYZWKMMD-UHFFFAOYSA-N 3-trimethoxysilylpropyl 2-methylprop-2-enoate Chemical compound CO[Si](OC)(OC)CCCOC(=O)C(C)=C XDLMVUHYZWKMMD-UHFFFAOYSA-N 0.000 description 1
- KBQVDAIIQCXKPI-UHFFFAOYSA-N 3-trimethoxysilylpropyl prop-2-enoate Chemical compound CO[Si](OC)(OC)CCCOC(=O)C=C KBQVDAIIQCXKPI-UHFFFAOYSA-N 0.000 description 1
- LVACOMKKELLCHJ-UHFFFAOYSA-N 3-trimethoxysilylpropylurea Chemical compound CO[Si](OC)(OC)CCCNC(N)=O LVACOMKKELLCHJ-UHFFFAOYSA-N 0.000 description 1
- KQIKKETXZQDHGE-FOCLMDBBSA-N 4,4'-diaminoazobenzene Chemical compound C1=CC(N)=CC=C1\N=N\C1=CC=C(N)C=C1 KQIKKETXZQDHGE-FOCLMDBBSA-N 0.000 description 1
- YBRVSVVVWCFQMG-UHFFFAOYSA-N 4,4'-diaminodiphenylmethane Chemical compound C1=CC(N)=CC=C1CC1=CC=C(N)C=C1 YBRVSVVVWCFQMG-UHFFFAOYSA-N 0.000 description 1
- BJDDKZDZTHIIJB-UHFFFAOYSA-N 4,5,6,7-tetrafluoro-2-benzofuran-1,3-dione Chemical compound FC1=C(F)C(F)=C2C(=O)OC(=O)C2=C1F BJDDKZDZTHIIJB-UHFFFAOYSA-N 0.000 description 1
- LNPMZQXEPNWCMG-UHFFFAOYSA-N 4-(2-aminoethyl)aniline Chemical compound NCCC1=CC=C(N)C=C1 LNPMZQXEPNWCMG-UHFFFAOYSA-N 0.000 description 1
- HLBLWEWZXPIGSM-UHFFFAOYSA-N 4-Aminophenyl ether Chemical compound C1=CC(N)=CC=C1OC1=CC=C(N)C=C1 HLBLWEWZXPIGSM-UHFFFAOYSA-N 0.000 description 1
- DZIHTWJGPDVSGE-UHFFFAOYSA-N 4-[(4-aminocyclohexyl)methyl]cyclohexan-1-amine Chemical compound C1CC(N)CCC1CC1CCC(N)CC1 DZIHTWJGPDVSGE-UHFFFAOYSA-N 0.000 description 1
- BGQWVIOOEFRPOV-UHFFFAOYSA-N 4-[1,1,1,3,3,3-hexafluoro-2-[4-hydroxy-3,5-bis(hydroxymethyl)phenyl]propan-2-yl]-2,6-bis(hydroxymethyl)phenol Chemical compound OCC1=C(O)C(CO)=CC(C(C=2C=C(CO)C(O)=C(CO)C=2)(C(F)(F)F)C(F)(F)F)=C1 BGQWVIOOEFRPOV-UHFFFAOYSA-N 0.000 description 1
- XHOBGNWYEBMMDN-UHFFFAOYSA-N 4-[2-(4-hydroxy-3,5-dimethoxyphenyl)propan-2-yl]-2,6-dimethoxyphenol Chemical compound COC1=C(O)C(OC)=CC(C(C)(C)C=2C=C(OC)C(O)=C(OC)C=2)=C1 XHOBGNWYEBMMDN-UHFFFAOYSA-N 0.000 description 1
- NNIPOYNUFNLQMO-UHFFFAOYSA-N 4-[2-(methylamino)ethyl]aniline Chemical compound CNCCC1=CC=C(N)C=C1 NNIPOYNUFNLQMO-UHFFFAOYSA-N 0.000 description 1
- ZRIRUWWYQXWRNY-UHFFFAOYSA-N 4-[2-[4-hydroxy-3,5-bis(hydroxymethyl)phenyl]propan-2-yl]-2,6-bis(hydroxymethyl)phenol Chemical compound C=1C(CO)=C(O)C(CO)=CC=1C(C)(C)C1=CC(CO)=C(O)C(CO)=C1 ZRIRUWWYQXWRNY-UHFFFAOYSA-N 0.000 description 1
- FAUAZXVRLVIARB-UHFFFAOYSA-N 4-[[4-[bis(oxiran-2-ylmethyl)amino]phenyl]methyl]-n,n-bis(oxiran-2-ylmethyl)aniline Chemical compound C1OC1CN(C=1C=CC(CC=2C=CC(=CC=2)N(CC2OC2)CC2OC2)=CC=1)CC1CO1 FAUAZXVRLVIARB-UHFFFAOYSA-N 0.000 description 1
- ALYNCZNDIQEVRV-PZFLKRBQSA-N 4-amino-3,5-ditritiobenzoic acid Chemical compound [3H]c1cc(cc([3H])c1N)C(O)=O ALYNCZNDIQEVRV-PZFLKRBQSA-N 0.000 description 1
- WUBBRNOQWQTFEX-UHFFFAOYSA-N 4-aminosalicylic acid Chemical compound NC1=CC=C(C(O)=O)C(O)=C1 WUBBRNOQWQTFEX-UHFFFAOYSA-N 0.000 description 1
- CCTOEAMRIIXGDJ-UHFFFAOYSA-N 4-hydroxy-2-benzofuran-1,3-dione Chemical compound OC1=CC=CC2=C1C(=O)OC2=O CCTOEAMRIIXGDJ-UHFFFAOYSA-N 0.000 description 1
- IFIUFEBEPGGBIJ-UHFFFAOYSA-N 4-methyl-4,5-dihydro-1,3-oxazole Chemical compound CC1COC=N1 IFIUFEBEPGGBIJ-UHFFFAOYSA-N 0.000 description 1
- DFEDSGSDEJKKGH-UHFFFAOYSA-N 4-n-[4-(4-amino-n-methylanilino)phenyl]-4-n-methylbenzene-1,4-diamine Chemical compound C=1C=C(N(C)C=2C=CC(N)=CC=2)C=CC=1N(C)C1=CC=C(N)C=C1 DFEDSGSDEJKKGH-UHFFFAOYSA-N 0.000 description 1
- UHIXFUMVHZAVGP-UHFFFAOYSA-N 4-n-[4-[4-(4-amino-n-methylanilino)phenyl]phenyl]-4-n-methylbenzene-1,4-diamine Chemical compound C=1C=C(C=2C=CC(=CC=2)N(C)C=2C=CC(N)=CC=2)C=CC=1N(C)C1=CC=C(N)C=C1 UHIXFUMVHZAVGP-UHFFFAOYSA-N 0.000 description 1
- QPDNZLWPWXPPIO-UHFFFAOYSA-N 4-n-[4-[4-(4-aminoanilino)phenyl]phenyl]benzene-1,4-diamine Chemical compound C1=CC(N)=CC=C1NC1=CC=C(C=2C=CC(NC=3C=CC(N)=CC=3)=CC=2)C=C1 QPDNZLWPWXPPIO-UHFFFAOYSA-N 0.000 description 1
- MKHDOBRSMHTMOK-UHFFFAOYSA-N 5-amino-2-(4-amino-2-carboxyphenyl)benzoic acid Chemical compound OC(=O)C1=CC(N)=CC=C1C1=CC=C(N)C=C1C(O)=O MKHDOBRSMHTMOK-UHFFFAOYSA-N 0.000 description 1
- CIIILUMBZOGKDF-UHFFFAOYSA-N 5-methyl-4,5-dihydro-1,3-oxazole Chemical compound CC1CN=CO1 CIIILUMBZOGKDF-UHFFFAOYSA-N 0.000 description 1
- LPEKGGXMPWTOCB-UHFFFAOYSA-N 8beta-(2,3-epoxy-2-methylbutyryloxy)-14-acetoxytithifolin Natural products COC(=O)C(C)O LPEKGGXMPWTOCB-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- MRABAEUHTLLEML-UHFFFAOYSA-N Butyl lactate Chemical compound CCCCOC(=O)C(C)O MRABAEUHTLLEML-UHFFFAOYSA-N 0.000 description 1
- LHDINEQYSPQRAP-UHFFFAOYSA-N C1=CC(=CC=C1N)OCCOC2=CC3=C(C=C2)C=C(C=C3)N Chemical compound C1=CC(=CC=C1N)OCCOC2=CC3=C(C=C2)C=C(C=C3)N LHDINEQYSPQRAP-UHFFFAOYSA-N 0.000 description 1
- SMEXSXVUSJNAEP-UHFFFAOYSA-N C1=CC2=C(C=CC(=C2)OCCOC3=CC4=C(C=C3)C=C(C=C4)N)C=C1N Chemical compound C1=CC2=C(C=CC(=C2)OCCOC3=CC4=C(C=C3)C=C(C=C4)N)C=C1N SMEXSXVUSJNAEP-UHFFFAOYSA-N 0.000 description 1
- HLUOZTYRNHMSON-UHFFFAOYSA-N COCCCCN1C(CCC1)=O Chemical compound COCCCCN1C(CCC1)=O HLUOZTYRNHMSON-UHFFFAOYSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- KMTRUDSVKNLOMY-UHFFFAOYSA-N Ethylene carbonate Chemical compound O=C1OCCO1 KMTRUDSVKNLOMY-UHFFFAOYSA-N 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical group C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- WJYIASZWHGOTOU-UHFFFAOYSA-N Heptylamine Chemical compound CCCCCCCN WJYIASZWHGOTOU-UHFFFAOYSA-N 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical group C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 1
- SUAKHGWARZSWIH-UHFFFAOYSA-N N,N‐diethylformamide Chemical compound CCN(CC)C=O SUAKHGWARZSWIH-UHFFFAOYSA-N 0.000 description 1
- SOHYYBJEJPWFPV-UHFFFAOYSA-N NC1=CC=C(C=C(CCC(C=CC2=C3)=CC2=CC=C3N)C=C2)C2=C1 Chemical compound NC1=CC=C(C=C(CCC(C=CC2=C3)=CC2=CC=C3N)C=C2)C2=C1 SOHYYBJEJPWFPV-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- LGRFSURHDFAFJT-UHFFFAOYSA-N Phthalic anhydride Natural products C1=CC=C2C(=O)OC(=O)C2=C1 LGRFSURHDFAFJT-UHFFFAOYSA-N 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920002396 Polyurea Polymers 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 239000004990 Smectic liquid crystal Substances 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical group C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical group C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- PWKVNRUSXHSJMJ-VLAKUBLNSA-N [(8s,9s,10r,13r,14s,17r)-6-(4-aminobenzoyl)oxy-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl] 4-aminobenzoate Chemical compound C([C@H]1[C@@H]2CC[C@@H]([C@]2(CC[C@@H]1[C@@]1(C)CCC(CC11)OC(=O)C=2C=CC(N)=CC=2)C)[C@H](C)CCCC(C)C)C1OC(=O)C1=CC=C(N)C=C1 PWKVNRUSXHSJMJ-VLAKUBLNSA-N 0.000 description 1
- QLBRROYTTDFLDX-UHFFFAOYSA-N [3-(aminomethyl)cyclohexyl]methanamine Chemical compound NCC1CCCC(CN)C1 QLBRROYTTDFLDX-UHFFFAOYSA-N 0.000 description 1
- FDLQZKYLHJJBHD-UHFFFAOYSA-N [3-(aminomethyl)phenyl]methanamine Chemical compound NCC1=CC=CC(CN)=C1 FDLQZKYLHJJBHD-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- HFBMWMNUJJDEQZ-UHFFFAOYSA-N acryloyl chloride Chemical compound ClC(=O)C=C HFBMWMNUJJDEQZ-UHFFFAOYSA-N 0.000 description 1
- 125000003647 acryloyl group Chemical group O=C([*])C([H])=C([H])[H] 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 125000004450 alkenylene group Chemical group 0.000 description 1
- 125000004419 alkynylene group Chemical group 0.000 description 1
- 235000016720 allyl isothiocyanate Nutrition 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229960004909 aminosalicylic acid Drugs 0.000 description 1
- 125000005577 anthracene group Chemical group 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 150000004984 aromatic diamines Chemical class 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 150000004074 biphenyls Chemical class 0.000 description 1
- ZLSMCQSGRWNEGX-UHFFFAOYSA-N bis(4-aminophenyl)methanone Chemical compound C1=CC(N)=CC=C1C(=O)C1=CC=C(N)C=C1 ZLSMCQSGRWNEGX-UHFFFAOYSA-N 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 1
- JHIWVOJDXOSYLW-UHFFFAOYSA-N butyl 2,2-difluorocyclopropane-1-carboxylate Chemical compound CCCCOC(=O)C1CC1(F)F JHIWVOJDXOSYLW-UHFFFAOYSA-N 0.000 description 1
- RRIRSNXZGJWTQM-UHFFFAOYSA-N butyl 3-methoxypropanoate Chemical compound CCCCOC(=O)CCOC RRIRSNXZGJWTQM-UHFFFAOYSA-N 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 238000005229 chemical vapour deposition Methods 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 230000003098 cholesteric effect Effects 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 229930003836 cresol Natural products 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 150000001924 cycloalkanes Chemical class 0.000 description 1
- 150000001925 cycloalkenes Chemical class 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- VKIRRGRTJUUZHS-UHFFFAOYSA-N cyclohexane-1,4-diamine Chemical compound NC1CCC(N)CC1 VKIRRGRTJUUZHS-UHFFFAOYSA-N 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000004956 cyclohexylene group Chemical group 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 125000006159 dianhydride group Chemical group 0.000 description 1
- OTARVPUIYXHRRB-UHFFFAOYSA-N diethoxy-methyl-[3-(oxiran-2-ylmethoxy)propyl]silane Chemical compound CCO[Si](C)(OCC)CCCOCC1CO1 OTARVPUIYXHRRB-UHFFFAOYSA-N 0.000 description 1
- UBPGILLNMDGSDS-UHFFFAOYSA-N diethylene glycol diacetate Chemical compound CC(=O)OCCOCCOC(C)=O UBPGILLNMDGSDS-UHFFFAOYSA-N 0.000 description 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
- WHGNXNCOTZPEEK-UHFFFAOYSA-N dimethoxy-methyl-[3-(oxiran-2-ylmethoxy)propyl]silane Chemical compound CO[Si](C)(OC)CCCOCC1CO1 WHGNXNCOTZPEEK-UHFFFAOYSA-N 0.000 description 1
- DMBHHRLKUKUOEG-UHFFFAOYSA-N diphenylamine Chemical group C=1C=CC=CC=1NC1=CC=CC=C1 DMBHHRLKUKUOEG-UHFFFAOYSA-N 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- ODQWQRRAPPTVAG-GZTJUZNOSA-N doxepin Chemical compound C1OC2=CC=CC=C2C(=C/CCN(C)C)/C2=CC=CC=C21 ODQWQRRAPPTVAG-GZTJUZNOSA-N 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- FWDBOZPQNFPOLF-UHFFFAOYSA-N ethenyl(triethoxy)silane Chemical compound CCO[Si](OCC)(OCC)C=C FWDBOZPQNFPOLF-UHFFFAOYSA-N 0.000 description 1
- NKSJNEHGWDZZQF-UHFFFAOYSA-N ethenyl(trimethoxy)silane Chemical compound CO[Si](OC)(OC)C=C NKSJNEHGWDZZQF-UHFFFAOYSA-N 0.000 description 1
- 125000001033 ether group Chemical group 0.000 description 1
- IJUHLFUALMUWOM-UHFFFAOYSA-N ethyl 3-methoxypropanoate Chemical compound CCOC(=O)CCOC IJUHLFUALMUWOM-UHFFFAOYSA-N 0.000 description 1
- WUDNUHPRLBTKOJ-UHFFFAOYSA-N ethyl isocyanate Chemical compound CCN=C=O WUDNUHPRLBTKOJ-UHFFFAOYSA-N 0.000 description 1
- 229940116333 ethyl lactate Drugs 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 125000002795 guanidino group Chemical group C(N)(=N)N* 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- IIRDTKBZINWQAW-UHFFFAOYSA-N hexaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCO IIRDTKBZINWQAW-UHFFFAOYSA-N 0.000 description 1
- RXTNIJMLAQNTEG-UHFFFAOYSA-N hexan-2-yl acetate Chemical compound CCCCC(C)OC(C)=O RXTNIJMLAQNTEG-UHFFFAOYSA-N 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 229960002885 histidine Drugs 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 150000003949 imides Chemical group 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 239000011229 interlayer Substances 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- ZLTPDFXIESTBQG-UHFFFAOYSA-N isothiazole Chemical group C=1C=NSC=1 ZLTPDFXIESTBQG-UHFFFAOYSA-N 0.000 description 1
- ZBKFYXZXZJPWNQ-UHFFFAOYSA-N isothiocyanate group Chemical group [N-]=C=S ZBKFYXZXZJPWNQ-UHFFFAOYSA-N 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 239000008204 material by function Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- VSQYNPJPULBZKU-UHFFFAOYSA-N mercury xenon Chemical compound [Xe].[Hg] VSQYNPJPULBZKU-UHFFFAOYSA-N 0.000 description 1
- KBOPZPXVLCULAV-UHFFFAOYSA-N mesalamine Chemical compound NC1=CC=C(O)C(C(O)=O)=C1 KBOPZPXVLCULAV-UHFFFAOYSA-N 0.000 description 1
- 229960004963 mesalazine Drugs 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M methacrylate group Chemical group C(C(=C)C)(=O)[O-] CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- VHRYZQNGTZXDNX-UHFFFAOYSA-N methacryloyl chloride Chemical compound CC(=C)C(Cl)=O VHRYZQNGTZXDNX-UHFFFAOYSA-N 0.000 description 1
- RBQRWNWVPQDTJJ-UHFFFAOYSA-N methacryloyloxyethyl isocyanate Chemical compound CC(=C)C(=O)OCCN=C=O RBQRWNWVPQDTJJ-UHFFFAOYSA-N 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 229940057867 methyl lactate Drugs 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- PHQOGHDTIVQXHL-UHFFFAOYSA-N n'-(3-trimethoxysilylpropyl)ethane-1,2-diamine Chemical compound CO[Si](OC)(OC)CCCNCCN PHQOGHDTIVQXHL-UHFFFAOYSA-N 0.000 description 1
- MQWFLKHKWJMCEN-UHFFFAOYSA-N n'-[3-[dimethoxy(methyl)silyl]propyl]ethane-1,2-diamine Chemical compound CO[Si](C)(OC)CCCNCCN MQWFLKHKWJMCEN-UHFFFAOYSA-N 0.000 description 1
- OKRNLSUTBJUVKA-UHFFFAOYSA-N n,n,n',n'-Tetrakis(2-hydroxyethyl)adipamide Chemical compound OCCN(CCO)C(=O)CCCCC(=O)N(CCO)CCO OKRNLSUTBJUVKA-UHFFFAOYSA-N 0.000 description 1
- MBHINSULENHCMF-UHFFFAOYSA-N n,n-dimethylpropanamide Chemical compound CCC(=O)N(C)C MBHINSULENHCMF-UHFFFAOYSA-N 0.000 description 1
- YKYONYBAUNKHLG-UHFFFAOYSA-N n-Propyl acetate Natural products CCCOC(C)=O YKYONYBAUNKHLG-UHFFFAOYSA-N 0.000 description 1
- SJPFBRJHYRBAGV-UHFFFAOYSA-N n-[[3-[[bis(oxiran-2-ylmethyl)amino]methyl]phenyl]methyl]-1-(oxiran-2-yl)-n-(oxiran-2-ylmethyl)methanamine Chemical compound C1OC1CN(CC=1C=C(CN(CC2OC2)CC2OC2)C=CC=1)CC1CO1 SJPFBRJHYRBAGV-UHFFFAOYSA-N 0.000 description 1
- 229940017144 n-butyl lactate Drugs 0.000 description 1
- PZYDAVFRVJXFHS-UHFFFAOYSA-N n-cyclohexyl-2-pyrrolidone Chemical compound O=C1CCCN1C1CCCCC1 PZYDAVFRVJXFHS-UHFFFAOYSA-N 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- IOQPZZOEVPZRBK-UHFFFAOYSA-N octan-1-amine Chemical compound CCCCCCCCN IOQPZZOEVPZRBK-UHFFFAOYSA-N 0.000 description 1
- 238000007645 offset printing Methods 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 125000000466 oxiranyl group Chemical group 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 238000000059 patterning Methods 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- JLFNLZLINWHATN-UHFFFAOYSA-N pentaethylene glycol Chemical compound OCCOCCOCCOCCOCCO JLFNLZLINWHATN-UHFFFAOYSA-N 0.000 description 1
- DGTNSSLYPYDJGL-UHFFFAOYSA-N phenyl isocyanate Chemical compound O=C=NC1=CC=CC=C1 DGTNSSLYPYDJGL-UHFFFAOYSA-N 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 150000008301 phosphite esters Chemical class 0.000 description 1
- 238000007699 photoisomerization reaction Methods 0.000 description 1
- 238000006303 photolysis reaction Methods 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- 125000003386 piperidinyl group Chemical group 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 238000012643 polycondensation polymerization Methods 0.000 description 1
- 238000006068 polycondensation reaction Methods 0.000 description 1
- 239000004848 polyfunctional curative Substances 0.000 description 1
- 239000003505 polymerization initiator Substances 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 229920006324 polyoxymethylene Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- XVSSGIXTKVRGAR-UHFFFAOYSA-N prop-2-enoxycarbonyl prop-2-enyl carbonate Chemical compound C=CCOC(=O)OC(=O)OCC=C XVSSGIXTKVRGAR-UHFFFAOYSA-N 0.000 description 1
- QLNJFJADRCOGBJ-UHFFFAOYSA-N propionamide Chemical compound CCC(N)=O QLNJFJADRCOGBJ-UHFFFAOYSA-N 0.000 description 1
- 229940080818 propionamide Drugs 0.000 description 1
- JCMFJIHDWDKYIL-UHFFFAOYSA-N propyl 3-methoxypropanoate Chemical compound CCCOC(=O)CCOC JCMFJIHDWDKYIL-UHFFFAOYSA-N 0.000 description 1
- 229940090181 propyl acetate Drugs 0.000 description 1
- RUOJZAUFBMNUDX-UHFFFAOYSA-N propylene carbonate Chemical compound CC1COC(=O)O1 RUOJZAUFBMNUDX-UHFFFAOYSA-N 0.000 description 1
- LLHKCFNBLRBOGN-UHFFFAOYSA-N propylene glycol methyl ether acetate Chemical compound COCC(C)OC(C)=O LLHKCFNBLRBOGN-UHFFFAOYSA-N 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical group C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 description 1
- HDOUGSFASVGDCS-UHFFFAOYSA-N pyridin-3-ylmethanamine Chemical compound NCC1=CC=CN=C1 HDOUGSFASVGDCS-UHFFFAOYSA-N 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- ATBIAJXSKNPHEI-UHFFFAOYSA-N pyridine-3-carbonyl chloride Chemical compound ClC(=O)C1=CC=CN=C1 ATBIAJXSKNPHEI-UHFFFAOYSA-N 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 239000002964 rayon Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000007650 screen-printing Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 150000003431 steroids Chemical group 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- UWHCKJMYHZGTIT-UHFFFAOYSA-N tetraethylene glycol Chemical compound OCCOCCOCCOCCO UWHCKJMYHZGTIT-UHFFFAOYSA-N 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- NBXZNTLFQLUFES-UHFFFAOYSA-N triethoxy(propyl)silane Chemical compound CCC[Si](OCC)(OCC)OCC NBXZNTLFQLUFES-UHFFFAOYSA-N 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- SRPWOOOHEPICQU-UHFFFAOYSA-N trimellitic anhydride Chemical compound OC(=O)C1=CC=C2C(=O)OC(=O)C2=C1 SRPWOOOHEPICQU-UHFFFAOYSA-N 0.000 description 1
- DQZNLOXENNXVAD-UHFFFAOYSA-N trimethoxy-[2-(7-oxabicyclo[4.1.0]heptan-4-yl)ethyl]silane Chemical compound C1C(CC[Si](OC)(OC)OC)CCC2OC21 DQZNLOXENNXVAD-UHFFFAOYSA-N 0.000 description 1
- BPSIOYPQMFLKFR-UHFFFAOYSA-N trimethoxy-[3-(oxiran-2-ylmethoxy)propyl]silane Chemical compound CO[Si](OC)(OC)CCCOCC1CO1 BPSIOYPQMFLKFR-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 238000011077 uniformity evaluation Methods 0.000 description 1
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G02—OPTICS
- G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
- G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
- G02F1/01—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour
- G02F1/13—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells
- G02F1/133—Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
- G02F1/1333—Constructional arrangements; Manufacturing methods
- G02F1/1337—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
- G02F1/133711—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by organic films, e.g. polymeric films
- G02F1/133723—Polyimide, polyamide-imide
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
- C08G73/10—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
- C08G73/10—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
- C08G73/1003—Preparatory processes
- C08G73/1007—Preparatory processes from tetracarboxylic acids or derivatives and diamines
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
- C08G73/10—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
- C08G73/1067—Wholly aromatic polyimides, i.e. having both tetracarboxylic and diamino moieties aromatically bound
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
- C08G73/10—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
- C08G73/1075—Partially aromatic polyimides
- C08G73/1078—Partially aromatic polyimides wholly aromatic in the diamino moiety
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/52—Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
- C09K19/54—Additives having no specific mesophase characterised by their chemical composition
- C09K19/56—Aligning agents
-
- G—PHYSICS
- G02—OPTICS
- G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
- G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
- G02F1/01—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour
- G02F1/13—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells
- G02F1/133—Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
- G02F1/1333—Constructional arrangements; Manufacturing methods
- G02F1/1337—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
-
- G—PHYSICS
- G02—OPTICS
- G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
- G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
- G02F1/01—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour
- G02F1/13—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells
- G02F1/133—Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
- G02F1/1333—Constructional arrangements; Manufacturing methods
- G02F1/1337—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
- G02F1/133711—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by organic films, e.g. polymeric films
Definitions
- the present invention relates to a liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display element.
- a liquid crystal display element for example, comprises a liquid crystal layer sandwiched between an element substrate and a color filter substrate, pixel electrodes and a common electrode that apply an electric field to the liquid crystal layer, a liquid crystal alignment film that controls the orientation of the liquid crystal molecules in the liquid crystal layer, and thin film transistors (TFTs) that switch the electrical signals supplied to the pixel electrodes.
- Known methods for driving liquid crystal molecules include vertical electric field methods such as the TN (Twisted Nematic) method and the VA (Vertical Alignment) method, and horizontal electric field methods such as the IPS (In-Plane Switching) method and the FFS (Fringe Field Switching) method.
- liquid crystal alignment film is produced by rubbing the surface of a film made of a polymer, typically polyamic acid and/or polyimide formed by imidizing it, formed on an electrode substrate in one direction with a cloth such as cotton, nylon, or polyester, a so-called rubbing process (see, for example, Patent Document 1).
- the rubbing process is an industrially useful method that is simple and has excellent productivity.
- a photoalignment method that imparts liquid crystal alignment ability by irradiating polarized radiation has been known as an alternative alignment method to the rubbing process.
- photoalignment methods methods that utilize photoisomerization reactions, photocrosslinking reactions, photodecomposition reactions, etc. have been proposed (see, for example, Patent Document 2 and Non-Patent Document 1).
- liquid crystal alignment films used in liquid crystal display elements require a high alignment control force to suppress image retention caused by long-term AC driving (hereinafter also referred to as AC image retention).
- the object of the present invention is to provide a liquid crystal alignment agent capable of producing a liquid crystal alignment film having excellent alignment uniformity of liquid crystals and excellent resistance to AC image retention, a liquid crystal alignment film obtained from the liquid crystal alignment agent, and a liquid crystal display element.
- a liquid crystal aligning agent comprising a polymer component (P) containing one or more polymers, and a compound (C) represented by the following formula (c):
- the liquid crystal aligning agent wherein the polymer component (P) contains at least one polymer (P) selected from the group consisting of polyimide precursors and polyimides which are imidized products of the polyimide precursors.
- R c 's each independently represent a monovalent organic group having 1 to 6 carbon atoms, and n is an integer of 1 or 2.
- Halogen atom includes a fluorine atom, a chlorine atom, a bromine atom, an iodine atom, and the like.
- * represents a bond
- Boc represents a tert-butoxycarbonyl group
- Fmoc represents a 9-fluorenylmethoxycarbonyl group.
- the present invention it is possible to obtain a liquid crystal aligning agent capable of obtaining a liquid crystal alignment film having excellent alignment uniformity of liquid crystal and excellent resistance to AC afterimage, a liquid crystal alignment film obtained from the liquid crystal aligning agent, and a liquid crystal display element.
- the liquid crystal display element has high display quality with few display defects.
- the mechanism by which the above-mentioned effects of the present invention are obtained is not necessarily clear, but is generally presumed to be as follows. It is presumed that the phosphorous acid compound acts on the polymer (P) described in the present invention to modify the film surface state, thereby improving the liquid crystal alignment.
- the polymer component (P) contained in the liquid crystal aligning agent of the present invention contains at least one polymer (P) selected from the group consisting of polyimide precursors and polyimides which are imidized products of the polyimide precursors. do.
- the polymer (P) has, for example, one or more structural units, and is selected from the group consisting of a structural unit (p0) represented by the following formula (P0) and an imidized structural unit of the structural unit (p0): It may be an embodiment having at least one selected structural unit.
- X represents a tetravalent organic group
- Y represents a divalent organic group
- R and Z each independently represent a hydrogen atom or a monovalent organic group. and Z each independently have the above definition.
- X in the above formula (P0) represents a tetravalent organic group, preferably a tetravalent tetracarboxylic acid residue.
- the tetravalent tetracarboxylic acid residue may be, for example, a tetravalent organic group present between four carbonyl groups of a tetracarboxylic acid dianhydride or a derivative thereof (e.g., a tetracarboxylic acid, a tetracarboxylic acid dihalide, a tetracarboxylic acid dialkyl ester, or a tetracarboxylic acid dialkyl ester dihalide, etc.).
- the above-mentioned X is preferably a tetravalent tetracarboxylic acid residue derived from an acyclic aliphatic tetracarboxylic acid dianhydride, an alicyclic tetracarboxylic acid dianhydride, an aromatic tetracarboxylic acid dianhydride, or a derivative thereof.
- the tetracarboxylic dianhydride or derivative thereof which gives the above X is more preferably a tetracarboxylic dianhydride or derivative thereof having at least one partial structure selected from the group consisting of a benzene ring, a cyclobutane ring, a cyclopentane ring, and a cyclohexane ring.
- the acyclic aliphatic tetracarboxylic acid dianhydride is an acid dianhydride obtained by intramolecular dehydration of four carboxy groups bonded to a chain hydrocarbon structure, but does not necessarily have to be composed of a chain hydrocarbon structure alone, and may have an alicyclic structure or an aromatic ring structure as a part thereof.
- Alicyclic tetracarboxylic dianhydrides are acid dianhydrides obtained by intramolecular dehydration of four carboxy groups, including at least one carboxy group bonded to an alicyclic structure. However, none of these four carboxy groups are bonded to an aromatic ring.
- An aromatic tetracarboxylic acid dianhydride is an acid dianhydride obtained by intramolecular dehydration of four carboxy groups, including at least one carboxy group bonded to an aromatic ring.
- the aromatic tetracarboxylic acid dianhydride it is not necessary for the aromatic tetracarboxylic acid dianhydride to be composed only of an aromatic ring structure, and it may have a chain hydrocarbon structure or an alicyclic structure as a part of the aromatic ring structure.
- X in the above formula (P0) may be a tetravalent organic group represented by any one of the following formulae (Xa1-1) to (Xa1-8), (X-1) to (X-17), or (X b1 -a) to (X b1 -c).
- R 1 to R 15 each independently represent a hydrogen atom, a halogen atom, an alkyl group having 1 to 6 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, an alkynyl group having 2 to 6 carbon atoms, a monovalent organic group having 1 to 6 carbon atoms containing a fluorine atom, or a phenyl group, and may be the same or different.
- alkyl group having 1 to 6 carbon atoms in R 1 to R 15 in the above formulas (Xa1-1) to (Xa1-3) include a methyl group, an ethyl group, a propyl group, an isopropyl group, an n-butyl group, an isobutyl group, a sec-butyl group, a tert-butyl group, an n-pentyl group, etc.
- alkenyl group having 2 to 6 carbon atoms in R 1 to R 15 include a vinyl group, a propenyl group, a butenyl group, etc., which may be linear or branched.
- alkynyl group having 2 to 6 carbon atoms in R 1 to R 15 include an ethynyl group, a 1-propynyl group, a 2-propynyl group, a 1-butynyl group, a 2-butynyl group, a 3-butynyl group, etc.
- fluorine atom-containing monovalent organic group having 1 to 6 carbon atoms in R 1 to R 15 include a fluoromethyl group, a trifluoromethyl group, a pentafluoroethyl group, and a pentafluoropropyl group.
- the X is preferably a tetravalent organic group represented by the above formula (Xa1-1). Furthermore, from the viewpoint of high photoreactivity, it is preferable that R 1 to R 4 are each independently a hydrogen atom or a methyl group, and at least one of R 1 to R 4 is a methyl group , and more preferably at least two of R 1 to R 4 are methyl groups. It is even more preferable that R 1 and R 4 are methyl groups, and R 2 and R 3 are hydrogen atoms.
- the above formula (Xa1-1) is preferably a tetravalent organic group selected from the group consisting of the following formulas (Xa1-1-1) to (Xa1-1-5).
- the tetravalent organic groups represented by the above formulas (X b1 -a) to (X b1 -c) are more preferably tetravalent organic groups represented by any of the following formulas (X b1 -1) to (X b1 -21):
- the divalent organic group for Y in the above formula (P0) is not particularly limited, but examples thereof include divalent organic groups represented by the following formulas (3) and (4).
- R 3 , R 4 , and R 4′ each independently represent a halogen atom, a hydroxy group, an optionally protected amino group, a thiol group, a nitro group, a phosphate group, or a monovalent organic group having 1 to 20 carbon atoms.
- A4 represents an ester bond, an amide bond, a thioester bond, or a divalent organic group having 2 to 20 carbon atoms, except for a 1,4-phenylene group, a divalent organic group in which 1 to 4 hydrogen atoms on the phenylene group are substituted with R4 and R4 ' , or a divalent organic group in which these divalent organic groups are linked to each other.
- a3, a4, and a4' each independently represents an integer of 0 to 4.
- a is an integer of 1 to 4.
- b and c are each independently an integer of 1 to 2.
- the monovalent organic group having 1 to 20 carbon atoms in R 3 , R 4 , and R 4′ in the above formulas (3) and (4) includes a monovalent hydrocarbon group having 1 to 20 carbon atoms, and any methylene group of the hydrocarbon group is -O-, -S-, -C( ⁇ O)-, -C( ⁇ O)-O-, -C( ⁇ O)-S-, -NR 3 - (wherein R 3 represents a hydrogen atom, a monovalent hydrocarbon group having 1 to 10 carbon atoms, or a tert-butoxycarbonyl group), -CO-NR 3 - (wherein R 3 represents a hydrogen atom, a monovalent hydrocarbon group having 1 to 10 carbon atoms, or a tert-butoxycarbonyl group), -Si(R 3 ) 2 - (wherein R 3 represents a hydrogen atom or a monovalent hydrocarbon group having 1 to 10 carbon atoms), -S( ⁇ O) 2 - or
- the number of carbon atoms in the group (A), the group (A2), and the monovalent group having a heterocycle is 1 to 20.
- the monovalent organic group having 1 to 20 carbon atoms for R 3 , R 4 , and R 4′ an alkyl group having 1 to 10 carbon atoms, an alkenyl group having 2 to 10 carbon atoms, an alkynyl group having 2 to 10 carbon atoms, or a monovalent group in which any methylene group of the hydrocarbon group is replaced with the heteroatom-containing group (A) is even more preferred.
- the optionally protected amino group includes --N(R) 2 , where R represents a hydrogen atom, a monovalent hydrocarbon group having 1 to 10 carbon atoms, or a tert-butoxycarbonyl group.
- the monovalent organic group having 1 to 20 carbon atoms in R 3 , R 4 , and R 4′ is preferably a methyl group, a methoxy group, a vinyl group, a halogen atom, a hydroxyl group, an amino group which may be protected by a protecting group, or a monovalent group in which at least one hydrogen atom of an alkyl group having 1 to 3 carbon atoms has been substituted with a halogen atom or an amino group which may be protected by a protecting group.
- a is preferably an integer of 1 to 2.
- a3 is preferably an integer of 0 to 2, and when there are multiple a3s, they may be the same or different.
- a4 and a4' are each independently preferably an integer of 0 to 2, and when there are multiple a4s and multiple a4's, they may be the same or different.
- R in the above -NR- represents a hydrogen atom, a monovalent hydrocarbon group having 1 to 5 carbon atoms, or a tert-butoxycarbonyl group.
- R 0 in the above -Si(R 0 ) 2 - represents a hydrogen atom or a monovalent hydrocarbon group having 1 to 10 carbon atoms.
- hydrocarbon group examples include a chain hydrocarbon group, an alicyclic hydrocarbon group, or a hydrocarbon group having an aromatic group (examples of the aromatic ring structure in the aromatic group include a benzene ring, a naphthalene ring, a biphenyl structure, an anthracene ring, etc.).
- chain hydrocarbon group examples include a divalent linear or branched hydrocarbon group having 1 to 20 carbon atoms not having a cyclic structure, and are preferably an alkylene group having 1 to 20 carbon atoms, an alkenylene group having 2 to 20 carbon atoms, or an alkynylene group having 2 to 20 carbon atoms.
- the alicyclic hydrocarbon group examples include an alicyclic structure (for example, a cyclohexylene group or a bicyclohexylene group), or a hydrocarbon group having an alicyclic structure and a chain hydrocarbon structure.
- the hydrocarbon group having an aromatic group examples include an aromatic group, a hydrocarbon group having an aromatic group and a chain hydrocarbon structure, and a hydrocarbon group having an aromatic group and an alicyclic structure.
- the heterocyclic ring in the divalent organic group (4d) may be a piperidine ring, a piperazine ring, a morpholine ring, a pyrrolidine ring, a pyrrole ring, a furan ring, a thiophene ring, an imidazole ring, a pyrazole ring, an imide ring, an oxazole ring, an isoxazole ring, a thiazole ring, an isothiazole ring, a pyridine ring, a pyrimidine ring, a pyridazine ring, or a pyrazine ring, or a condensed ring containing these ring structures as part of its structure, and the hydrogen atoms on the ring may be substituted.
- the substituent include a halogen atom, a methyl group, or a methoxy group.
- a 4 in the above formula (4) is preferably a group "-L 1 -AL 1'- " or a divalent organic group having 2 to 20 carbon atoms and a heterocycle.
- the total number of carbon atoms of L 1 , L 1 ' and A in the group "-L 1 -AL 1 ' -" satisfies 2 to 20.
- R a in -Si(R a ) 2 - represents a hydrogen atom or a monovalent hydrocarbon group having 1 to 3 carbon atoms. Any hydrogen atom possessed by A may be substituted with a halogen atom.
- Ar represents a phenylene group or a biphenyl structure.
- More preferred specific examples of the above formulae (3) and (4) include structures represented by the following formulae (d AL -1) to (d AL -12), (5-1) to (5-6), (z-1) to (z-7), (o2-1) to (o2-12), (h-1) to (h-13), and (Im-1) to (Im-6).
- the bonding positions of the benzene ring bonded to * are the 1,4-positions.
- the bonding positions of all benzene rings are the 1,4-positions.
- the polymer (P) is preferably a polymer containing a structural unit having a divalent organic group selected from the group consisting of a divalent organic group having a urea bond; a divalent organic group having an amide bond; a divalent organic group having at least one nitrogen atom-containing structure selected from the group consisting of a nitrogen atom-containing heterocycle, a secondary amino group, and a tertiary amino group; and a divalent organic group having a carboxy group (collectively referred to as specific divalent organic group (b)).
- the divalent organic group having an amide bond includes a divalent organic group represented by the above formula (4) in which A4 in the above formula (4) has an amide bond.
- Examples of the divalent organic group having at least one nitrogen atom-containing structure selected from the group consisting of a nitrogen atom-containing heterocycle, a secondary amino group, and a tertiary amino group include 2,6-diaminopyridine, 3,4-diaminopyridine, 2,4-diaminopyrimidine, 3,6-diaminocarbazole, N-methyl-3,6-diaminocarbazole, 3,6-diaminoacridine, N-ethyl-3,6-diaminocarbazole, N-phenyl-3,6-diaminocarbazole, and those having the structures represented by the above formulae (z-1) to (z-7).
- diamines selected from the group consisting of heterocycle-containing diamines such as diamine, 4,4'-diaminodiphenylamine, 4,4'-diaminodiphenyl-N-methylamine, N,N'-bis(4-aminophenyl)-benzidine, N,N'-bis(4-aminophenyl)-N,N'-dimethylbenzidine, or diamines having a diphenylamine structure such as N,N'-bis(4-aminophenyl)-N,N'-dimethyl-1,4-benzenediamine.
- heterocycle-containing diamines such as diamine, 4,4'-diaminodiphenylamine, 4,4'-diaminodiphenyl-N-methylamine, N,N'-bis(4-aminophenyl)-benzidine, N,N'-bis(4-aminophenyl)-N,N'-dimethylbenzidine, or diamines having
- divalent organic group having a carboxy group examples include divalent organic groups obtained by removing two amino groups from a diamine having a carboxy group, such as 2,4-diaminobenzoic acid, 2,5-diaminobenzoic acid, 3,5-diaminobenzoic acid, 4,4'-diaminobiphenyl-3-carboxylic acid, 4,4'-diaminodiphenylmethane-3-carboxylic acid, 1,2-bis(4-aminophenyl)ethane-3-carboxylic acid, 4,4'-diaminobiphenyl-3,3'-dicarboxylic acid, 4,4'-diaminobiphenyl-2,2'-dicarboxylic acid, 3,3'-diaminobiphenyl-4,4'-dicarboxylic acid, 3,3'-diaminobiphenyl-2,4'-dicarboxylic acid, 4,4'-diaminodiphenylme
- the divalent organic group of Y a1 in the above formula (A1) may have a structure other than the divalent organic groups represented by the above formulas (3) and (4).
- Other structures include a divalent organic group (3L) in which the bonding position of the benzene ring bonding to * in the above formula (3) is changed from 1,4-position to 2,5-position; a divalent organic group (4L) in which at least one bonding position of the benzene ring bonding to * in the above formula (4) is changed from 1,4-position to 2,5-position; or a divalent organic group obtained by removing two amino groups from the following diamines (these diamines are also collectively referred to as diamines (W)).
- R 3 , R 4 , R 4' , A 4 , a3, a4, a4', a, b, and c are the same as those in the above formulas (3) to (4).
- Aromatic diamines having a naphthalene ring such as 1,2-bis(6-amino-2-naphthyloxy)ethane, 1,2-bis(6-amino-2-naphthyl)ethane, or 6-[2-(4-aminophenoxy)ethoxy]-2-naphthylamine, 4,4'-diaminoazobenzene, 3,3'-diaminodiphenylmethane, 3,4'-diaminodiphenylmethane, 4,4'-diaminodiphenylmethane, 3,3'-diaminodiphenyl ether, 3,4'-diaminodiphenyl ether, 4,4'-diaminodiphenyl ether, 4,4' -Diaminobenzophenone, 2,6-diaminopyridine, 3,4-diaminopyridine, 2,4-diaminopyrimidine, 3,
- diamines having a siloxane bond such as 1,3-bis(3-aminopropyl)-tetramethyldisiloxane; metaxylylenediamine, 1,3-propanediamine, tetramethylenediamine, pentamethylenediamine, hexamethylenediamine, 1,3-bis(aminomethyl)cyclohexane, 1,4-diaminocyclohexane, 4,4'-methylenebis(cyclohexylamine), diamines having two amino groups bonded to a group represented by any one of formulas (Y-1) to (Y-167) described in WO2018/117239, etc.
- siloxane bond such as 1,3-bis(3-aminopropyl)-tetramethyldisiloxane; metaxylylenediamine, 1,3-propanediamine, tetramethylenediamine, pentamethylenediamine, hexamethylenediamine, 1,3-bis(a
- the polymer (P) preferably contains the structural unit (p0) and the imidized structural unit of the structural unit (p0) in an amount of 10 to 100 mol %, and more preferably 15 to 100 mol %, of the total structural units contained in the polymer (P).
- the total here includes the case where either the structural unit (p0) or the imidized structural unit of the structural unit (p0) is 0 mol %. In the following, the total also includes the case where one or more of the structural unit elements are 0 mol %.
- the polymer (P) preferably contains structural units having a divalent organic group represented by the above formulas (3) to (4) in an amount of 10 to 100 mol %, and more preferably 15 to 100 mol %, of all structural units contained in the polymer (P).
- the monovalent organic groups for R and Z in the above formula (P0) include monovalent hydrocarbon groups having 1 to 20 carbon atoms, and monovalent groups A in which a methylene group of the hydrocarbon group is replaced by -O-, -S-, -CO-, -COO-, -COS-, -NR 3 -, -CO-NR 3 -, -Si(R 3 ) 2 -, -SO 2 - or the like (wherein R 3 is a hydrogen atom or a monovalent hydrocarbon group having 1 to 10 carbon atoms, and when there are a plurality of R 3's , each R 3 may be the same or different.
- R and Z in the above formula (1) an alkyl group having 1 to 10 carbon atoms, an alkenyl group having 2 to 10 carbon atoms, an alkynyl group having 2 to 10 carbon atoms, Boc, or Fmoc is preferable, an alkyl group having 1 to 3 carbon atoms is more preferable, and a methyl group is even more preferable.
- R and Z are each independently preferably a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, and more preferably a hydrogen atom or a methyl group.
- the polymer component (P) contained in the liquid crystal aligning agent of the present invention may be a polymer component containing two or more kinds of polymers and satisfying at least one of the following conditions (i) to (iii): (i) A polymer component (P1) having one or more types of structural units and including two or more types of at least one polymer selected from the group consisting of a polyimide precursor (A) having a structural unit (a1) represented by the following formula (A1) and a polyimide which is an imidized product of the polyimide precursor: (ii) A polymer component (P2) which is a polymer different from the polyimide precursor (A) and has one or more types of structural units and contains two or more types of polyimide precursors (B) having a structural unit (b1) represented by the following formula (B1): (iii) A polymer component (P3) containing at least one polymer selected from the group consisting of the polyimide precursor (A) and a polyimide which is an imidization product of the poly
- X a1 represents a tetravalent organic group selected from the group consisting of formulas (Xa1-1) to (Xa1-8) above, and Y a1 represents a divalent organic group.
- R and Z have the same meanings as in formula (P0) above.
- X b1 represents a tetravalent organic group having an aromatic group having 6 to 30 carbon atoms, and at least one of the carbonyl carbons bonded to X b1 is bonded to the aromatic group of X b1 .
- Y b1 represents a divalent organic group.
- R and Z are defined as in formula (P0).
- the polymer component (P) may be composed of a polymer having no acid-dissociable group.
- the acid-dissociable group is a group having a bond that is cleaved by an acid, and a part or all of the acid-dissociable group is eliminated from the main chain of the polymer by cleavage of the bond.
- Preferred examples of the acid-dissociable group include protecting groups that protect amino groups, hydroxy groups, etc. Examples of such protecting groups include carbamate-based protecting groups (specific examples include tert-butoxycarbonyl and 9-fluorenylmethyloxycarbonyl groups), and groups that form an acetal structure or a tertiary ether structure together with the protected oxygen atom.
- a polymer having no acid-leaving group can be obtained, for example, by using a raw material component having no acid-leaving group (specific examples of raw materials having no acid-leaving group include a diamine having no acid-leaving group, a tetracarboxylic dianhydride or a derivative thereof having no acid-leaving group, and a terminal modifier that does not form an acid-leaving group).
- a raw material component having no acid-leaving group specifically examples include a diamine having no acid-leaving group, a tetracarboxylic dianhydride or a derivative thereof having no acid-leaving group, and a terminal modifier that does not form an acid-leaving group.
- the divalent organic group of Y a1 in the above formula (A1) is not particularly limited, and examples thereof include divalent organic groups represented by the above formulas (3) to (4).
- the divalent organic group is introduced into the structural unit of the polyimide precursor (A), for example, by using a diamine having the above divalent organic group as a diamine component for obtaining the polyimide precursor (A).
- At least one of the structural units constituting the polyimide precursor (A) preferably has a structure selected from the group consisting of divalent organic groups represented by the above formulas (3) to (4), and more preferably has a structure selected from the group consisting of divalent organic groups represented by the above formulas (3) to (4) in which * is bonded to a nitrogen atom derived from a diamine.
- Y a1 in the above formula (A1) is preferably a divalent organic group selected from the group consisting of the above formulas (3) and (4).
- More preferred specific examples of the above formulae (3) and (4) are the same as the preferred embodiments of the above formulae (3) to (4) in the polymer (P).
- more preferred specific examples include structures represented by the above formulae (d AL -1) to (d AL -12), (5-1) to (5-6), (z-1) to (z-7), (o2-1) to (o2-12), (h-1) to (h-13), and (Im-1) to (Im-6).
- the bonding positions of the benzene ring bonded to * are the 1,4-positions.
- the bonding positions of all benzene rings are 1,4-positions.
- the divalent organic group of Y a1 in the above formula (A1) may have a structure other than the divalent organic groups represented by the above formulas (3) and (4).
- Other structures include a divalent organic group (3L) in which the bonding positions of the benzene ring bonding to * in the above formula (3) are changed from 1,4-positions to 2,5-positions, a divalent organic group (4L) in which at least one bonding position of the benzene ring bonding to * in the above formula (4) is changed from 1,4-positions to 2,5-positions, or a divalent organic group in which two amino groups have been removed from the above diamine (W), etc.
- R 3 , R 4 , R 4' , A 4 , a3, a4, a4', a, b, and c are the same as those in the above formulas (3) to (4).
- the polyimide precursor (A) may be a polyimide precursor having, in addition to the structural unit (a1) represented by the above formula (A1), a structural unit (a2) represented by the following formula (A2):
- X a2 represents a tetravalent organic group represented by any one of formulas (X-1) to (X-17) above, or a tetravalent organic group derived from an aromatic tetracarboxylic dianhydride
- Y a2 represents a divalent organic group.
- R and Z have the same meanings as in formula (P0).
- divalent organic group of Y a2 in the above formula (A2) include the structures exemplified for the divalent organic group of Y a1 in the above formula (A1), including preferred embodiments.
- the aromatic tetracarboxylic dianhydride is as defined above, including preferred embodiments.
- Preferred specific examples of the aromatic tetracarboxylic dianhydride include tetravalent organic groups represented by any one of the above formulae (X b1 -a) to (X b1 -c), and more preferably tetravalent organic groups represented by any one of the above formulae (X b1 -1) to (X b1 -21).
- the polyimide precursor (A) preferably contains the structural unit (a1) and the imidized structural unit of the structural unit (a1) in an amount of 10 to 100 mol %, and more preferably 15 to 100 mol %, of the total structural units contained in the polyimide precursor (A).
- the polyimide precursor (A) preferably contains structural units having a divalent organic group represented by the above formulas (3) to (4) in an amount of 10 to 100 mol %, more preferably 15 to 100 mol %, of all structural units contained in the polyimide precursor (A).
- the sum of the structural unit (a1) and the imidized structural unit of the structural unit (a1) preferably accounts for 95 mol % or less, and more preferably 90 mol % or less, of all structural units contained in the polyimide precursor (A).
- the polymer components (P2) and (P3) contained in the liquid crystal alignment agent of the present invention contain a polyimide precursor (B) which is a polymer different from the polyimide precursor (A), has one or more structural units, and has a structural unit (b1) represented by the following formula (B1).
- the polyimide precursor (B) may be one or more polymers.
- the polyimide precursor (B) may have one type of structural unit, or may have two or more different structural units, or may have three or more different structural units, or may have four or more different structural units.
- X b1 represents a tetravalent organic group having an aromatic group having 6 to 30 carbon atoms, and at least one of the carbonyl carbons bonded to X b1 is bonded to the aromatic group of X b1 .
- Y b1 represents a divalent organic group.
- R and Z are defined as in formula (P0).
- X b1 in the above formula (B1) represents a tetravalent organic group having an aromatic group having 6 to 30 carbon atoms, and at least one of the carbonyl carbons bonded to X b1 is bonded to the aromatic group of X b1 . More preferably, it is a tetravalent organic group derived from an acid dianhydride obtained by intramolecular dehydration of four carboxy groups including at least one carboxy group bonded to an aromatic ring (benzene ring, naphthalene ring, etc.). However, it is not necessary for the group to be composed of only an aromatic ring structure, and it may have a chain hydrocarbon structure or an alicyclic structure as a part thereof.
- X b1 is a tetravalent organic group derived from an aromatic tetracarboxylic acid compound.
- X b1 is preferably a tetravalent organic group represented by any one of the above formulas (X b1 -a) to (X b1 -c), more preferably a tetravalent organic group represented by any one of the above formulas (X b1 -1) to (X b1 -21), and even more preferably a tetravalent organic group represented by any one of the above formulas (X b1 -1) to (X b1 -13).
- X b1 is a tetravalent organic group selected from the group consisting of the above formulas (X b1 -1) to (X b1 -7).
- Examples of the divalent organic group in Y b1 include the divalent organic groups exemplified for Y a1 .
- the polyimide precursor (B) is preferably a polymer containing a structural unit having the specific divalent organic group (b).
- the polyimide precursor (B) is preferably a polymer containing a structural unit in which Y b1 is the specific divalent organic group (b) described above.
- the polyimide precursor (B) preferably contains structural units having the specific divalent organic group (b) (more preferably structural units having the specific divalent organic group bonded to a nitrogen atom derived from a diamine) in an amount of 1 mol % or more, preferably 5 mol % or more, more preferably 10 mol % or more, and even more preferably 20 mol % or more of all structural units contained in the polyimide precursor (B).
- the polyimide precursor (B) preferably contains structural units in which Y b1 is the specific divalent organic group (b) in an amount of 1 mol % or more, preferably 5 mol % or more, more preferably 10 mol % or more, and even more preferably 20 mol % or more of all structural units contained in the polyimide precursor (B).
- the polyimide precursor (B) may be a polyimide precursor having, in addition to the structural unit (b1) represented by the above formula (B1), a structural unit (b2) represented by the following formula (B2):
- X b2 represents a tetravalent organic group derived from an acyclic aliphatic tetracarboxylic acid dianhydride or an alicyclic tetracarboxylic acid dianhydride
- Y b2 represents a divalent organic group.
- R and Z have the same meanings as in formula (P0).
- X b2 is preferably a tetravalent organic group represented by any one of the above formulas (X-1) to (X-17) or (Xa1-1) to (Xa1-8).
- the polyimide precursor (B) preferably contains the structural unit (b1) and the imidized structural unit of the structural unit (b1) in an amount of 10 to 100 mol %, and more preferably 15 to 100 mol %, of the total structural units contained in the polyimide precursor (B).
- the structural unit (b1) preferably accounts for 95 mol % or less, and more preferably 90 mol % or less, of all structural units contained in the polyimide precursor (B).
- the polyimide precursor (B) preferably contains the structural unit (b2) in an amount of 5 mol % or more, more preferably 10 mol % or more, based on the total structural units contained in the polyimide precursor (B), and preferably contains the structural unit (b2) in an amount of 90 mol % or less, more preferably 85 mol % or less, based on the total structural units contained in the polyimide precursor (B).
- the mass ratio of the content of the first polyimide precursor to the content of the second polyimide precursor is preferably 10/90 to 90/10, more preferably 20/80 to 90/10, and even more preferably 20/80 to 80/20.
- the mass ratio of the content of the polyimide precursor (A) to the content of the polyimide precursor (B) is preferably from 10/90 to 90/10, more preferably from 20/80 to 90/10, and even more preferably from 20/80 to 80/20.
- polymer (P), polyimide precursor (A), and polyimide precursor (B) ⁇ Methods for producing polymer (P), polyimide precursor (A), and polyimide precursor (B)>
- the polymer (P) and the polyimide precursors (A) and (B) in the present invention can be synthesized by a known method such as that described in WO2013/157586.
- the ratio of the tetracarboxylic dianhydride and the diamine used in the synthesis reaction of the polyimide precursor is preferably such that the acid anhydride group of the tetracarboxylic dianhydride is 0.5 to 2 equivalents, more preferably 0.8 to 1.2 equivalents, per equivalent of the amino group of the diamine.
- the closer the equivalent of the acid anhydride group of the tetracarboxylic dianhydride is to 1 equivalent the higher the molecular weight of the polyimide precursor produced.
- the reaction temperature in the synthesis reaction of the polyimide precursor is preferably ⁇ 20 to 150° C., more preferably 0 to 100° C.
- the reaction time is preferably 0.1 to 24 hours, more preferably 0.5 to 12 hours.
- the synthesis reaction of the polyimide precursor can be carried out at any concentration, but the concentration of the polyimide precursor in the reaction solution is preferably 1 to 50% by mass, more preferably 5 to 30% by mass.
- the reaction can be carried out at a high concentration in the early stage, and then a solvent can be added.
- solvent used when reacting the diamine component with the tetracarboxylic acid derivative component include N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone, ⁇ -butyrolactone, N,N-dimethylformamide, N,N-dimethylacetamide, dimethylsulfoxide, and 1,3-dimethyl-2-imidazolidinone.
- the polymer (P), the polyimide precursor (A), and the polyimide precursor (B) preferably have a solution viscosity of, for example, 10 to 1000 mPa ⁇ s when made into a solution of 10 to 15% by mass from the viewpoint of workability, but are not particularly limited thereto.
- the solution viscosity (mPa ⁇ s) of the polymer is a value measured at 25° C. using an E-type rotational viscometer for a polymer solution of 10 to 15% by mass prepared using a good solvent for the polymer (e.g., ⁇ -butyrolactone, N-methyl-2-pyrrolidone, etc.).
- the weight average molecular weight (Mw) of the polymer (P), polyimide precursor (A), and polyimide precursor (B) measured by gel permeation chromatography (GPC) in terms of polystyrene is preferably 1,000 to 500,000, and more preferably 2,000 to 300,000.
- the molecular weight distribution (Mw/Mn), which is expressed as the ratio of Mw to the number average molecular weight (Mn) measured by GPC in terms of polystyrene, is preferably 15 or less, and more preferably 10 or less. From the viewpoint of optimally obtaining the effects of the present invention, it is preferable for the molecular weight to be within this range.
- ⁇ End-capping agent> In synthesizing the polymer (P), polyimide precursor (A), and polyimide precursor (B) in the present invention, a suitable end-capping agent may be used together with the above-mentioned tetracarboxylic acid derivative component and diamine component to form an end-capping type polymer.
- the end-capping type polymer has the effect of improving the film hardness of the liquid crystal alignment film obtained by coating and improving the adhesion property between the sealant and the liquid crystal alignment film.
- terminals of the polymer (P), polyimide precursor (A), and polyimide precursor (B) in the present invention include amino groups, carboxy groups, acid anhydride groups, and derivatives thereof.
- the amino groups, carboxy groups, and acid anhydride groups can be obtained by a normal condensation reaction, or by blocking the terminals with the following terminal blocking agents, and can be obtained in the same manner, for example, by using the following terminal blocking agents.
- the proportion of the end-capping agent used is preferably 0.01 to 20 molar parts, and more preferably 0.01 to 10 molar parts, per 100 molar parts of the total diamine components used.
- the liquid crystal aligning agent of the present invention contains the compound (C) represented by the above formula (c).
- the compound (C) may be one type or two or more types of compounds.
- Specific examples of the monovalent organic group for R c in the above formula (c) include an alkyl group having 1 to 6 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, an alkynyl group having 2 to 6 carbon atoms, a monovalent organic group containing a fluorine atom having 1 to 6 carbon atoms, or an aromatic group having 6 carbon atoms.
- alkyl group having 1 to 6 carbon atoms in the above R c include a methyl group, an ethyl group, a propyl group, an isopropyl group, an n-butyl group, an isobutyl group, a sec-butyl group, a tert-butyl group, and an n-pentyl group.
- alkenyl group having 2 to 6 carbon atoms in the above R c include a vinyl group, a propenyl group, and a butenyl group, which may be linear or branched.
- alkynyl group having 2 to 6 carbon atoms in the above R c include an ethynyl group, a 1-propynyl group, a 2-propynyl group, a 1-butynyl group, a 2-butynyl group, and a 3-butynyl group.
- Examples of the monovalent organic group having 1 to 6 carbon atoms and containing a fluorine atom in the above R c include a fluoromethyl group, a trifluoromethyl group, a pentafluoroethyl group, and a pentafluoropropyl group.
- R c is preferably an alkyl group having 1 to 6 carbon atoms, and more preferably an alkyl group having 1 to 4 carbon atoms.
- More preferred specific examples of the compound (C) include methyl phosphite, ethyl phosphite, propyl phosphite, butyl phosphite, hexyl phosphite, phenyl phosphite; dimethyl phosphite, diethyl phosphite, dipropyl phosphite, dibutyl phosphite, dihexyl phosphite, diphenyl phosphite, and the like.
- the total content of the compound (C) is preferably 0.1 mass % or more, more preferably 0.2 mass % or more, and even more preferably 0.3 mass % or more, when all components in the liquid crystal aligning agent are taken as 100 mass %.
- the total content of the compound (C) is preferably 10% by mass or less, more preferably 5% by mass or less, and even more preferably 3% by mass or less, from the viewpoint of suitably obtaining the effects of the present invention, when all components in the liquid crystal alignment agent are 100% by mass.
- the liquid crystal alignment agent of the present invention contains an organic solvent.
- organic solvents include N,N-dimethylformamide, N,N-dimethylacetamide, N,N-dimethyllactamide, N,N-dimethylpropionamide, tetramethylurea, N,N-diethylformamide, N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone, dimethylsulfoxide, ⁇ -butyrolactone, ⁇ -valerolactone, 1,3-dimethyl-2-imidazolidinone, methyl ethyl ketone, cyclohexanone, cyclopentanone, 3-methoxy-N ...propionamide, tetramethylurea, N,N-diethylpropionamide, tetramethylurea, N,N-diethylpropionamide, tetramethylurea, N,N-diethylpropionamide, tetramethylurea, N
- N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone, 3-methoxy-N,N-dimethylpropanamide, 3-butoxy-N,N-dimethylpropanamide, and ⁇ -butyrolactone are preferred.
- the content of the good solvent is preferably 20% by mass or more, and more preferably 30% by mass or more, assuming that the total components in the liquid crystal alignment agent are 100% by mass.
- the organic solvent contained in the liquid crystal alignment agent is preferably a mixed solvent containing a solvent (also called a poor solvent) that improves the coatability and surface smoothness of the coating film when applying the liquid crystal alignment agent in addition to the above-mentioned solvent.
- the content of the poor solvent is preferably 1% by mass or more, more preferably 5% by mass or more, and even more preferably 10% by mass or more, when the total components in the liquid crystal alignment agent are taken as 100% by mass.
- the total content of the good solvent and the poor solvent is preferably 99.9% by mass or less, more preferably 99.8% by mass or less, and even more preferably 99.7% by mass or less, when the total amount of all components in the liquid crystal alignment agent is 100% by mass.
- the type and content of the poor solvent are appropriately selected depending on the coating device, coating conditions, coating environment, etc. of the liquid crystal alignment agent. Specific examples of the poor solvent are listed below, but are not limited thereto.
- diisobutyl carbinol propylene glycol monobutyl ether, propylene glycol diacetate, diethylene glycol diethyl ether, dipropylene glycol monomethyl ether, dipropylene glycol dimethyl ether, 4-hydroxy-4-methyl-2-pentanone, ethylene glycol monobutyl ether, ethylene glycol monobutyl ether acetate, and diisobutyl ketone are preferred.
- Preferred solvent combinations of good and poor solvents include N-methyl-2-pyrrolidone and ethylene glycol monobutyl ether, N-methyl-2-pyrrolidone, ⁇ -butyrolactone and ethylene glycol monobutyl ether, N-methyl-2-pyrrolidone, ⁇ -butyrolactone and propylene glycol monobutyl ether, N-ethyl-2-pyrrolidone and propylene glycol monobutyl ether, N-ethyl-2-pyrrolidone and 4-hydroxy-4-methyl-2-pentanone, N-ethyl-2-pyrrolidone and propylene glycol diacetate, and N,N-dimethyl lactamide and diisopropyl ether.
- N-methyl-2-pyrrolidone and ethyl 3-ethoxypropionate N-ethyl-2-pyrrolidone and ethyl 3-ethoxypropionate
- N-ethyl-2-pyrrolidone and ethyl 3-ethoxypropionate N-ethyl-2-pyrrolidone and ethyl 3-ethoxypropionate and propylene glycol monobutyl ether
- N-methyl-2-pyrrolidone and ethyl 3-ethoxypropionate and diethylene glycol monopropyl ether N-ethyl-2-pyrrolidone and ethyl 3-ethoxypropionate and diethylene glycol monopropyl ether
- N-methyl-2-pyrrolidone and ethylene glycol monobutyl ether acetate N-ethyl-2-pyrrolidone and ethylene glycol monobutyl ether acetate
- propylene glycol monobutyl ether and dipropylene glycol monomethyl ether N-ethyl-2-pyrrolidone, diethylene glycol diethyl ether and dipropylene glycol monomethyl ether, N-ethyl-2-pyrrolidone, propylene glycol monobutyl ether and propylene glycol diacetate, N-ethyl-2-pyrrolidone, propylene glycol monobutyl ether and diisobutyl ketone, N-ethyl-2-pyrrolidone, ⁇ -butyrolactone and diisobutyl ketone, N-ethyl-2-pyrrolidone, N,N-dimethyl lactamide and diisobutyl ketone, N-methyl Examples of such compounds include N-ethyl-2-pyrrolidone, ethylene glycol monobutyl ether, and ethylene glycol monobutyl ether acetate, ⁇ -butyrolactone,
- the solid content concentration in the liquid crystal alignment agent (the ratio of the total mass of the components other than the solvent of the liquid crystal alignment agent to the total mass of the liquid crystal alignment agent) is appropriately selected in consideration of viscosity, volatility, etc., and is preferably in the range of 1 to 10 mass%. From the viewpoint of forming a uniform and defect-free coating film, 1 mass% or more is preferable, and from the viewpoint of storage stability of the solution, 10 mass% or less is preferable. A particularly preferable solid content concentration is 2 to 8 mass%.
- the range of the solid content may be appropriately selected depending on the method used when applying the liquid crystal alignment agent to the substrate. For example, when spin-coating is performed, it is particularly preferable that the solid content is 1.5 to 4.5% by mass.
- the solid content is 3 to 9% by mass, thereby making the solution viscosity 12 to 50 mPa ⁇ s.
- the solid content is 1 to 5% by mass, thereby making the solution viscosity 3 to 15 mPa ⁇ s.
- the temperature when preparing the liquid crystal alignment agent is preferably 10 to 50°C, more preferably 20 to 30°C.
- the concentration of the polymer component in the liquid crystal alignment agent can be appropriately changed depending on the thickness of the coating film to be formed.
- the content of the polymer component (P) is preferably 99.9 parts by mass or less, more preferably 99 parts by mass or less, per 100 parts by mass of the total of the polymers contained in the liquid crystal alignment agent.
- the liquid crystal alignment agent of the present invention may contain other components as necessary.
- such components include other polymers than the polymer (P) and the polyimide precursors (A) and (B); at least one compound selected from the group consisting of crosslinkable compounds having at least one substituent selected from an epoxy group, an isocyanate group, an oxetanyl group, a cyclocarbonate group, a blocked isocyanate group, a hydroxyl group, and an alkoxy group (excluding the above compound (C)), and crosslinkable compounds having a polymerizable unsaturated group; functional silane compounds; metal chelate compounds; curing accelerators; surfactants; antioxidants; sensitizers; preservatives; compounds for adjusting the dielectric constant and electrical resistance of the liquid crystal alignment film; compounds for promoting imidization, and the like.
- polysiloxanes examples include polymers selected from the group consisting of polysiloxanes, polyesters, polyamides, polyureas, polyurethanes, polyorganosiloxanes, cellulose derivatives, polyacetals, polystyrene derivatives, poly(styrene-maleic anhydride) copolymers, poly(isobutylene-maleic anhydride) copolymers, poly(vinyl ether-maleic anhydride) copolymers, poly(styrene-phenylmaleimide) derivatives, and poly(meth)acrylates.
- polysiloxanes examples include polymers selected from the group consisting of polysiloxanes, polyesters, polyamides, polyureas, polyurethanes, polyorganosiloxanes, cellulose derivatives, polyacetals, polystyrene derivatives, poly(styrene-maleic anhydride) copolymers, poly(isobutylene-male
- poly(styrene-maleic anhydride) copolymers include SMA1000, 2000, 3000 (Cray Valley) and GSM301 (Gifu Ceramics Manufacturing).
- poly(isobutylene-maleic anhydride) copolymers include ISOBAM-600 (Kuraray).
- poly(vinyl ether-maleic anhydride) copolymers include Gantrez AN-139 (methyl vinyl ether maleic anhydride resin, Ashland).
- the other polymers may be used alone or in combination of two or more.
- the content of the other polymers is preferably 90 parts by mass or less, more preferably 80 parts by mass or less, relative to a total of 100 parts by mass of the polymers contained in the liquid crystal alignment agent.
- the content of the other polymers is preferably 0.1 parts by mass or more, more preferably 1 part by mass or more, relative to a total of 100 parts by mass of the polymers contained in the liquid crystal alignment agent.
- crosslinkable compounds include ethylene glycol diglycidyl ether, polyethylene glycol diglycidyl ether, propylene glycol diglycidyl ether, tripropylene glycol diglycidyl ether, polypropylene glycol diglycidyl ether, neopentyl glycol diglycidyl ether, 1,6-hexanediol diglycidyl ether, glycerin diglycidyl ether, dibromoneopentyl glycol diglycidyl ether, 1,3,5,6-tetraglycidyl-2,4-hexanediol, bisphenol A type epoxy resins such as Epicoat 828 (manufactured by Mitsubishi Chemical Corporation), bisphenol F type epoxy resins such as Epicoat 807 (manufactured by Mitsubishi Chemical Corporation), hydrogenated bisphenol A type epoxy resins such as YX-8000 (manufactured by Mitsubishi Chemical Corporation), and biphenyls such as YX
- phenol novolac type epoxy resins such as EPPN-201 (manufactured by Nippon Kayaku Co., Ltd.), (o, m, p-) cresol novolac type epoxy resins such as EOCN-102S (manufactured by Nippon Kayaku Co., Ltd.), triglycidyl isocyanurates such as TEPIC (manufactured by Nissan Chemical Industries, Ltd.), alicyclic epoxy resins such as Celloxide 2021P (manufactured by Daicel Corporation), N,N,N',N'-tetraglycidyl-m-xylylenediamine, 1,3-bis(2-methyl-2-propanediol), compounds containing a tertiary nitrogen atom, such as tetrakis(glycidyloxymethyl)methane, and compounds having two or more oxiranyl groups, such as tetrakis(N,N-diglycidy
- the compound for adjusting the dielectric constant and electrical resistance is, for example, a monoamine having a nitrogen atom-containing aromatic heterocycle, such as 3-picolylamine.
- the content of the monoamine having a nitrogen atom-containing aromatic heterocycle is preferably 0.1 to 30 parts by mass, more preferably 0.1 to 20 parts by mass, per 100 parts by mass of the polymer component contained in the liquid crystal alignment agent.
- Preferred specific examples of the functional silane compounds include 3-aminopropyltrimethoxysilane, 3-aminopropyltriethoxysilane, 3-aminopropyldiethoxymethylsilane, 2-aminopropyltrimethoxysilane, 2-aminopropyltriethoxysilane, N-(2-aminoethyl)-3-aminopropyltrimethoxysilane, N-(2-aminoethyl)-3-aminopropylmethyldimethoxysilane, 3-ureidopropyltrimethoxysilane, 3-ureidopropyltriethoxysilane, vinyltrimethoxysilane, vinyltriethoxysilane, 2-(3,4-epoxycyclohexyl)ethyltrimethoxysilane, 3-glycidoxypropylmethyldimethoxysilane, Examples of the functional silane include 3-glycidoxypropyl trime
- a compound having a basic site e.g., a primary amino group, an aliphatic heterocycle (e.g., a pyrrolidine skeleton), an aromatic heterocycle (e.g., an imidazole ring, an indole ring), or a guanidino group, etc.) (excluding the above-mentioned crosslinking compound and adhesion aid), or a compound which generates the above-mentioned basic site upon baking, is preferred.
- a compound which generates the above-mentioned basic site upon baking is more preferred, and preferred specific examples include amino acids in which some or all of the basic sites of the amino acid are protected.
- Examples of protecting groups for the basic sites of the above-mentioned amino acids include carbamate-based protecting groups such as a Boc group.
- Specific examples of the above-mentioned amino acids include glycine, alanine, cysteine, methionine, asparagine, glutamine, valine, leucine, phenylalanine, tyrosine, tryptophan, proline, hydroxyproline, arginine, histidine, lysine, and ornithine.
- a more preferred example of the compound for promoting imidization is N- ⁇ -(9-fluorenylmethoxycarbonyl)-N- ⁇ -(tert-butoxycarbonyl)-L-histidine.
- the content of the compound for promoting imidization contained in the liquid crystal alignment agent of the present invention is preferably 0.1 to 30 parts by mass, more preferably 0.1 to 20 parts by mass, and even more preferably 5 to 20 parts by mass, relative to 100 parts by mass of the polymer component contained in the liquid crystal alignment agent.
- the liquid crystal display element according to the present invention comprises a liquid crystal alignment film formed using the liquid crystal aligning agent.
- the liquid crystal alignment film of the present invention can be produced, for example, by a method including the following steps (1) to (2) or a method including the following steps (1) to (3).
- the operation mode of the liquid crystal display element is not particularly limited, and various operation modes can be applied, such as the TN mode, STN mode, vertical alignment mode (including the VA-MVA mode, VA-PVA mode, etc.), in-plane switching mode (IPS mode, FFS mode), and optical compensation bend mode (OCB mode).
- the liquid crystal display element of the present invention can be produced, for example, by a method including the following steps (1) to (4), a method including steps (1) to (2) and (4), a method including steps (1) to (3), (4-2) and (4-4), or a method including steps (1) to (3), (4-3) and (4-4).
- one embodiment of the liquid crystal display element of the present invention is a liquid crystal display element having a liquid crystal alignment film formed by a method for producing a liquid crystal alignment film, the method including the following steps (1) to (2) or steps (1) to (3):
- Step (1) is a step of applying a liquid crystal alignment agent onto a substrate.
- a specific example of step (1) is as follows.
- a liquid crystal alignment agent is applied to one side of a substrate on which a patterned transparent conductive film is provided, for example, by a suitable application method such as a roll coater method, a spin coat method, a printing method, or an inkjet method.
- the material of the substrate is not particularly limited as long as it is a highly transparent substrate, and plastics such as acrylic and polycarbonate can be used in addition to glass and silicon nitride.
- an opaque material such as a silicon wafer can be used for only one substrate, and in this case, a material that reflects light such as aluminum can be used for the electrode.
- a substrate on which an electrode made of a transparent conductive film or a metal film patterned into a comb tooth shape is provided and an opposing substrate on which no electrode is provided are used.
- An IPS substrate which is a comb-tooth electrode substrate used in an IPS-type liquid crystal display element, has, for example, a base material, a plurality of linear electrodes formed on the base material and arranged in a comb-tooth shape, and a liquid crystal alignment film formed on the base material so as to cover the linear electrodes.
- An FFS substrate which is a comb-tooth electrode substrate used in an FFS-type liquid crystal display element, has, for example, a base material, a surface electrode formed on the base material, an insulating film formed on the surface electrode, a plurality of linear electrodes formed on the insulating film and arranged in a comb-tooth shape, and a liquid crystal alignment film formed on the insulating film so as to cover the linear electrodes.
- Methods for applying the liquid crystal alignment agent to a substrate and forming a film include screen printing, offset printing, flexographic printing, the inkjet method, and the spray method.
- the inkjet method is the most suitable for application and film formation.
- Step (2) Step of baking the applied liquid crystal alignment agent>
- the liquid crystal alignment agent applied on the substrate is baked to form a film.
- the solvent can be evaporated or the polyimide precursor, typified by polyamic acid, can be thermally imidized by a heating means such as a hot plate, a hot air circulation oven, or an IR (infrared) oven.
- the drying and baking process after the application of the liquid crystal alignment agent can be performed at any temperature and time, and may be performed multiple times.
- the temperature for baking the liquid crystal alignment agent can be, for example, 40 to 180°C.
- the baking time is not particularly limited, but may be 1 to 10 minutes or 1 to 5 minutes.
- a baking process at, for example, 150 to 300°C or 150 to 250°C may be added after the above process.
- the baking time is not particularly limited, but may be 5 to 40 minutes or 5 to 30 minutes. If the film-like material after firing is too thin, the reliability of the liquid crystal display device may decrease, so the film thickness is preferably 5 to 300 nm, and more preferably 10 to 200 nm.
- Step (3) is a step of subjecting the film obtained in step (2) to an alignment treatment, if necessary. That is, in a horizontal alignment type liquid crystal display element such as an IPS type or FFS type, an alignment ability imparting treatment is performed on the coating film. On the other hand, in a vertical alignment type liquid crystal display element such as a VA type or PSA type, the formed coating film can be used as a liquid crystal alignment film as it is, but the coating film may be subjected to an alignment ability imparting treatment. Examples of the alignment treatment method for the liquid crystal alignment film include a rubbing alignment treatment method and a photo-alignment treatment method.
- Examples of the photo-alignment treatment method include a method in which the surface of the above-mentioned film-like material is irradiated with radiation, preferably polarized in a certain direction, and preferably heated to impart liquid crystal alignment (also called liquid crystal alignment ability).
- radiation ultraviolet rays or visible light having a wavelength of 100 to 800 nm can be used. Among them, ultraviolet rays having a wavelength of 100 to 400 nm are preferable, and more preferably, ultraviolet rays having a wavelength of 200 to 400 nm are more preferable.
- the radiation dose is preferably 1 to 10,000 mJ/cm 2 , and more preferably 100 to 5,000 mJ/cm 2.
- the substrate having the film-like material may be irradiated while being heated at 50 to 250° C. in order to improve the liquid crystal alignment.
- the liquid crystal alignment film thus produced can stably align liquid crystal molecules in a certain direction.
- Examples of light sources for the irradiation light include low-pressure mercury lamps, high-pressure mercury lamps, deep UV lamps, deuterium lamps, metal halide lamps, argon resonance lamps, xenon lamps, mercury-xenon lamps, excimer lasers (e.g., KrF excimer lasers), fluorescent lamps, LED lamps, halogen lamps (e.g., sodium lamps), and microwave-excited electrodeless lamps.
- excimer lasers e.g., KrF excimer lasers
- fluorescent lamps e.g., LED lamps
- halogen lamps e.g., sodium lamps
- microwave-excited electrodeless lamps e.g., microwave-excited electrodeless lamps.
- the extinction ratio of the polarized ultraviolet light is more preferably 10:1 or greater, and even more preferably 20:1 or greater.
- the coating film irradiated with polarized radiation or the coating film that has been subjected to rubbing alignment treatment by the above method may be subjected to a contact treatment using water or a solvent.
- the film that has been subjected to the above alignment treatment may be subjected to a heat treatment without being subjected to a contact treatment.
- the film that has been subjected to the above contact treatment may be further subjected to a heat treatment.
- the solvent used in the contact treatment is not particularly limited, so long as it dissolves the decomposition products generated from the film-like material by irradiation with radiation.
- Specific examples include water, methanol, ethanol, 2-propanol, acetone, methyl ethyl ketone, 1-methoxy-2-propanol, 1-methoxy-2-propanol acetate, butyl cellosolve, ethyl lactate, methyl lactate, diacetone alcohol, methyl 3-methoxypropionate, ethyl 3-ethoxypropionate, propyl acetate, butyl acetate, cyclohexyl acetate, and the like.
- the solvent may be one type or a combination of two or more types.
- the temperature for the heat treatment of the coating film irradiated with the above radiation or the film that has been contact-treated is preferably 50 to 300°C, more preferably 120 to 300°C, even more preferably 150 to 300°C, and most preferably 150 to 250°C.
- the heat treatment time is preferably 1 to 30 minutes, respectively.
- Step (4) Step of Producing a Liquid Crystal Cell> Two substrates on which the liquid crystal alignment film is formed as described above are prepared, and liquid crystal is disposed between the two substrates arranged opposite to each other. Specifically, the following two methods can be mentioned.
- the first method first, two substrates are arranged facing each other with a gap (cell gap) between them so that the liquid crystal alignment films face each other, and then the peripheries of the two substrates are bonded together using a sealant, and a liquid crystal composition is injected into the substrate surfaces and the cell gap defined by the sealant so that the liquid crystal composition comes into contact with the film surface, and then the injection hole is sealed.
- the second method is a method called ODF (One Drop Fill) method.
- ODF One Drop Fill
- a UV-curable sealant is applied to a predetermined location on one of the two substrates on which a liquid crystal alignment film is formed, and a liquid crystal composition is dropped at several predetermined locations on the liquid crystal alignment film surface.
- the other substrate is bonded so that the liquid crystal alignment film faces the other substrate, and the liquid crystal composition is spread over the entire surface of the substrate and contacted with the film surface.
- the entire surface of the substrate is irradiated with UV light to cure the sealant.
- it is preferable to remove the flow alignment during liquid crystal filling by heating to a temperature at which the liquid crystal composition used has an isotropic phase and then slowly cooling to room temperature.
- the two substrates are disposed opposite to each other so that the rubbing directions of the coating films are at a predetermined angle, for example, perpendicular or anti-parallel to each other.
- the sealing agent for example, an epoxy resin containing a hardener and aluminum oxide spheres as spacers can be used.
- the liquid crystal composition is not particularly limited, and may be a composition containing at least one liquid crystal compound (liquid crystal molecule), and may be a liquid crystal composition exhibiting a nematic phase (hereinafter also referred to as nematic liquid crystal), a liquid crystal exhibiting a smectic phase, or a liquid crystal composition exhibiting a cholesteric phase, among which nematic liquid crystal is preferred.
- various liquid crystal compositions having positive or negative dielectric anisotropy may be used.
- a liquid crystal composition having a positive dielectric anisotropy is also referred to as a positive liquid crystal
- a liquid crystal composition having a negative dielectric anisotropy is also referred to as a negative liquid crystal.
- the liquid crystal composition may contain a liquid crystal compound having a fluorine atom, a hydroxy group, an amino group, a fluorine atom-containing group (e.g., a trifluoromethyl group), a cyano group, an alkyl group, an alkoxy group, an alkenyl group, an isothiocyanate group, a heterocycle, a cycloalkane, a cycloalkene, a steroid skeleton, a benzene ring, or a naphthalene ring, and may contain a compound having two or more rigid moieties (mesogenic skeletons) that exhibit liquid crystallinity within the molecule (e.g., a bimesogenic compound in which two rigid biphenyl structures or terphenyl structures are linked by an alkyl group).
- a fluorine atom-containing group e.g., a trifluoromethyl group
- a cyano group e.g.,
- the liquid crystal composition may further contain an additive from the viewpoint of improving the liquid crystal alignment property.
- additives include a photopolymerizable monomer such as a compound having a polymerizable group (e.g., a (meth)acryloyl group), an optically active compound (e.g., S-811 manufactured by Merck Ltd.), an antioxidant, an ultraviolet absorber, a dye, an antifoaming agent, a polymerization initiator, or a polymerization inhibitor.
- a photopolymerizable monomer such as a compound having a polymerizable group (e.g., a (meth)acryloyl group)
- an optically active compound e.g., S-811 manufactured by Merck Ltd.
- an antioxidant e.g., S-811 manufactured by Merck Ltd.
- an ultraviolet absorber e.g., S-811 manufactured by Merck Ltd.
- examples of the positive type liquid crystal include ZLI-2293, ZLI-4792, MLC-2003,
- Examples of negative type liquid crystals include MLC-6608, MLC-6609, MLC-6610, MLC-7026, and MLC-7026-100 manufactured by Merck. Furthermore, an example of a liquid crystal containing a compound having a polymerizable group is MLC-3023 manufactured by Merck.
- the liquid crystal aligning agent of the present invention is also preferably used for a liquid crystal display element (PSA type liquid crystal display element) which has a liquid crystal layer between a pair of substrates provided with electrodes, and is manufactured through a process of disposing a liquid crystal composition containing a polymerizable compound which is polymerized by at least one of active energy rays and heat between the pair of substrates, and polymerizing the polymerizable compound by at least one of irradiation with active energy rays and heating while applying a voltage between the electrodes.
- PSA type liquid crystal display element which has a liquid crystal layer between a pair of substrates provided with electrodes, and is manufactured through a process of disposing a liquid crystal composition containing a polymerizable compound which is polymerized by at least one of active energy rays and heat between the pair of substrates, and polymerizing the polymerizable compound by at least one of irradiation with active energy rays and heating while applying a voltage between the electrodes.
- the liquid crystal aligning agent of the present invention is also preferably used for a liquid crystal display element (SC-PVA type liquid crystal display element) which has a liquid crystal layer between a pair of substrates having electrodes, and is manufactured through a process of disposing a liquid crystal alignment film containing a polymerizable group that is polymerized by at least one of active energy rays and heat between the pair of substrates, and applying a voltage between the electrodes.
- SC-PVA type liquid crystal display element which has a liquid crystal layer between a pair of substrates having electrodes, and is manufactured through a process of disposing a liquid crystal alignment film containing a polymerizable group that is polymerized by at least one of active energy rays and heat between the pair of substrates, and applying a voltage between the electrodes.
- Step (4-2) In the case of a PSA type liquid crystal display element> The method is carried out in the same manner as in (4) above, except that a liquid crystal composition containing a polymerizable compound is injected or dropped.
- the polymerizable compound include polymerizable compounds having one or more polymerizable unsaturated groups in the molecule, such as an acrylate group or a methacrylate group.
- Step (4-3) In the case of an SC-PVA type liquid crystal display element> A method of manufacturing a liquid crystal display element through a step of irradiating ultraviolet light described later after the same procedure as in (4) above may be adopted. According to this method, a liquid crystal display element having excellent response speed can be obtained with a small amount of light irradiation, as in the case of manufacturing the PSA type liquid crystal display element.
- the compound having a polymerizable group may be a compound having one or more of the above-mentioned polymerizable unsaturated groups in the molecule, and the content thereof is preferably 0.1 to 30 parts by mass, more preferably 1 to 20 parts by mass, relative to 100 parts by mass of the polymer component contained in the liquid crystal alignment agent.
- the polymerizable group may be contained in the polymer used in the liquid crystal alignment agent, and an example of such a polymer includes a polymer obtained by using a diamine component containing a diamine having the above-mentioned photopolymerizable group at its terminal in a reaction.
- Step (4-4) Step of irradiating with ultraviolet light>
- the liquid crystal cell is irradiated with light while a voltage is applied between the conductive films of the pair of substrates obtained in (4-2) or (4-3) above.
- the voltage applied here can be, for example, 5 to 50 V DC or AC.
- the light to be irradiated can be, for example, ultraviolet light and visible light containing light with a wavelength of 150 to 800 nm, but ultraviolet light containing light with a wavelength of 300 to 400 nm is preferred.
- the light source for the irradiation light can be, for example, a low-pressure mercury lamp, a high-pressure mercury lamp, a deuterium lamp, a metal halide lamp, an argon resonance lamp, a xenon lamp, an excimer laser, or the like.
- the amount of light irradiation is preferably 1,000 to 200,000 J/m 2 , more preferably 1,000 to 100,000 J/m 2 .
- a polarizing plate can be attached to the outer surface of the liquid crystal cell to obtain a liquid crystal display element.
- polarizing plates that can be attached to the outer surface of the liquid crystal cell include a polarizing film called an "H film" made by absorbing iodine while stretching and aligning polyvinyl alcohol, sandwiched between cellulose acetate protective films, and a polarizing plate made of the H film itself.
- NMP N-methyl-2-pyrrolidone
- GBL ⁇ -butyrolactone
- BCS Ethylene glycol monobutyl ether
- DA-1 to DA12 Compounds represented by the following structural formulas (DA-1) to (DA-12), respectively.
- CA-1 to CA-5 Compounds represented by the following structural formulas (CA-1) to (CA-5), respectively.
- AD-1 Compound represented by the following structural formula (AD-1)
- AD-2 3-glycidoxypropyltriethoxysilane
- AD-3 3-aminopropyltriethoxysilane
- AD-4 N- ⁇ -(9-fluorenylmethoxycarbonyl)-N- ⁇ -(tert-butoxycarbonyl)-L-histidine
- the viscosity of the polymer solution was measured using an E-type viscometer TVE-22H (manufactured by Toki Sangyo Co., Ltd.) with a sample amount of 1.1 mL, a cone rotor TE-1 (1°34′, R24), and a temperature of 25°C.
- the imidization rate of the polyimide in the synthesis example was measured as follows. 30 mg of polyimide powder was placed in an NMR (nuclear magnetic resonance) sample tube (NMR sampling tube standard, ⁇ 5 (Kusano Scientific Co., Ltd.)), deuterated dimethyl sulfoxide (DMSO-d6, 0.05 mass % TMS (tetramethylsilane) mixture) (0.53 mL) was added, and the mixture was completely dissolved by applying ultrasonic waves. This solution was measured for proton NMR at 500 MHz using an NMR measurement device (JNW-ECA500) (JEOL Datum Co., Ltd.).
- x is the integrated value of the proton peak derived from the NH group of the amic acid
- y is the integrated value of the peak of the reference proton
- ⁇ is the ratio of the number of reference protons to one NH group proton of the amic acid in the case of polyamic acid (imidization rate 0%).
- Synthesis Example 8 50 g of the polymer solution (Polymer-7) obtained in Synthesis Example 7 was weighed out into a 100 mL four-neck flask equipped with a stirrer and a nitrogen inlet tube, and 25 g of NMP was added and stirred for 30 minutes. 4.16 g of acetic anhydride and 1.07 g of pyridine were added to the obtained polyamic acid solution, and the mixture was heated at 55° C. for 2 hours and 30 minutes to perform chemical imidization. The obtained reaction solution was poured into 300 mL of methanol while stirring, and the precipitate was filtered out. Subsequently, the precipitate was washed three times with 300 mL of methanol.
- the obtained resin powder was dried at 60° C. for 12 hours to obtain a polyimide resin powder.
- the imidization rate of this polyimide resin powder was 70%.
- 4.80 g of the obtained polyimide resin powder was weighed out into a 100 mL Erlenmeyer flask containing a stirrer, 35.20 g of NMP was added, and the mixture was stirred at 70° C. for 12 hours to dissolve the polyimide resin powder, thereby obtaining a polymer solution (polymer-8) having a solid content of 12% by mass.
- the specifications of the polymer obtained in the above synthesis example are shown in Table 1.
- the numbers in parentheses for the tetracarboxylic acid components indicate the amount (parts by mole) of each tetracarboxylic dianhydride used per 100 parts by mole of the total amount of tetracarboxylic acid components used in the polymerization.
- the numbers in parentheses for the diamine components indicate the amount (parts by mole) of each diamine used per 100 parts by mole of the total amount of diamine components used in the polymerization.
- Example 1 In a 30 mL Erlenmeyer flask containing a stirrer, the solution (9.17 g) of the polymer (polymer-1) obtained in Synthesis Example 1 was weighed out, and NMP (2.83 g), BCS (6.00 g), a 10 mass% NMP solution of AD-1 (0.56 g), a 1 mass% NMP solution of AD-2 (1.10 g), AD-4 (0.15 g), and compound (c) (0.20 g) were added, and the mixture was stirred at room temperature for 2 hours to obtain a liquid crystal alignment agent (1).
- Example 2 In a 30 mL Erlenmeyer flask containing a stirrer, the solution (3.67 g) of the polymer (polymer-1) obtained in Synthesis Example 1 and the solution (5.50 g) of the polymer (polymer-2) obtained in Synthesis Example 2 were weighed out, and NMP (2.83 g), BCS (6.00 g), 10 mass% NMP solution (0.56 g) of AD-1, 1 mass% NMP solution (1.10 g) of AD-2, AD-4 (0.15 g), and compound (c) (0.20 g) were added, and the mixture was stirred at room temperature for 2 hours to obtain a liquid crystal alignment agent (2).
- Example 4 In a 30 mL Erlenmeyer flask containing a stirrer, the solution (3.00 g) of the polymer (polymer-8) obtained in Synthesis Example 8 and the solution (4.50 g) of the polymer (polymer-2) obtained in Synthesis Example 2 were weighed out, and NMP (0.86 g), GBL (6.00 g), BCS (4.00 g), 10 mass% NMP solution of AD-1 (0.45 g), 1 mass% NMP solution of AD-2 (0.90 g), AD-4 (0.09 g), and compound (c) (0.20 g) were added, and the mixture was stirred at room temperature for 2 hours to obtain a liquid crystal alignment agent (4).
- Example 5 In a 30 mL Erlenmeyer flask containing a stirrer, the solution (2.00 g) of the polymer (polymer-3) obtained in Synthesis Example 3 and the solution (9.60 g) of the polymer (polymer-4) obtained in Synthesis Example 4 were weighed out, and NMP (3.24 g), BCS (4.00 g), a 1 mass % NMP solution of AD-3 (0.96 g), and compound (c) (0.20 g) were added, and the mixture was stirred at room temperature for 2 hours to obtain a liquid crystal alignment agent (5).
- a liquid crystal cell having the configuration of a liquid crystal display element of an FFS driving method was fabricated.
- a substrate with electrodes was prepared.
- the substrate was a glass substrate with a size of 30 mm x 50 mm and a thickness of 0.7 mm.
- An ITO electrode with a solid pattern was formed on the substrate, which constituted the counter electrode as the first layer.
- a SiN (silicon nitride) film formed by a CVD method was formed as the second layer on the first layer of the counter electrode.
- the second layer of the SiN film was a 500 nm thick film that functioned as an interlayer insulating film.
- a comb-shaped pixel electrode formed by patterning an ITO film as the third layer was arranged on the second layer of the SiN film, and two pixels, a first pixel and a second pixel, were formed.
- the size of each pixel was 10 mm long and about 5 mm wide.
- the first layer of the counter electrode and the third layer of the pixel electrode were electrically insulated by the action of the second layer of the SiN film.
- the pixel electrode of the third layer had a comb-tooth shape in which multiple electrode elements, each 3 ⁇ m wide and bent at an interior angle of 160° in the center, were arranged in parallel at intervals of 6 ⁇ m, and each pixel had a first region and a second region separated by a line connecting the bent portions of the multiple electrode elements.
- the electrode elements of the pixel electrodes constituting them were formed in different directions.
- the electrode elements of the pixel electrodes in the first region of the pixel were formed to form an angle of 80° clockwise, and the electrode elements of the pixel electrodes in the second region of the pixel were formed to form an angle of 80° counterclockwise. That is, in the first and second regions of each pixel, the directions of rotational movement (in-plane switching) of liquid crystal molecules in the substrate plane induced by application of a voltage between the pixel electrode and the counter electrode were configured to be opposite to each other.
- liquid crystal alignment agents (1) to (4) and the liquid crystal alignment agents (7) to (10) obtained in Examples 1 to 4 and Comparative Examples 1 to 4 of the liquid crystal alignment agent were filtered through a 1.0 ⁇ m filter, and then applied by spin coating to the above-mentioned electrode-attached substrate and a glass substrate having a columnar spacer with a height of 4 ⁇ m and an ITO film formed on the back surface. After drying for 5 minutes on a hot plate at 80°C, it was baked for 30 minutes in a hot air circulation oven at 230°C to form a coating film with a thickness of 100 nm. Next, a photoalignment treatment was performed.
- the coating surface was irradiated with linearly polarized ultraviolet light with a wavelength of 254 nm and an extinction ratio of 10:1 or more through a polarizing plate.
- the irradiation amount of the ultraviolet light was performed under the conditions shown in Table 3 below.
- a heating process was performed in which the above-mentioned coating-attached substrate was heated on a hot plate at 230°C for 30 minutes, and a substrate with a liquid crystal alignment film was obtained.
- the substrate on which the coating film was formed was rubbed with a rayon cloth (roller diameter: 140 mm, roller rotation speed: 1000 rpm, moving speed: 30 mm/sec, indentation length: 0.3 mm). Thereafter, the substrate was cleaned by irradiating ultrasonic waves in pure water for 1 minute, water droplets were removed by air blowing, and then dried at 80°C for 10 minutes to obtain a substrate with a liquid crystal alignment film. Two substrates with the liquid crystal alignment film thus obtained were prepared, and a liquid crystal cell of the FFS driving system was fabricated in the same manner as above, and used for the following evaluations.
- a liquid crystal cell was placed between two polarizing plates arranged so that the polarization axes were perpendicular to each other, and the backlight was turned on to adjust the arrangement angle of the liquid crystal cell so that the transmitted light intensity of the first region of the pixel was minimized.
- the rotation angle ( ⁇ ) required when the liquid crystal cell was rotated so that the transmitted light intensity of the second region of the pixel was minimized was calculated. It can be said that the smaller the value of this rotation angle, the better the afterimage characteristics due to long-term AC driving.
- the voltage holding ratio of the liquid crystal cell prepared above was evaluated. Specifically, an AC voltage of 2 VPP was applied to the liquid crystal cell obtained by the above method for 60 ⁇ s at a temperature of 60° C., the voltage after 1 second was measured, and the voltage that could be held was calculated as the voltage holding ratio (also referred to as VHR). The measurement was performed using a voltage holding ratio measuring device (VHR-1, manufactured by Toyo Corporation) with the settings of Voltage: ⁇ 1 V, Pulse Width: 60 ⁇ s, and Flame Period: 1000 ms.
- VHR-1 voltage holding ratio measuring device
- liquid crystal display element having the configuration of the present invention By using a liquid crystal display element having the configuration of the present invention, it is possible to obtain a liquid crystal display element in which the variation (non-uniformity) in the twist angle of the liquid crystal within the liquid crystal alignment film plane is small and AC afterimages can be suppressed. Furthermore, since a liquid crystal display element with a high voltage retention rate is obtained, it is expected that it will be used in liquid crystal display elements that require high display quality. These elements are also useful in liquid crystal displays for display purposes, and in light control windows and optical shutters that control the transmission and blocking of light.
Landscapes
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Nonlinear Science (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Mathematical Physics (AREA)
- General Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Materials Engineering (AREA)
- Engineering & Computer Science (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
Abstract
Description
本発明は、液晶配向剤、液晶配向膜及び液晶表示素子に関する。 The present invention relates to a liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display element.
液晶表示素子は、例えば、素子基板とカラーフィルタ基板との間に挟持された液晶層、液晶層に電界を印加する画素電極及び共通電極、液晶層の液晶分子の配向性を制御する液晶配向膜、画素電極に供給される電気信号をスイッチングする薄膜トランジスタ(TFT)等を備えている。液晶分子の駆動方式としては、TN(Twisted Nematic)方式、VA(Vertical Alignment)方式等の縦電界方式や、IPS(In-Plane Switching)方式、FFS(Fringe Field Switching)方式等の横電界方式が知られている。 A liquid crystal display element, for example, comprises a liquid crystal layer sandwiched between an element substrate and a color filter substrate, pixel electrodes and a common electrode that apply an electric field to the liquid crystal layer, a liquid crystal alignment film that controls the orientation of the liquid crystal molecules in the liquid crystal layer, and thin film transistors (TFTs) that switch the electrical signals supplied to the pixel electrodes. Known methods for driving liquid crystal molecules include vertical electric field methods such as the TN (Twisted Nematic) method and the VA (Vertical Alignment) method, and horizontal electric field methods such as the IPS (In-Plane Switching) method and the FFS (Fringe Field Switching) method.
現在、工業的に最も普及している液晶配向膜は、電極基板上に形成された、ポリアミック酸及び/又はこれをイミド化したポリイミドに代表される重合体からなる膜の表面を、綿、ナイロン、ポリエステル等の布で一方向に擦る、いわゆるラビング処理を行うことで作製されている(例えば、特許文献1参照)。ラビング処理は、簡便で生産性に優れた工業的に有用な方法である。一方、液晶表示素子の高性能化、高精細化、大型化に伴い、ラビング処理に代わる配向処理方法として、偏光された放射線を照射することにより、液晶配向能を付与する光配向法が知られている。光配向法は、光異性化反応を利用したもの、光架橋反応を利用したもの、光分解反応を利用したもの等が提案されている(例えば、特許文献2、非特許文献1参照)。 Currently, the most widely used liquid crystal alignment film industrially is produced by rubbing the surface of a film made of a polymer, typically polyamic acid and/or polyimide formed by imidizing it, formed on an electrode substrate in one direction with a cloth such as cotton, nylon, or polyester, a so-called rubbing process (see, for example, Patent Document 1). The rubbing process is an industrially useful method that is simple and has excellent productivity. On the other hand, as liquid crystal display elements have become higher in performance, definition, and size, a photoalignment method that imparts liquid crystal alignment ability by irradiating polarized radiation has been known as an alternative alignment method to the rubbing process. As for photoalignment methods, methods that utilize photoisomerization reactions, photocrosslinking reactions, photodecomposition reactions, etc. have been proposed (see, for example, Patent Document 2 and Non-Patent Document 1).
近年では、大画面で高精細な液晶表示素子が主体となり、またスマートフォン、タブレットPCやカーナビゲーションといった小型の表示端末の普及が進み、液晶表示素子に対する高品質化の要求は従来よりも増してさらに高まっている。特に、液晶表示素子が大型化するに伴い、製造工程でのバラツキによって液晶表示素子面内での液晶のツイスト角がわずかにばらついてしまう、という不具合が発生するようになった。このようなバラツキは、液晶表示素子では黒表示とした際に明るさが面内で不均一となり、液晶表示素子の品位を低下させることにつながる。
また、IPS方式やFFS方式に代表される液晶表示素子に用いられる液晶配向膜には、長期交流駆動によって発生する残像(以下、AC残像ともいう)を抑制するための、高い配向規制力が必要とされる。
In recent years, large-screen, high-definition liquid crystal display elements have become mainstream, and small display terminals such as smartphones, tablet PCs, and car navigation systems have become more widespread, so the demand for high quality liquid crystal display elements is increasing more than ever before. In particular, as liquid crystal display elements become larger, a defect has occurred in which the twist angle of the liquid crystal within the liquid crystal display element surface varies slightly due to variations in the manufacturing process. Such variations cause the brightness of the liquid crystal display element to become non-uniform within the surface when the liquid crystal display element is set to display black, which leads to a decrease in the quality of the liquid crystal display element.
In addition, liquid crystal alignment films used in liquid crystal display elements, such as those of the IPS and FFS modes, require a high alignment control force to suppress image retention caused by long-term AC driving (hereinafter also referred to as AC image retention).
以上のようなことから、本発明の目的は、液晶の配向均一性に優れ、且つ、AC残像に対する耐性に優れた、液晶配向膜を得ることが出来る液晶配向剤、該液晶配向剤から得られる液晶配向膜、及び液晶表示素子を提供することにある。 In view of the above, the object of the present invention is to provide a liquid crystal alignment agent capable of producing a liquid crystal alignment film having excellent alignment uniformity of liquid crystals and excellent resistance to AC image retention, a liquid crystal alignment film obtained from the liquid crystal alignment agent, and a liquid crystal display element.
本発明者は、上記課題を達成するために鋭意研究を行った結果、1種類以上の重合体を含有する重合体成分(P)と、亜リン酸エステル化合物と、を含む液晶配向剤を用いることが、上記の目的を達成するために極めて有効であることを見出し、本発明を完成させた。 As a result of intensive research into achieving the above object, the inventors have discovered that using a liquid crystal aligning agent containing a polymer component (P) containing one or more types of polymers and a phosphite ester compound is extremely effective in achieving the above object, and have completed the present invention.
本発明は、以下の態様を包含するものである。
1種類以上の重合体を含有する重合体成分(P)、及び下記式(c)で表される化合物(C)を含有する液晶配向剤であって、
上記重合体成分(P)が、ポリイミド前駆体、及び該ポリイミド前駆体のイミド化物であるポリイミドからなる群から選ばれる少なくとも1種の重合体(P)を含有する、前記液晶配向剤。
(RcO)nP(=O)(OH)2-nH (c)
(式(c)中、Rcは、互いに独立に、炭素数1~6の1価の有機基を表す。nは、1又は2の整数である。)
なお、本明細書全体を通して、以下の用語及び略号の意味は、それぞれ、以下のとおりである。ハロゲン原子は、フッ素原子、塩素原子、臭素原子、ヨウ素原子などである。
*は、いずれの場合も、結合手を表す。また、Bocは、tert-ブトキシカルボニル基を表し、Fmocは、9-フルオレニルメトキシカルボニル基を表す。
The present invention includes the following aspects.
A liquid crystal aligning agent comprising a polymer component (P) containing one or more polymers, and a compound (C) represented by the following formula (c):
The liquid crystal aligning agent, wherein the polymer component (P) contains at least one polymer (P) selected from the group consisting of polyimide precursors and polyimides which are imidized products of the polyimide precursors.
(R c O) n P(=O)(OH) 2-n H (c)
(In formula (c), R c 's each independently represent a monovalent organic group having 1 to 6 carbon atoms, and n is an integer of 1 or 2.)
Throughout this specification, the following terms and abbreviations have the following meanings: Halogen atom includes a fluorine atom, a chlorine atom, a bromine atom, an iodine atom, and the like.
In each case, * represents a bond, Boc represents a tert-butoxycarbonyl group, and Fmoc represents a 9-fluorenylmethoxycarbonyl group.
本発明によれば、液晶の配向均一性に優れ、且つ、AC残像に対する耐性に優れた、液晶配向膜を得ることが出来る液晶配向剤、該液晶配向剤から得られる液晶配向膜、及び液晶表示素子を得ることができる。また、該液晶表示素子は、表示不良の少ない高い表示品位を有する。
本発明の上記効果が得られるメカニズムは必ずしも明らかではないが、ほぼ次のように推定される。亜リン酸化合物が本発明に記載の重合体(P)に作用し、膜表面状態を改質することにより、液晶配向性が良化したと推測される。また、2種類以上の重合体を用いた場合、特にその傾向が顕著に発現し、亜リン酸化合物が層分離促進剤として作用し、液晶配向性が良好な成分が膜表層に偏在し、液晶配向性が良化したと推測され、上記の効果が得られたと考えられる。
According to the present invention, it is possible to obtain a liquid crystal aligning agent capable of obtaining a liquid crystal alignment film having excellent alignment uniformity of liquid crystal and excellent resistance to AC afterimage, a liquid crystal alignment film obtained from the liquid crystal aligning agent, and a liquid crystal display element. In addition, the liquid crystal display element has high display quality with few display defects.
The mechanism by which the above-mentioned effects of the present invention are obtained is not necessarily clear, but is generally presumed to be as follows. It is presumed that the phosphorous acid compound acts on the polymer (P) described in the present invention to modify the film surface state, thereby improving the liquid crystal alignment. In addition, when two or more types of polymers are used, this tendency is particularly pronounced, and it is presumed that the phosphorous acid compound acts as a layer separation promoter, and components with good liquid crystal alignment are unevenly distributed on the film surface layer, improving the liquid crystal alignment, and the above-mentioned effects are obtained.
<重合体成分(P)>
本発明の液晶配向剤に含有される重合体成分(P)は、ポリイミド前駆体、及び該ポリイミド前駆体のイミド化物であるポリイミドからなる群から選ばれる少なくとも1種の重合体(P)を含有する。
上記重合体(P)は、例えば、1種以上の構造単位を有し、下記式(P0)で表される構造単位(p0)及び該構造単位(p0)のイミド化構造単位からなる群から選ばれる少なくとも一つの構造単位を有する態様であってもよい。
The polymer component (P) contained in the liquid crystal aligning agent of the present invention contains at least one polymer (P) selected from the group consisting of polyimide precursors and polyimides which are imidized products of the polyimide precursors. do.
The polymer (P) has, for example, one or more structural units, and is selected from the group consisting of a structural unit (p0) represented by the following formula (P0) and an imidized structural unit of the structural unit (p0): It may be an embodiment having at least one selected structural unit.
上記式(P0)におけるXは、4価の有機基を表し、好ましくは、4価のテトラカルボン酸残基を表す。ここで、4価のテトラカルボン酸残基とは、例えば、テトラカルボン酸二無水物、又はその誘導体(例えば、テトラカルボン酸、テトラカルボン酸ジハライド、テトラカルボン酸ジアルキルエステル、又はテトラカルボン酸ジアルキルエステルジハライドなど)が有する4つのカルボニル基の間に存在する4価の有機基が挙げられる。
上記Xは、本発明の効果を好適に得る観点から、中でも非環式脂肪族テトラカルボン酸二無水物、脂環式テトラカルボン酸二無水物、芳香族テトラカルボン酸二無水物、又はこれらの誘導体に由来する4価のテトラカルボン酸残基であることが好ましい。
上記Xを与えるテトラカルボン酸二無水物、又はその誘導体は、なかでも、ベンゼン環、シクロブタン環、シクロペンタン環及びシクロヘキサン環よりなる群から選ばれる少なくとも一種の部分構造を有するテトラカルボン酸二無水物又はその誘導体がより好ましい。
ここで、非環式脂肪族テトラカルボン酸二無水物は、鎖状炭化水素構造に結合する4つのカルボキシ基が分子内脱水することにより得られる酸二無水物である。但し、鎖状炭化水素構造のみで構成されている必要はなく、その一部に脂環式構造や芳香環構造を有していてもよい。
脂環式テトラカルボン酸二無水物は、脂環式構造に結合する少なくとも1つのカルボキシ基を含めて4つのカルボキシ基が分子内脱水することにより得られる酸二無水物である。但し、これら4つのカルボキシ基はいずれも芳香環には結合していない。また、脂環式構造のみで構成されている必要はなく、その一部に鎖状炭化水素構造や芳香環構造を有していてもよい。
芳香族テトラカルボン酸二無水物は、芳香環に結合する少なくとも1つのカルボキシ基を含めて4つのカルボキシ基が分子内脱水することにより得られる酸二無水物である。但し、芳香環構造のみで構成されている必要はなく、その一部に鎖状炭化水素構造や脂環式構造を有していてもよい。
X in the above formula (P0) represents a tetravalent organic group, preferably a tetravalent tetracarboxylic acid residue. Here, the tetravalent tetracarboxylic acid residue may be, for example, a tetravalent organic group present between four carbonyl groups of a tetracarboxylic acid dianhydride or a derivative thereof (e.g., a tetracarboxylic acid, a tetracarboxylic acid dihalide, a tetracarboxylic acid dialkyl ester, or a tetracarboxylic acid dialkyl ester dihalide, etc.).
From the viewpoint of suitably obtaining the effects of the present invention, the above-mentioned X is preferably a tetravalent tetracarboxylic acid residue derived from an acyclic aliphatic tetracarboxylic acid dianhydride, an alicyclic tetracarboxylic acid dianhydride, an aromatic tetracarboxylic acid dianhydride, or a derivative thereof.
The tetracarboxylic dianhydride or derivative thereof which gives the above X is more preferably a tetracarboxylic dianhydride or derivative thereof having at least one partial structure selected from the group consisting of a benzene ring, a cyclobutane ring, a cyclopentane ring, and a cyclohexane ring.
Here, the acyclic aliphatic tetracarboxylic acid dianhydride is an acid dianhydride obtained by intramolecular dehydration of four carboxy groups bonded to a chain hydrocarbon structure, but does not necessarily have to be composed of a chain hydrocarbon structure alone, and may have an alicyclic structure or an aromatic ring structure as a part thereof.
Alicyclic tetracarboxylic dianhydrides are acid dianhydrides obtained by intramolecular dehydration of four carboxy groups, including at least one carboxy group bonded to an alicyclic structure. However, none of these four carboxy groups are bonded to an aromatic ring. In addition, they do not necessarily have to be composed of an alicyclic structure alone, and may have a chain hydrocarbon structure or an aromatic ring structure as part of them.
An aromatic tetracarboxylic acid dianhydride is an acid dianhydride obtained by intramolecular dehydration of four carboxy groups, including at least one carboxy group bonded to an aromatic ring. However, it is not necessary for the aromatic tetracarboxylic acid dianhydride to be composed only of an aromatic ring structure, and it may have a chain hydrocarbon structure or an alicyclic structure as a part of the aromatic ring structure.
上記式(P0)におけるXは、本発明の効果を好適に得る観点から、下記式(Xa1-1)~(Xa1-8)、下記式(X-1)~(X-17)、又は下記式(Xb1-a)~(Xb1-c)のいずれかで表される4価の有機基が挙げられる。
上記式(Xa1-1)~(Xa1-3)のR1~R15における炭素数1~6のアルキル基の具体例としては、メチル基、エチル基、プロピル基、イソプロピル基、n-ブチル基、イソブチル基、sec-ブチル基、tert-ブチル基、n-ペンチル基等が挙げられる。上記R1~R15における炭素数2~6のアルケニル基の具体例としては、ビニル基、プロペニル基、ブテニル基等が挙げられ、これらは直鎖状でも分岐状でもよい。上記R1~R15における炭素数2~6のアルキニル基の具体例としては、エチニル基、1-プロピニル基、2-プロピニル基、1-ブチニル基、2-ブチニル基、3-ブチニル基等が挙げられる。上記R1~R15における、フッ素原子を含有する炭素数1~6の1価の有機基としては、フルオロメチル基、トリフルオロメチル基、ペンタフルオロエチル基、ペンタフルオロプロピル基等が挙げられる。
液晶配向性や液晶表示素子の信頼性を高める観点から、上記Xは、上記式(Xa1-1)で表される4価の有機基が好ましい。さらに、光反応性が高い観点から、R1~R4がそれぞれ独立して水素原子又はメチル基であり、R1~R4の少なくとも1つがメチル基であることが好ましく、R1~R4の少なくとも2つがメチル基であることがより好ましい。更に好ましいのは、R1及びR4がメチル基であり、R2及びR3が水素原子である場合である。上記式(Xa1-1)は、下記式(Xa1-1-1)~(Xa1-1-5)からなる群から選ばれる4価の有機基であることが好ましい。
From the viewpoint of improving the liquid crystal alignment property and the reliability of the liquid crystal display element, the X is preferably a tetravalent organic group represented by the above formula (Xa1-1). Furthermore, from the viewpoint of high photoreactivity, it is preferable that R 1 to R 4 are each independently a hydrogen atom or a methyl group, and at least one of R 1 to R 4 is a methyl group , and more preferably at least two of R 1 to R 4 are methyl groups. It is even more preferable that R 1 and R 4 are methyl groups, and R 2 and R 3 are hydrogen atoms. The above formula (Xa1-1) is preferably a tetravalent organic group selected from the group consisting of the following formulas (Xa1-1-1) to (Xa1-1-5).
上記式(Xb1-a)~(Xb1-c)で表される4価の有機基は、本発明の効果を好適に得る観点から、下記式(Xb1-1)~(Xb1-21)のいずれかで表される4価の有機基がより好ましい。
上記式(P0)におけるYの2価の有機基は、特に限定されないが、例えば、下記式(3)~(4)で表される2価の有機基が挙げられる。
A4は、エステル結合、アミド結合、チオエステル結合、又は炭素数2~20の2価の有機基を表す。但し、1,4-フェニレン基、該フェニレン基上の水素原子の1~4つがR4、及びR4’で置換されている2価の有機基、又はこれらの2価の有機基同士が連結した2価の有機基を除く。
a3、a4、及びa4’は、それぞれ独立して0~4の整数である。
aは、1~4の整数である。b及びcはそれぞれ独立して1~2の整数である。R3、R4、R4’が複数存在する場合、R3、R4、及びR4’の構造は同一でも異なってもよい。a3、a4、及びa4’が複数存在する場合、それぞれ同一でも異なっていてもよい。*は結合手を表す。)
The divalent organic group for Y in the above formula (P0) is not particularly limited, but examples thereof include divalent organic groups represented by the following formulas (3) and (4).
A4 represents an ester bond, an amide bond, a thioester bond, or a divalent organic group having 2 to 20 carbon atoms, except for a 1,4-phenylene group, a divalent organic group in which 1 to 4 hydrogen atoms on the phenylene group are substituted with R4 and R4 ' , or a divalent organic group in which these divalent organic groups are linked to each other.
a3, a4, and a4' each independently represents an integer of 0 to 4.
a is an integer of 1 to 4. b and c are each independently an integer of 1 to 2. When a plurality of R 3 , R 4 , and R 4' are present, the structures of R 3 , R 4 , and R 4' may be the same or different. When a plurality of a3, a4, and a4' are present, they may be the same or different. * represents a bond.
上記式(3)及び(4)のR3、R4、及びR4’における炭素数1~20の1価の有機基としては、炭素数1~20の1価の炭化水素基、当該炭化水素基の任意のメチレン基を-O-、-S-、-C(=O)-、-C(=O)-O-、-C(=O)-S-、-NR3-(ただし、R3は、水素原子、炭素数1~10の1価の炭化水素基、又はtert-ブトキシカルボニル基を表す。)、-CO-NR3-(ただし、R3は、水素原子、炭素数1~10の1価の炭化水素基、又はtert-ブトキシカルボニル基を表す。)、-Si(R3)2-(ただし、R3は、水素原子又は炭素数1~10の1価の炭化水素基を表す。)、-S(=O)2-等(以下、これらの基をヘテロ原子含有基(A)ともいう。)で置き換えてなる1価の基(A)、1価の炭化水素基、若しくは1価の基Aの炭素原子に結合する水素原子の少なくとも1個をハロゲン原子、ヒドロキシ基、アルコキシ基、ニトロ基、保護基で保護されてもよいアミノ基、メルカプト基、ニトロソ基、アルキルシリル基、アルコキシシリル基、シラノール基、スルフィノ基、ホスフィノ基、カルボキシ基、シアノ基、スルホ基、アシル基等で置換してなる1価の基(A2)、複素環を有する1価の基が挙げられる。なお、基(A)、基(A2)及び複素環を有する1価の基の炭素数は、1~20である。
R3、R4、及びR4’における炭素数1~20の1価の有機基としては、中でも、炭素数1~10のアルキル基、炭素数2~10のアルケニル基、炭素数2~10のアルキニル基、及び当該炭化水素基の任意のメチレン基を上記ヘテロ原子含有基(A)で置き換えてなる1価の基がより一層好ましい。
上記保護されてもよいアミノ基としては、-N(R)2が挙げられ、Rは、水素原子、炭素数1~10の1価の炭化水素基、又はtert-ブトキシカルボニル基を表す。
R3、R4、及びR4’における炭素数1~20の1価の有機基は、好ましくは、メチル基、メトキシ基、ビニル基、ハロゲン原子、ヒドロキシ基、保護基で保護されても良いアミノ基、又は、炭素数1~3のアルキル基が有する水素原子の少なくとも一つをハロゲン原子、若しくは、保護基で保護されても良いアミノ基で置換してなる1価の基である。
The monovalent organic group having 1 to 20 carbon atoms in R 3 , R 4 , and R 4′ in the above formulas (3) and (4) includes a monovalent hydrocarbon group having 1 to 20 carbon atoms, and any methylene group of the hydrocarbon group is -O-, -S-, -C(═O)-, -C(═O)-O-, -C(═O)-S-, -NR 3 - (wherein R 3 represents a hydrogen atom, a monovalent hydrocarbon group having 1 to 10 carbon atoms, or a tert-butoxycarbonyl group), -CO-NR 3 - (wherein R 3 represents a hydrogen atom, a monovalent hydrocarbon group having 1 to 10 carbon atoms, or a tert-butoxycarbonyl group), -Si(R 3 ) 2 - (wherein R 3 represents a hydrogen atom or a monovalent hydrocarbon group having 1 to 10 carbon atoms), -S(═O) 2 - or the like (hereinafter, these groups are also referred to as heteroatom-containing group (A)), a monovalent hydrocarbon group or a monovalent group (A2) in which at least one hydrogen atom bonded to a carbon atom of the monovalent group A is substituted with a halogen atom, a hydroxy group, an alkoxy group, a nitro group, an amino group which may be protected by a protecting group, a mercapto group, a nitroso group, an alkylsilyl group, an alkoxysilyl group, a silanol group, a sulfino group, a phosphino group, a carboxy group, a cyano group, a sulfo group, an acyl group, or the like, and a monovalent group having a heterocycle. The number of carbon atoms in the group (A), the group (A2), and the monovalent group having a heterocycle is 1 to 20.
As the monovalent organic group having 1 to 20 carbon atoms for R 3 , R 4 , and R 4′, an alkyl group having 1 to 10 carbon atoms, an alkenyl group having 2 to 10 carbon atoms, an alkynyl group having 2 to 10 carbon atoms, or a monovalent group in which any methylene group of the hydrocarbon group is replaced with the heteroatom-containing group (A) is even more preferred.
The optionally protected amino group includes --N(R) 2 , where R represents a hydrogen atom, a monovalent hydrocarbon group having 1 to 10 carbon atoms, or a tert-butoxycarbonyl group.
The monovalent organic group having 1 to 20 carbon atoms in R 3 , R 4 , and R 4′ is preferably a methyl group, a methoxy group, a vinyl group, a halogen atom, a hydroxyl group, an amino group which may be protected by a protecting group, or a monovalent group in which at least one hydrogen atom of an alkyl group having 1 to 3 carbon atoms has been substituted with a halogen atom or an amino group which may be protected by a protecting group.
上記式(3)におけるaは、好ましくは、1~2の整数である。上記式(3)におけるa3は、好ましくは、0~2の整数であり、a3が複数存在する場合、それぞれ同一でも異なっていてもよい。上記式(4)におけるa4、及びa4’は、それぞれ独立して、好ましくは、0~2の整数であり、a4、及びa4’ が複数存在する場合、それぞれ同一でも異なっていてもよい。 In the above formula (3), a is preferably an integer of 1 to 2. In the above formula (3), a3 is preferably an integer of 0 to 2, and when there are multiple a3s, they may be the same or different. In the above formula (4), a4 and a4' are each independently preferably an integer of 0 to 2, and when there are multiple a4s and multiple a4's, they may be the same or different.
上記式(4)のA4における炭素数2~20の2価の有機基としては、炭素数2~20の炭化水素基;該炭化水素基が有する任意のアルキレン基を、-C(=O)-、-NR-、-C(=O)-O-、-Si(R0)2-、及び-O-C(=O)-の少なくとも一つの基で置き換えてなる2価の有機基(4a)(但し、2価の有機基(4a)の炭素数は、2~20である。);炭素数2~20の炭化水素基の末端、及び、当該炭化水素基が有する任意のアルキレン基の炭素-炭素結合の間、の少なくとも1箇所以上に-O-が挿入されてなる2価の有機基(4b);2価の有機基(4a)が有する任意のアルキレン基の炭素-炭素結合の間の少なくとも1箇所以上に-O-が挿入されてなる2価の有機基(4c);複素環を有する炭素数2~20の2価の有機基(4d);等が挙げられる。
上記-NR-におけるRは、水素原子、炭素数1~5の1価の炭化水素基、又はtert-ブトキシカルボニル基を表す。上記-Si(R0)2-におけるR0は、水素原子又は炭素数1~10の1価の炭化水素基を表す。
The divalent organic group having 2 to 20 carbon atoms in A 4 of the above formula (4) is a hydrocarbon group having 2 to 20 carbon atoms; any alkylene group contained in the hydrocarbon group may be -C(=O)-, -NR-, -C(=O)-O-, -Si(R 0 ) 2 and a divalent organic group (4a) in which the carbon atom is replaced by at least one of -, -O-C(=O)- (provided that the divalent organic group (4a) has 2 to 20 carbon atoms); a divalent organic group (4b) in which -O- is inserted at at least one position between the terminal of a hydrocarbon group having 2 to 20 carbon atoms and between the carbon-carbon bonds of any alkylene groups contained in the hydrocarbon group; a divalent organic group (4c) in which -O- is inserted at at least one position between the carbon-carbon bonds of any alkylene groups contained in the divalent organic group (4a); and a divalent organic group (4d) having 2 to 20 carbon atoms and having a heterocycle.
R in the above -NR- represents a hydrogen atom, a monovalent hydrocarbon group having 1 to 5 carbon atoms, or a tert-butoxycarbonyl group. R 0 in the above -Si(R 0 ) 2 - represents a hydrogen atom or a monovalent hydrocarbon group having 1 to 10 carbon atoms.
上記炭化水素基としては、鎖状炭化水素基、又は、脂環式炭化水素基、若しくは、芳香族基(芳香族基における芳香族環構造としては、例えば、ベンゼン環、ナフタレン環、ビフェニル構造、アントラセン環等)を有する炭化水素基等、が挙げられる。
鎖状炭化水素基の具体例としては、環状構造を有しない、炭素数1~20の2価の直鎖状炭化水素基、又は分岐状炭化水素基が挙げられ、好ましくは炭素数1~20のアルキレン基、炭素数2~20のアルケニレン基、炭素数2~20のアルキニレン基である。
脂環式炭化水素基の具体例として、脂環式構造(例:シクロヘキシレン基、又はビシクロヘキシレン基)、又は、脂環式構造と鎖状炭化水素構造を有する炭化水素基、等があげられる。
芳香族基を有する炭化水素基の具体例として、芳香族基、芳香族基と鎖状炭化水素構造を有する炭化水素基、芳香族基と脂環式構造を有する炭化水素基、等が挙げられる。
Examples of the hydrocarbon group include a chain hydrocarbon group, an alicyclic hydrocarbon group, or a hydrocarbon group having an aromatic group (examples of the aromatic ring structure in the aromatic group include a benzene ring, a naphthalene ring, a biphenyl structure, an anthracene ring, etc.).
Specific examples of the chain hydrocarbon group include a divalent linear or branched hydrocarbon group having 1 to 20 carbon atoms not having a cyclic structure, and are preferably an alkylene group having 1 to 20 carbon atoms, an alkenylene group having 2 to 20 carbon atoms, or an alkynylene group having 2 to 20 carbon atoms.
Specific examples of the alicyclic hydrocarbon group include an alicyclic structure (for example, a cyclohexylene group or a bicyclohexylene group), or a hydrocarbon group having an alicyclic structure and a chain hydrocarbon structure.
Specific examples of the hydrocarbon group having an aromatic group include an aromatic group, a hydrocarbon group having an aromatic group and a chain hydrocarbon structure, and a hydrocarbon group having an aromatic group and an alicyclic structure.
上記2価の有機基(4d)における複素環としては、ピペリジン環、ピペラジン環、モルホリン環、ピロリジン環、ピロール環、フラン環、チオフェン環、イミダゾール環、ピラゾール環、イミド環、オキサゾール環、イソオキサゾール環、チアゾール環、イソチアゾール環、ピリジン環、ピリミジン環、ピリダジン環、又は、ピラジン環、又は、これらの環構造を構造の一部に含む縮合環等が挙げられ、上記環上の水素原子は置換されてもよい。該置換基としては、ハロゲン原子、メチル基、又は、メトキシ基、等が挙げられる。 The heterocyclic ring in the divalent organic group (4d) may be a piperidine ring, a piperazine ring, a morpholine ring, a pyrrolidine ring, a pyrrole ring, a furan ring, a thiophene ring, an imidazole ring, a pyrazole ring, an imide ring, an oxazole ring, an isoxazole ring, a thiazole ring, an isothiazole ring, a pyridine ring, a pyrimidine ring, a pyridazine ring, or a pyrazine ring, or a condensed ring containing these ring structures as part of its structure, and the hydrogen atoms on the ring may be substituted. Examples of the substituent include a halogen atom, a methyl group, or a methoxy group.
上記式(4)のA4は、本発明の効果を好適に得る観点から、基「-L1-A-L1’-」、又は、複素環を有する炭素数2~20の2価の有機基が好ましい。
なお、基「-L1-A-L1’-」におけるL1、L1’及びAの炭素数の合計は、2~20を満たす。
L1及びL1’は、それぞれ、独立して、単結合、-O-、-NR-、-C(=O)-NR-、-C(=O)-、又は-O-C(=O)-を表し、Rは、水素原子、炭素数1~5の1価の炭化水素基、又はtert-ブトキシカルボニル基を表す。
基「-L1-A-L1’-」におけるAは、本発明の効果を好適に得る観点から、炭素数1~12のアルキレン基、-CH=CH-、-C≡C-、-CR0=CR0’-C(=O)-O-(R0及びR0’は、それぞれ独立して、水素原子又はメチル基を表す。)、又は該アルキレン基の炭素-炭素結合の間に、-O-、-NR-、-C(=O)-NR-、-C(=O)-NR-C(=O)-、-C(=O)-O-、-Si(Ra)2-及び-O-C(=O)-の少なくともいずれかの基が挿入されてなる2価の有機基、-O-Ar-O-、-O-C(=O)-Ar-C(=O)-O-、-C(=O)-O-Ar-O-C(=O)-を表す。但し、L1及びL1’が、単結合を表す場合、Aはメチレン基以外の基を表す。
上記-C(=O)-NR-、及び-C(=O)-NR-C(=O)-におけるRは、水素原子、炭素数1~5の1価の炭化水素基、又はtert-ブトキシカルボニル基を表す。-Si(Ra)2-におけるRaは、水素原子又は炭素数1~3の1価の炭化水素基を表す。Aが有する任意の水素原子は、ハロゲン原子で置換されていてもよい。
上記-O-Ar-O-、-O-C(=O)-Ar-C(=O)-O-、及び-C(=O)-O-Ar-O-C(=O)-におけるArは、フェニレン基、又はビフェニル構造を表す。
In order to obtain the effects of the present invention favorably, A 4 in the above formula (4) is preferably a group "-L 1 -AL 1'- " or a divalent organic group having 2 to 20 carbon atoms and a heterocycle.
The total number of carbon atoms of L 1 , L 1 ' and A in the group "-L 1 -AL 1 ' -" satisfies 2 to 20.
L1 and L1 ' each independently represent a single bond, -O-, -NR-, -C(=O)-NR-, -C(=O)-, or -O-C(=O)-, and R represents a hydrogen atom, a monovalent hydrocarbon group having 1 to 5 carbon atoms, or a tert-butoxycarbonyl group.
In terms of suitably obtaining the effects of the present invention, A in the group "-L 1 -A-L 1 ' -" is an alkylene group having 1 to 12 carbon atoms, -CH=CH-, -C≡C-, -CR 0 ≡CR 0 ' -C(=O)-O- (R 0 and R 0 ' each independently represent a hydrogen atom or a methyl group), or -O-, -NR-, -C(=O)-NR-, -C(=O)-NR-C(=O)-, -C(=O)-O-, -Si(R a ) 2 A divalent organic group having at least one of - and -O-C(=O)- inserted therein, -O-Ar-O-, -O-C(=O)-Ar-C(=O)-O-, -C(=O)-O-Ar-O-C(=O)-, provided that when L1 and L1 ' represent single bonds, A represents a group other than a methylene group.
R in the above -C(=O)-NR- and -C(=O)-NR-C(=O)- represents a hydrogen atom, a monovalent hydrocarbon group having 1 to 5 carbon atoms, or a tert-butoxycarbonyl group. R a in -Si(R a ) 2 - represents a hydrogen atom or a monovalent hydrocarbon group having 1 to 3 carbon atoms. Any hydrogen atom possessed by A may be substituted with a halogen atom.
In the above-mentioned -O-Ar-O-, -O-C(=O)-Ar-C(=O)-O-, and -C(=O)-O-Ar-O-C(=O)-, Ar represents a phenylene group or a biphenyl structure.
上記式(3)及び(4)のより好ましい具体例として、下記式(dAL-1)~(dAL-12)、(5-1)~(5-6)、(z-1)~(z-7)、(o2-1)~(o2-12)、(h-1)~(h-13)及び(Im-1)~(Im-6)で表される構造が挙げられる。なお、下記式(dAL-1)~(dAL-8)、(5-1)~(5-6)、(z-1)~(z-7)、(o2-1)~(o2-12)及び(h-1)~(h-13)で表される構造において、*と結合するベンゼン環の結合位置は、1,4-位とする。下記式(dAL-9)において、全てのベンゼン環の結合位置は、1,4-位とする。
また、液晶パネルを高温下で長時間使用した場合でも高い表示品位を得ることを目的に、液晶配向膜にはこれまで以上に高い電圧保持率(以下、電圧保持率をVHRともいう。)が求められる場合がある。高いVHRを得る観点から、重合体(P)は、ウレア結合を有する2価の有機基;アミド結合を有する2価の有機基;窒素原子含有複素環、第二級アミノ基及び第三級アミノ基よりなる群から選ばれる少なくとも一種の窒素原子含有構造を有する2価の有機基;及びカルボキシ基を有する2価の有機基からなる群から選ばれる2価の有機基(これらを総称して特定の2価の有機基(b)ともいう。)を有する構造単位を含む重合体であることが好ましい。 In order to obtain high display quality even when the liquid crystal panel is used for a long time at high temperatures, a higher voltage holding ratio (hereinafter, voltage holding ratio is also referred to as VHR) than ever before may be required for the liquid crystal alignment film. From the viewpoint of obtaining a high VHR, the polymer (P) is preferably a polymer containing a structural unit having a divalent organic group selected from the group consisting of a divalent organic group having a urea bond; a divalent organic group having an amide bond; a divalent organic group having at least one nitrogen atom-containing structure selected from the group consisting of a nitrogen atom-containing heterocycle, a secondary amino group, and a tertiary amino group; and a divalent organic group having a carboxy group (collectively referred to as specific divalent organic group (b)).
上記ウレア結合を有する2価の有機基としては、例えば、上記式(4)のA4が基「-NH-C(=O)-NR-」を有する、上記式(4)で表される2価の有機基が挙げられる。
上記アミド結合を有する2価の有機基としては、上記式(4)のA4がアミド結合を有する、上記式(4)で表される2価の有機基が挙げられる。
上記窒素原子含有複素環、第二級アミノ基及び第三級アミノ基よりなる群から選ばれる少なくとも一種の窒素原子含有構造を有する2価の有機基としては、2,6-ジアミノピリジン、3,4-ジアミノピリジン、2,4-ジアミノピリミジン、3,6-ジアミノカルバゾール、N-メチル-3,6-ジアミノカルバゾール、3,6-ジアミノアクリジン、N-エチル-3,6-ジアミノカルバゾール、N-フェニル-3,6-ジアミノカルバゾール、上記式(z-1)~式(z-7)で表される構造を有するジアミンなどの複素環含有ジアミン;4,4’-ジアミノジフェニルアミン、4,4’-ジアミノジフェニル-N-メチルアミン、N,N’-ビス(4-アミノフェニル)-ベンジジン、N,N’-ビス(4-アミノフェニル)-N,N’-ジメチルベンジジン、若しくは、N,N’-ビス(4-アミノフェニル)-N,N’-ジメチル-1,4-ベンゼンジアミンに代表されるジフェニルアミン構造を有するジアミン;からなる群から選ばれるジアミンから2つのアミノ基を除いた2価の有機基が挙げられる。
上記カルボキシ基を有する2価の有機基としては、2,4-ジアミノ安息香酸、2,5-ジアミノ安息香酸、3,5-ジアミノ安息香酸、4,4’-ジアミノビフェニル-3-カルボン酸、4,4’-ジアミノジフェニルメタン-3-カルボン酸、1,2-ビス(4-アミノフェニル)エタン-3-カルボン酸、4,4’-ジアミノビフェニル-3,3’-ジカルボン酸、4,4’-ジアミノビフェニル-2,2’-ジカルボン酸、3,3’-ジアミノビフェニル-4,4’-ジカルボン酸、3,3’-ジアミノビフェニル-2,4’-ジカルボン酸、4,4’-ジアミノジフェニルメタン-3,3’-ジカルボン酸、1,2-ビス(4-アミノフェニル)エタン-3,3’-ジカルボン酸、4,4’-ジアミノジフェニルエーテル-3,3’-ジカルボン酸などのカルボキシ基を有するジアミンから2つのアミノ基を除いた2価の有機基が挙げられる。
An example of the divalent organic group having a urea bond is a divalent organic group represented by the above formula (4) in which A4 in the above formula (4) has the group "-NH-C(=O)-NR-".
The divalent organic group having an amide bond includes a divalent organic group represented by the above formula (4) in which A4 in the above formula (4) has an amide bond.
Examples of the divalent organic group having at least one nitrogen atom-containing structure selected from the group consisting of a nitrogen atom-containing heterocycle, a secondary amino group, and a tertiary amino group include 2,6-diaminopyridine, 3,4-diaminopyridine, 2,4-diaminopyrimidine, 3,6-diaminocarbazole, N-methyl-3,6-diaminocarbazole, 3,6-diaminoacridine, N-ethyl-3,6-diaminocarbazole, N-phenyl-3,6-diaminocarbazole, and those having the structures represented by the above formulae (z-1) to (z-7). and divalent organic groups obtained by removing two amino groups from a diamine selected from the group consisting of heterocycle-containing diamines such as diamine, 4,4'-diaminodiphenylamine, 4,4'-diaminodiphenyl-N-methylamine, N,N'-bis(4-aminophenyl)-benzidine, N,N'-bis(4-aminophenyl)-N,N'-dimethylbenzidine, or diamines having a diphenylamine structure such as N,N'-bis(4-aminophenyl)-N,N'-dimethyl-1,4-benzenediamine.
Examples of the divalent organic group having a carboxy group include divalent organic groups obtained by removing two amino groups from a diamine having a carboxy group, such as 2,4-diaminobenzoic acid, 2,5-diaminobenzoic acid, 3,5-diaminobenzoic acid, 4,4'-diaminobiphenyl-3-carboxylic acid, 4,4'-diaminodiphenylmethane-3-carboxylic acid, 1,2-bis(4-aminophenyl)ethane-3-carboxylic acid, 4,4'-diaminobiphenyl-3,3'-dicarboxylic acid, 4,4'-diaminobiphenyl-2,2'-dicarboxylic acid, 3,3'-diaminobiphenyl-4,4'-dicarboxylic acid, 3,3'-diaminobiphenyl-2,4'-dicarboxylic acid, 4,4'-diaminodiphenylmethane-3,3'-dicarboxylic acid, 1,2-bis(4-aminophenyl)ethane-3,3'-dicarboxylic acid, and 4,4'-diaminodiphenylether-3,3'-dicarboxylic acid.
また、上記式(A1)におけるYa1の2価の有機基は、上記式(3)~(4)で表される2価の有機基以外のその他の構造であってもよい。
その他の構造として、上記式(3)における*と結合するベンゼン環の結合位置が1,4-位から2,5-位に変更された2価の有機基(3L);上記式(4)における*と結合するベンゼン環の少なくとも一つの結合位置が1,4-位から2,5-位に変更された2価の有機基(4L);又は、以下のジアミン(該ジアミンを纏めてジアミン(W)ともいう。)から2つのアミノ基を除いた2価の有機基等が挙げられる。なお、上記2価の有機基(3L)及び(4L)において、R3、R4、R4’、A4、a3、a4、a4’、a、b、及びcの好ましい態様は、上記式(3)~(4)と同義である。
Furthermore, the divalent organic group of Y a1 in the above formula (A1) may have a structure other than the divalent organic groups represented by the above formulas (3) and (4).
Other structures include a divalent organic group (3L) in which the bonding position of the benzene ring bonding to * in the above formula (3) is changed from 1,4-position to 2,5-position; a divalent organic group (4L) in which at least one bonding position of the benzene ring bonding to * in the above formula (4) is changed from 1,4-position to 2,5-position; or a divalent organic group obtained by removing two amino groups from the following diamines (these diamines are also collectively referred to as diamines (W)). In the above divalent organic groups (3L) and (4L), preferred aspects of R 3 , R 4 , R 4' , A 4 , a3, a4, a4', a, b, and c are the same as those in the above formulas (3) to (4).
1,2-ビス(6-アミノ-2-ナフチルオキシ)エタン、1,2-ビス(6-アミノ-2-ナフチル)エタン、又は、6-[2-(4-アミノフェノキシ)エトキシ]-2-ナフチルアミンなどのナフタレン環を有する芳香族ジアミン、4,4’-ジアミノアゾベンゼン、3,3’-ジアミノジフェニルメタン、3,4’-ジアミノジフェニルメタン、4,4’-ジアミノジフェニルメタン、3,3’-ジアミノジフェニルエーテル、3,4’-ジアミノジフェニルエーテル、4,4’-ジアミノジフェニルエーテル、4,4’-ジアミノベンゾフェノン、2,6-ジアミノピリジン、3,4-ジアミノピリジン、2,4-ジアミノピリミジン、3,6-ジアミノカルバゾール、N-メチル-3,6-ジアミノカルバゾール、3,6-ジアミノアクリジン、N-エチル-3,6-ジアミノカルバゾール、N-フェニル-3,6-ジアミノカルバゾール、4,4’-ジアミノジフェニルアミン、4,4’-ジアミノジフェニル-N-メチルアミン、4-(2-(メチルアミノ)エチル)アニリン、4-(2-アミノエチル)アニリン、1-(4-アミノフェニル)-1,3,3-トリメチル-1H-インダン-5-アミン、1-(4-アミノフェニル)-2,3-ジヒドロ-1,3,3-トリメチル-1H-インデン-6-アミン、コレスタニルオキシ-3,5-ジアミノベンゼン、コレステニルオキシ-3,5-ジアミノベンゼン、コレスタニルオキシ-2,4-ジアミノベンゼン、3,5-ジアミノ安息香酸コレスタニル、3,5-ジアミノ安息香酸コレステニル、3,5-ジアミノ安息香酸ラノスタニル及び3,6-ビス(4-アミノベンゾイルオキシ)コレスタン等のステロイド骨格を有するジアミン、1,3-ビス(3-アミノプロピル)-テトラメチルジシロキサン等のシロキサン結合を有するジアミン;メタキシリレンジアミン、1,3-プロパンジアミン、テトラメチレンジアミン、ペンタメチレンジアミン、ヘキサメチレンジアミン、1,3-ビス(アミノメチル)シクロヘキサン、1,4-ジアミノシクロヘキサン、4,4’-メチレンビス(シクロヘキシルアミン)、WO2018/117239号に記載の式(Y-1)~(Y-167)のいずれかで表される基に2つのアミノ基が結合したジアミン等。 Aromatic diamines having a naphthalene ring such as 1,2-bis(6-amino-2-naphthyloxy)ethane, 1,2-bis(6-amino-2-naphthyl)ethane, or 6-[2-(4-aminophenoxy)ethoxy]-2-naphthylamine, 4,4'-diaminoazobenzene, 3,3'-diaminodiphenylmethane, 3,4'-diaminodiphenylmethane, 4,4'-diaminodiphenylmethane, 3,3'-diaminodiphenyl ether, 3,4'-diaminodiphenyl ether, 4,4'-diaminodiphenyl ether, 4,4' -Diaminobenzophenone, 2,6-diaminopyridine, 3,4-diaminopyridine, 2,4-diaminopyrimidine, 3,6-diaminocarbazole, N-methyl-3,6-diaminocarbazole, 3,6-diaminoacridine, N-ethyl-3,6-diaminocarbazole, N-phenyl-3,6-diaminocarbazole, 4,4'-diaminodiphenylamine, 4,4'-diaminodiphenyl-N-methylamine, 4-(2-(methylamino)ethyl)aniline, 4-(2-aminoethyl)aniline, 1-(4-aminophenyl) 1,3,3-trimethyl-1H-indan-5-amine, 1-(4-aminophenyl)-2,3-dihydro-1,3,3-trimethyl-1H-inden-6-amine, cholestanyloxy-3,5-diaminobenzene, cholestanyloxy-3,5-diaminobenzene, cholestanyloxy-2,4-diaminobenzene, cholestanyl 3,5-diaminobenzoate, cholestanyl 3,5-diaminobenzoate, lanostannyl 3,5-diaminobenzoate, and 3,6-bis(4-aminobenzoyloxy)cholestane. diamines having a siloxane bond such as 1,3-bis(3-aminopropyl)-tetramethyldisiloxane; metaxylylenediamine, 1,3-propanediamine, tetramethylenediamine, pentamethylenediamine, hexamethylenediamine, 1,3-bis(aminomethyl)cyclohexane, 1,4-diaminocyclohexane, 4,4'-methylenebis(cyclohexylamine), diamines having two amino groups bonded to a group represented by any one of formulas (Y-1) to (Y-167) described in WO2018/117239, etc.
重合体(P)は、本発明の効果を好適に得る観点から、構造単位(p0)と該構造単位(p0)のイミド化構造単位との合計を重合体(P)が有する全構造単位の10~100モル%含むことが好ましく、15~100モル%含むことがより好ましい。
なお、ここでの合計においては、構造単位(p0)と該構造単位(p0)のイミド化構造単位とのいずれかが0モル%である場合も含まれる。以下においても合計という場合、構成単位要素の1又は2以上が0モル%である場合も含まれる。
From the viewpoint of suitably obtaining the effects of the present invention, the polymer (P) preferably contains the structural unit (p0) and the imidized structural unit of the structural unit (p0) in an amount of 10 to 100 mol %, and more preferably 15 to 100 mol %, of the total structural units contained in the polymer (P).
In addition, the total here includes the case where either the structural unit (p0) or the imidized structural unit of the structural unit (p0) is 0 mol %. In the following, the total also includes the case where one or more of the structural unit elements are 0 mol %.
重合体(P)は、本発明の効果を好適に得る観点から、上記式(3)~(4)で表される2価の有機基を有する構造単位を、重合体(P)が有する全構造単位の10~100モル%含むことが好ましく、15~100モル%含むことがより好ましい。 From the viewpoint of optimally obtaining the effects of the present invention, the polymer (P) preferably contains structural units having a divalent organic group represented by the above formulas (3) to (4) in an amount of 10 to 100 mol %, and more preferably 15 to 100 mol %, of all structural units contained in the polymer (P).
上記式(P0)のR、Zにおける1価の有機基としては、炭素数1~20の1価の炭化水素基、該炭化水素基のメチレン基を-O-、-S-、-CO-、-COO-、-COS-、-NR3-、-CO-NR3-、-Si(R3)2-、-SO2-等で置き換えてなる1価の基A(但し、R3は、水素原子又は炭素数1~10の1価の炭化水素基であり、R3が複数ある場合、各R3は同一であっても良く、異なっていても良い。)、かかる1価の炭化水素基若しくは1価の基Aの炭素原子に結合する水素原子の少なくとも1個をハロゲン原子、ヒドロキシ基、アルコキシ基、ニトロ基、アミノ基、メルカプト基、ニトロソ基、アルキルシリル基、アルコキシシリル基、シラノール基、スルフィノ基、ホスフィノ基、カルボキシ基、シアノ基、スルホ基、アシル基等で置換してなる1価の基、複素環を有する1価の基、等が挙げられる。上記式(1)におけるR、Zにおける1価の有機基としては、炭素数1~10のアルキル基、炭素数2~10のアルケニル基、炭素数2~10のアルキニル基、Boc、又はFmocが好ましく、炭素数1~3のアルキル基が更に好ましく、メチル基がより一層好ましい。
R及びZは、本発明の効果を好適に得る観点から、それぞれ独立に、水素原子又は炭素数1~3のアルキル基が好ましく、水素原子又はメチル基がより好ましい。
The monovalent organic groups for R and Z in the above formula (P0) include monovalent hydrocarbon groups having 1 to 20 carbon atoms, and monovalent groups A in which a methylene group of the hydrocarbon group is replaced by -O-, -S-, -CO-, -COO-, -COS-, -NR 3 -, -CO-NR 3 -, -Si(R 3 ) 2 -, -SO 2 - or the like (wherein R 3 is a hydrogen atom or a monovalent hydrocarbon group having 1 to 10 carbon atoms, and when there are a plurality of R 3's , each R 3 may be the same or different. ), a monovalent group in which at least one hydrogen atom bonded to a carbon atom of the monovalent hydrocarbon group or the monovalent group A is substituted with a halogen atom, a hydroxy group, an alkoxy group, a nitro group, an amino group, a mercapto group, a nitroso group, an alkylsilyl group, an alkoxysilyl group, a silanol group, a sulfino group, a phosphino group, a carboxy group, a cyano group, a sulfo group, an acyl group, or the like, a monovalent group having a heterocycle, etc. As the monovalent organic group for R and Z in the above formula (1), an alkyl group having 1 to 10 carbon atoms, an alkenyl group having 2 to 10 carbon atoms, an alkynyl group having 2 to 10 carbon atoms, Boc, or Fmoc is preferable, an alkyl group having 1 to 3 carbon atoms is more preferable, and a methyl group is even more preferable.
From the viewpoint of suitably obtaining the effects of the present invention, R and Z are each independently preferably a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, and more preferably a hydrogen atom or a methyl group.
本発明の液晶配向剤に含有される重合体成分(P)は、2種類以上の重合体を含有し、且つ、以下の条件(i)~(iii)の少なくとも一つを満たす、重合体成分であってもよい。
(i)1種以上の構造単位を有し、下記式(A1)で表される構造単位(a1)を有するポリイミド前駆体(A)及び該ポリイミド前駆体のイミド化物であるポリイミドからなる群から選ばれる少なくとも1種の重合体を2種類以上含む、重合体成分(P1)。
(ii)上記ポリイミド前駆体(A)と異なる重合体であって、1種以上の構造単位を有し、下記式(B1)で表される構造単位(b1)を有するポリイミド前駆体(B)を2種類以上含む、重合体成分(P2)。
(iii)上記ポリイミド前駆体(A)及び該ポリイミド前駆体のイミド化物であるポリイミドからなる群から選ばれる少なくとも1種の重合体と、上記ポリイミド前駆体(B)と、を含む、重合体成分(P3)。
(i) A polymer component (P1) having one or more types of structural units and including two or more types of at least one polymer selected from the group consisting of a polyimide precursor (A) having a structural unit (a1) represented by the following formula (A1) and a polyimide which is an imidized product of the polyimide precursor:
(ii) A polymer component (P2) which is a polymer different from the polyimide precursor (A) and has one or more types of structural units and contains two or more types of polyimide precursors (B) having a structural unit (b1) represented by the following formula (B1):
(iii) A polymer component (P3) containing at least one polymer selected from the group consisting of the polyimide precursor (A) and a polyimide which is an imidization product of the polyimide precursor, and the polyimide precursor (B).
重合体成分(P)は、酸脱離性基を有しない重合体で構成されていてもよい。ここで、酸脱離性基とは、酸により開裂する結合を有する基であり、上記結合の開裂により酸脱離性基の一部又は全部が重合体の主鎖から脱離する基である。
好ましい酸脱離性基として、アミノ基やヒドロキシ基等を保護する保護基が挙げられる。該保護基としては、カルバメート系保護基(具体例として、tert-ブトキシカルボニル基、又は9-フルオレニルメチルオキシカルボニルなど)、又は、保護される酸素原子と共にアセタール構造や3級エーテル構造を形成する基、等が挙げられる。
酸脱離性基を有しない重合体は、例えば、酸脱離性基を有しない原料成分(酸脱離性基を有しない原料の具体例として、酸脱離性基を有しないジアミン、酸脱離性基を有しないテトラカルボン酸二無水物又はその誘導体、酸脱離性基を形成しない末端修飾剤、等)を用いることで得られる。
The polymer component (P) may be composed of a polymer having no acid-dissociable group. Here, the acid-dissociable group is a group having a bond that is cleaved by an acid, and a part or all of the acid-dissociable group is eliminated from the main chain of the polymer by cleavage of the bond.
Preferred examples of the acid-dissociable group include protecting groups that protect amino groups, hydroxy groups, etc. Examples of such protecting groups include carbamate-based protecting groups (specific examples include tert-butoxycarbonyl and 9-fluorenylmethyloxycarbonyl groups), and groups that form an acetal structure or a tertiary ether structure together with the protected oxygen atom.
A polymer having no acid-leaving group can be obtained, for example, by using a raw material component having no acid-leaving group (specific examples of raw materials having no acid-leaving group include a diamine having no acid-leaving group, a tetracarboxylic dianhydride or a derivative thereof having no acid-leaving group, and a terminal modifier that does not form an acid-leaving group).
<ポリイミド前駆体(A)>
本発明の液晶配向剤に含有される重合体成分(P1)及び(P3)は、1種以上の構造単位を有し、上記式(A1)で表される構造単位(a1)を有する、ポリイミド前駆体(A)を含有する。尚、ポリイミド前駆体(A)は1種類又は2種類以上の重合体を用いてもよい。また、ポリイミド前駆体(A)は、1種類の構造単位を有しても良く、又は2種類以上の異なる構造単位を有しても良く、又は3種類以上の異なる構造単位を有しても良く、又は4種類以上の異なる構造単位を有しても良い。
<Polyimide precursor (A)>
The polymer components (P1) and (P3) contained in the liquid crystal alignment agent of the present invention contain one or more structural units and contain a polyimide precursor (A) having a structural unit (a1) represented by the above formula (A1). The polyimide precursor (A) may be one or more polymers. The polyimide precursor (A) may have one type of structural unit, or may have two or more different structural units, or may have three or more different structural units, or may have four or more different structural units.
上記式(A1)におけるYa1の2価の有機基は、特に限定されないが、例えば、上記式(3)~(4)で表される2価の有機基が挙げられる。なお、上記2価の有機基は、例えば、ポリイミド前駆体(A)を得るためのジアミン成分として、上記2価の有機基を有するジアミンを用いることで、ポリイミド前駆体(A)の構造単位中に導入される。
本発明の効果を好適に得る観点から、ポリイミド前駆体(A)を構成する構造単位の少なくとも一つは、上記式(3)~(4)で表される2価の有機基からなる群から選ばれる構造を有することが好ましく、*がジアミン由来の窒素原子に結合する上記式(3)~(4)で表される2価の有機基からなる群から選ばれる構造を有することがより好ましい。
また、本発明の効果を好適に得る観点から、上記式(A1)において、Ya1が上記式(3)~(4)からなる群から選ばれる2価の有機基であることが好ましい。
The divalent organic group of Y a1 in the above formula (A1) is not particularly limited, and examples thereof include divalent organic groups represented by the above formulas (3) to (4). The divalent organic group is introduced into the structural unit of the polyimide precursor (A), for example, by using a diamine having the above divalent organic group as a diamine component for obtaining the polyimide precursor (A).
From the viewpoint of suitably obtaining the effects of the present invention, at least one of the structural units constituting the polyimide precursor (A) preferably has a structure selected from the group consisting of divalent organic groups represented by the above formulas (3) to (4), and more preferably has a structure selected from the group consisting of divalent organic groups represented by the above formulas (3) to (4) in which * is bonded to a nitrogen atom derived from a diamine.
In order to preferably obtain the effects of the present invention, Y a1 in the above formula (A1) is preferably a divalent organic group selected from the group consisting of the above formulas (3) and (4).
上記式(3)及び(4)のより好ましい具体例として、上記重合体(P)における上記式(3)~(4)の好ましい態様と同様である。中でも、より好ましい具体例として、上記式(dAL-1)~(dAL-12)、(5-1)~(5-6)、(z-1)~(z-7)、(o2-1)~(o2-12)、(h-1)~(h-13)及び(Im-1)~(Im-6)で表される構造が挙げられる。なお、上記式(dAL-1)~(dAL-8)、(5-1)~(5-6)、(z-1)~(z-7)、(o2-1)~(o2-12)及び(h-1)~(h-13)で表される構造において、*と結合するベンゼン環の結合位置は、1,4-位とする。下記式(dAL-9)において、全てのベンゼン環の結合位置は、1,4-位とする。 More preferred specific examples of the above formulae (3) and (4) are the same as the preferred embodiments of the above formulae (3) to (4) in the polymer (P). Among them, more preferred specific examples include structures represented by the above formulae (d AL -1) to (d AL -12), (5-1) to (5-6), (z-1) to (z-7), (o2-1) to (o2-12), (h-1) to (h-13), and (Im-1) to (Im-6). In the structures represented by the above formulae (d AL -1) to (d AL -8), (5-1) to (5-6), (z-1) to (z-7), (o2-1) to (o2-12), and (h-1) to (h-13), the bonding positions of the benzene ring bonded to * are the 1,4-positions. In the following formula (d AL -9), the bonding positions of all benzene rings are 1,4-positions.
また、上記式(A1)におけるYa1の2価の有機基は、上記式(3)~(4)で表される2価の有機基以外のその他の構造であってもよい。
その他の構造として、上記式(3)における*と結合するベンゼン環の結合位置が1,4-位から2,5-位に変更された2価の有機基(3L);上記式(4)における*と結合するベンゼン環の少なくとも一つの結合位置が1,4-位から2,5-位に変更された2価の有機基(4L);又は、上記ジアミン(W)から2つのアミノ基を除いた2価の有機基、等が挙げられる。なお、上記2価の有機基(3L)及び(4L)において、R3、R4、R4’、A4、a3、a4、a4’、a、b、及びcの好ましい態様は、上記式(3)~(4)と同義である。
Furthermore, the divalent organic group of Y a1 in the above formula (A1) may have a structure other than the divalent organic groups represented by the above formulas (3) and (4).
Other structures include a divalent organic group (3L) in which the bonding positions of the benzene ring bonding to * in the above formula (3) are changed from 1,4-positions to 2,5-positions, a divalent organic group (4L) in which at least one bonding position of the benzene ring bonding to * in the above formula (4) is changed from 1,4-positions to 2,5-positions, or a divalent organic group in which two amino groups have been removed from the above diamine (W), etc. In the above divalent organic groups (3L) and (4L), preferred aspects of R 3 , R 4 , R 4' , A 4 , a3, a4, a4', a, b, and c are the same as those in the above formulas (3) to (4).
上記ポリイミド前駆体(A)は、本発明の効果を好適に得る観点から、上記式(A1)で表される構造単位(a1)とともに、更に、下記式(A2)で表される構造単位(a2)を有するポリイミド前駆体であってもよい。
上記式(A2)におけるYa2の2価の有機基の具体例として、上記式(A1)におけるYa1の2価の有機基で例示した構造が好ましい態様を含めて挙げられる。 Specific examples of the divalent organic group of Y a2 in the above formula (A2) include the structures exemplified for the divalent organic group of Y a1 in the above formula (A1), including preferred embodiments.
上記芳香族テトラカルボン酸二無水物とは、好ましい態様を含めて上記で定義したとおりである。芳香族テトラカルボン酸二無水物の好ましい具体例として、上記式(Xb1-a)~(Xb1-c)のいずれかで表される4価の有機基が挙げられ、より好ましくは、上記式(Xb1-1)~(Xb1-21)のいずれかで表される4価の有機基が挙げられる。 The aromatic tetracarboxylic dianhydride is as defined above, including preferred embodiments. Preferred specific examples of the aromatic tetracarboxylic dianhydride include tetravalent organic groups represented by any one of the above formulae (X b1 -a) to (X b1 -c), and more preferably tetravalent organic groups represented by any one of the above formulae (X b1 -1) to (X b1 -21).
ポリイミド前駆体(A)は、本発明の効果を好適に得る観点から、構造単位(a1)と該構造単位(a1)のイミド化構造単位との合計をポリイミド前駆体(A)が有する全構造単位の10~100モル%含むことが好ましく、15~100モル%含むことがより好ましい。
ポリイミド前駆体(A)は、本発明の効果を好適に得る観点から、上記式(3)~(4)で表される2価の有機基を有する構造単位を、ポリイミド前駆体(A)が有する全構造単位の10~100モル%含むことが好ましく、15~100モル%含むことがより好ましい。
ポリイミド前駆体(A)が構造単位(a1)及び/又は、繰り返し単位(a1)のイミド化構造単位以外の構造単位を含む場合は、上記構造単位(a1)と該構造単位(a1)のイミド化構造単位との合計は、ポリイミド前駆体(A)が有する全構造単位の95モル%以下含むことが好ましく、90モル%以下含むことがより好ましい。
From the viewpoint of suitably obtaining the effects of the present invention, the polyimide precursor (A) preferably contains the structural unit (a1) and the imidized structural unit of the structural unit (a1) in an amount of 10 to 100 mol %, and more preferably 15 to 100 mol %, of the total structural units contained in the polyimide precursor (A).
From the viewpoint of suitably obtaining the effects of the present invention, the polyimide precursor (A) preferably contains structural units having a divalent organic group represented by the above formulas (3) to (4) in an amount of 10 to 100 mol %, more preferably 15 to 100 mol %, of all structural units contained in the polyimide precursor (A).
When the polyimide precursor (A) contains a structural unit other than the structural unit (a1) and/or the imidized structural unit of the repeating unit (a1), the sum of the structural unit (a1) and the imidized structural unit of the structural unit (a1) preferably accounts for 95 mol % or less, and more preferably 90 mol % or less, of all structural units contained in the polyimide precursor (A).
<ポリイミド前駆体(B)>
本発明の液晶配向剤に含有される重合体成分(P2)及び(P3)は、ポリイミド前駆体(A)と異なる重合体であって、1種以上の構造単位を有し、下記式(B1)で表される構造単位(b1)を有する、ポリイミド前駆体(B)を含有する。尚、ポリイミド前駆体(B)は1種類又は2種類以上の重合体を用いてもよい。また、ポリイミド前駆体(B)は、1種類の構造単位を有しても良く、又は2種類以上の異なる構造単位を有しても良く、又は3種類以上の異なる構造単位を有しても良く、又は4種類以上の異なる構造単位を有しても良い。
The polymer components (P2) and (P3) contained in the liquid crystal alignment agent of the present invention contain a polyimide precursor (B) which is a polymer different from the polyimide precursor (A), has one or more structural units, and has a structural unit (b1) represented by the following formula (B1). The polyimide precursor (B) may be one or more polymers. The polyimide precursor (B) may have one type of structural unit, or may have two or more different structural units, or may have three or more different structural units, or may have four or more different structural units.
上記式(B1)におけるXb1は、炭素数6~30の芳香族基を有する4価の有機基を表し、Xb1と結合するカルボニル炭素の少なくとも一つはXb1の芳香族基と結合する。より好ましくは、芳香環(ベンゼン環、ナフタレン環等)に結合する少なくとも1つのカルボキシ基を含めて4つのカルボキシ基が分子内脱水することにより得られる酸二無水物に由来する4価の有機基である。但し、芳香環構造のみで構成されている必要はなく、その一部に鎖状炭化水素構造や脂環式構造を有していてもよい。
Xb1の好ましい具体例として、芳香族テトラカルボン酸化合物に由来する4価の有機基が挙げられる。Xb1は好ましくは、上記式(Xb1-a)~(Xb1-c)のいずれかで表される4価の有機基であり、より好ましくは、上記式(Xb1-1)~(Xb1-21)のいずれかで表される4価の有機基であり、さらに好ましくは、上記式(Xb1-1)~(Xb1-13)のいずれかで表される4価の有機基である。より一層好ましいのは、上記式(Xb1-1)~(Xb1-7)からなる群から選ばれる4価の有機基である。
X b1 in the above formula (B1) represents a tetravalent organic group having an aromatic group having 6 to 30 carbon atoms, and at least one of the carbonyl carbons bonded to X b1 is bonded to the aromatic group of X b1 . More preferably, it is a tetravalent organic group derived from an acid dianhydride obtained by intramolecular dehydration of four carboxy groups including at least one carboxy group bonded to an aromatic ring (benzene ring, naphthalene ring, etc.). However, it is not necessary for the group to be composed of only an aromatic ring structure, and it may have a chain hydrocarbon structure or an alicyclic structure as a part thereof.
A preferred specific example of X b1 is a tetravalent organic group derived from an aromatic tetracarboxylic acid compound. X b1 is preferably a tetravalent organic group represented by any one of the above formulas (X b1 -a) to (X b1 -c), more preferably a tetravalent organic group represented by any one of the above formulas (X b1 -1) to (X b1 -21), and even more preferably a tetravalent organic group represented by any one of the above formulas (X b1 -1) to (X b1 -13). Even more preferably, X b1 is a tetravalent organic group selected from the group consisting of the above formulas (X b1 -1) to (X b1 -7).
上記Yb1における2価の有機基としては、上記Ya1で例示した2価の有機基が挙げられる。残留DC由来の残像が少ない観点から、ポリイミド前駆体(B)は、上記特定の2価の有機基(b)を有する構造単位を含む重合体であることが好ましい。
また、残留DC由来の残像が少ない観点から、ポリイミド前駆体(B)は、Yb1が、上記特定の2価の有機基(b)である構造単位を含む重合体であることが好ましい。
Examples of the divalent organic group in Y b1 include the divalent organic groups exemplified for Y a1 . From the viewpoint of reducing residual images caused by residual DC, the polyimide precursor (B) is preferably a polymer containing a structural unit having the specific divalent organic group (b).
From the viewpoint of reducing afterimages resulting from residual DC, the polyimide precursor (B) is preferably a polymer containing a structural unit in which Y b1 is the specific divalent organic group (b) described above.
ポリイミド前駆体(B)は、残留DC由来の残像が少ない観点において、上記特定の2価の有機基(b)を有する構造単位(より好ましくは、ジアミン由来の窒素原子に結合する上記特定の2価の有機基を有する構造単位である。)を、ポリイミド前駆体(B)に含まれる全構造単位の1モル%以上、好ましくは5モル%以上、より好ましくは10モル%以上、更に好ましくは20モル%以上含むことが好ましい。
また、ポリイミド前駆体(B)は、残留DC由来の残像が少ない観点において、Yb1が上記特定の2価の有機基(b)である構造単位を、ポリイミド前駆体(B)に含まれる全構造単位の1モル%以上、好ましくは5モル%以上、より好ましくは10モル%以上、更に好ましくは20モル%以上含むことが好ましい。
From the viewpoint of reducing afterimages derived from residual DC, the polyimide precursor (B) preferably contains structural units having the specific divalent organic group (b) (more preferably structural units having the specific divalent organic group bonded to a nitrogen atom derived from a diamine) in an amount of 1 mol % or more, preferably 5 mol % or more, more preferably 10 mol % or more, and even more preferably 20 mol % or more of all structural units contained in the polyimide precursor (B).
From the viewpoint of reducing an afterimage derived from residual DC, the polyimide precursor (B) preferably contains structural units in which Y b1 is the specific divalent organic group (b) in an amount of 1 mol % or more, preferably 5 mol % or more, more preferably 10 mol % or more, and even more preferably 20 mol % or more of all structural units contained in the polyimide precursor (B).
上記ポリイミド前駆体(B)は、本発明の効果を好適に得る観点から、上記式(B1)で表される構造単位(b1)とともに、更に、下記式(B2)で表される構造単位(b2)を有するポリイミド前駆体であってもよい。
上記式(B2)における、非環式脂肪族テトラカルボン酸二無水物及び脂環式テトラカルボン酸二無水物の定義は上記したとおりである。 In the above formula (B2), the acyclic aliphatic tetracarboxylic acid dianhydride and the alicyclic tetracarboxylic acid dianhydride are defined as above.
Xb2は、本発明の効果を好適に得る観点から、好ましくは、上記式(X-1)~(X-17)、又は(Xa1-1)~(Xa1-8)のいずれかで表される4価の有機基である。 From the viewpoint of suitably obtaining the effects of the present invention, X b2 is preferably a tetravalent organic group represented by any one of the above formulas (X-1) to (X-17) or (Xa1-1) to (Xa1-8).
本発明の効果を好適に得る観点から、ポリイミド前駆体(B)は、構造単位(b1)と該構造単位(b1)のイミド化構造単位との合計をポリイミド前駆体(B)が有する全構造単位の10~100モル%含むことが好ましく、15~100モル%含むことがより好ましい。
また、ポリイミド前駆体(B)が構造単位(b1)及び/又は、繰り返し単位(b1)のイミド化構造単位以外の構造単位を含む場合は、構造単位(b1)は、ポリイミド前駆体(B)が有する全構造単位の95モル%以下含むことが好ましく、90モル%以下含むことがより好ましい。
ポリイミド前駆体(B)は、上記構造単位(b2)をポリイミド前駆体(B)が有する全構造単位の5モル%以上含むことが好ましく、10モル%以上含むことがより好ましい。また、上記構造単位(b2)をポリイミド前駆体(B)が有する全構造単位の90モル%以下含むことが好ましく、85モル%以下含むことがより好ましい。
From the viewpoint of suitably obtaining the effects of the present invention, the polyimide precursor (B) preferably contains the structural unit (b1) and the imidized structural unit of the structural unit (b1) in an amount of 10 to 100 mol %, and more preferably 15 to 100 mol %, of the total structural units contained in the polyimide precursor (B).
In addition, when the polyimide precursor (B) contains a structural unit other than the structural unit (b1) and/or the imidized structural unit of the repeating unit (b1), the structural unit (b1) preferably accounts for 95 mol % or less, and more preferably 90 mol % or less, of all structural units contained in the polyimide precursor (B).
The polyimide precursor (B) preferably contains the structural unit (b2) in an amount of 5 mol % or more, more preferably 10 mol % or more, based on the total structural units contained in the polyimide precursor (B), and preferably contains the structural unit (b2) in an amount of 90 mol % or less, more preferably 85 mol % or less, based on the total structural units contained in the polyimide precursor (B).
上記重合体成分(P)における、第二のポリイミド前駆体の含有量に対する第一のポリイミド前駆体の含有量の質量比率(第一のポリイミド前駆体の含有量/第二のポリイミド前駆体の含有量)は、10/90~90/10が好ましく、20/80~90/10がより好ましく、20/80~80/20が更に好ましい。
残留DC由来の残像が少ない観点において、ポリイミド前駆体(B)の含有量に対するポリイミド前駆体(A)の含有量の質量比率(ポリイミド前駆体(A)の含有量/ポリイミド前駆体(B)の含有量)は、10/90~90/10が好ましく、20/80~90/10がより好ましく、20/80~80/20が更に好ましい。
In the polymer component (P), the mass ratio of the content of the first polyimide precursor to the content of the second polyimide precursor (content of the first polyimide precursor/content of the second polyimide precursor) is preferably 10/90 to 90/10, more preferably 20/80 to 90/10, and even more preferably 20/80 to 80/20.
From the viewpoint of reducing an afterimage caused by residual DC, the mass ratio of the content of the polyimide precursor (A) to the content of the polyimide precursor (B) (the content of the polyimide precursor (A)/the content of the polyimide precursor (B)) is preferably from 10/90 to 90/10, more preferably from 20/80 to 90/10, and even more preferably from 20/80 to 80/20.
<重合体(P)、ポリイミド前駆体(A)及びポリイミド前駆体(B)の製造方法>
本発明における重合体(P)、ポリイミド前駆体(A)及び(B)は、例えば、WO2013/157586号公報に記載されるような既知の方法で合成できる。
<Methods for producing polymer (P), polyimide precursor (A), and polyimide precursor (B)>
The polymer (P) and the polyimide precursors (A) and (B) in the present invention can be synthesized by a known method such as that described in WO2013/157586.
具体的には、テトラカルボン酸二無水物を含むテトラカルボン酸誘導体成分とジアミン成分とを溶媒中で(縮重合)反応させることにより得られる。溶媒としては、生成した重合体が溶解するものであれば特に限定されない。 Specifically, it is obtained by reacting (condensation polymerization) a tetracarboxylic acid derivative component containing a tetracarboxylic dianhydride with a diamine component in a solvent. There are no particular limitations on the solvent as long as it dissolves the resulting polymer.
例えば、上記式(A1)で表される繰り返し単位を有するポリイミド前駆体(A)を合成する場合、ジアミン成分としては、-NZ-Ya1-NZ-の構造(Ya1、Zは式(A1)のYa1と同じ定義である。)を有するジアミンが使用され、また、テトラカルボン酸誘導体成分としては、上記式(Xa1)の構造(Xa1は式(A1)のXa1と同じ定義である。)を有するテトラカルボン酸二無水物が使用される。 For example, when synthesizing a polyimide precursor (A) having a repeating unit represented by the above formula (A1), a diamine having a structure of -NZ-Y a1 -NZ- (Y a1 and Z are defined the same as Y a1 in formula (A1)) is used as the diamine component, and a tetracarboxylic acid dianhydride having a structure of the above formula (X a1 ) (X a1 is defined the same as X a1 in formula (A1)) is used as the tetracarboxylic acid derivative component.
ポリイミド前駆体の合成反応に供されるテトラカルボン酸二無水物とジアミンとの使用割合は、ジアミンのアミノ基1当量に対して、テトラカルボン酸二無水物の酸無水物基が0.5~2当量となる割合が好ましく、さらに好ましくは0.8~1.2当量となる割合である。通常の重縮合反応と同様に、このテトラカルボン酸二無水物の酸無水物基の当量が1当量に近いほど、生成するポリイミド前駆体の分子量は大きくなる。
ポリイミド前駆体の合成反応における反応温度は-20~150℃が好ましく、0~100℃がより好ましい。また、反応時間は0.1~24時間が好ましく、0.5~12時間がより好ましい。
ポリイミド前駆体の合成反応は任意の濃度で行うことができるが、反応液におけるポリイミド前駆体の濃度は、好ましくは1~50質量%、より好ましくは5~30質量%である。反応初期は高濃度で行い、その後、溶媒を追加することもできる。
The ratio of the tetracarboxylic dianhydride and the diamine used in the synthesis reaction of the polyimide precursor is preferably such that the acid anhydride group of the tetracarboxylic dianhydride is 0.5 to 2 equivalents, more preferably 0.8 to 1.2 equivalents, per equivalent of the amino group of the diamine. As in the case of a normal polycondensation reaction, the closer the equivalent of the acid anhydride group of the tetracarboxylic dianhydride is to 1 equivalent, the higher the molecular weight of the polyimide precursor produced.
The reaction temperature in the synthesis reaction of the polyimide precursor is preferably −20 to 150° C., more preferably 0 to 100° C. The reaction time is preferably 0.1 to 24 hours, more preferably 0.5 to 12 hours.
The synthesis reaction of the polyimide precursor can be carried out at any concentration, but the concentration of the polyimide precursor in the reaction solution is preferably 1 to 50% by mass, more preferably 5 to 30% by mass. The reaction can be carried out at a high concentration in the early stage, and then a solvent can be added.
ジアミン成分とテトラカルボン酸誘導体成分とを反応させる際の上記溶媒の具体例としては、N-メチル-2-ピロリドン、N-エチル-2-ピロリドン、γ-ブチロラクトン、N,N-ジメチルホルムアミド、N,N-ジメチルアセトアミド、ジメチルスルホキシド、1,3-ジメチル-2-イミダゾリジノンが挙げられる。また、重合体の溶媒溶解性が高い場合は、メチルエチルケトン、シクロヘキサノン、シクロペンタノン、4-ヒドロキシ-4-メチル-2-ペンタノン、又はH3C-CH(OH)-CH2-O-D1(D1は炭素数1~3のアルキル基を表す。)、HO-CH2-CH2-O-D2(D2は炭素数1~3のアルキル基を表す。)、HO-CH2-CH2-O-CH2-CH2-D3(D3は炭素数1~4のアルキル基を表す。)で示される溶媒を用いることができる。これら溶媒は単独で使用しても、混合して使用してもよい。 Specific examples of the solvent used when reacting the diamine component with the tetracarboxylic acid derivative component include N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone, γ-butyrolactone, N,N-dimethylformamide, N,N-dimethylacetamide, dimethylsulfoxide, and 1,3-dimethyl-2-imidazolidinone. In addition, when the polymer has high solvent solubility, it is possible to use a solvent represented by the formula: methyl ethyl ketone, cyclohexanone, cyclopentanone, 4-hydroxy-4-methyl-2-pentanone, or H 3 C-CH(OH)-CH 2 -O -D 1 (D 1 represents an alkyl group having 1 to 3 carbon atoms), HO-CH 2 -CH 2 -O-D 2 (D 2 represents an alkyl group having 1 to 3 carbon atoms), or HO-CH 2 -CH 2 -O-CH 2 -CH 2 -D 3 (D 3 represents an alkyl group having 1 to 4 carbon atoms). These solvents may be used alone or in combination.
上記H3C-CH(OH)-CH2-O-D1、HO-CH2-CH2-O-D2、HO-CH2-CH2-O-CH2-CH2-D3で示される溶媒の具体例としては、プロピレングリコールモノメチルエーテル、エチレングリコールモノメチルエーテル、エチレングリコールモノエチルエーテル、エチレングリコールモノプロピルエーテル、ジエチレングリコールモノメチルエーテル、ジエチレングリコールモノエチルエーテルなどが挙げられる。 Specific examples of the solvent represented by the above H 3 C—CH(OH)—CH 2 -O-D 1 , HO-CH 2 -CH 2 -O-D 2 , and HO-CH 2 -CH 2 -O-CH 2 -CH 2 -D 3 include propylene glycol monomethyl ether, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol monopropyl ether, diethylene glycol monomethyl ether, and diethylene glycol monoethyl ether.
<重合体の溶液粘度・分子量>
本発明における重合体(P)、ポリイミド前駆体(A)、及びポリイミド前駆体(B)は、これを濃度10~15質量%の溶液としたときに、例えば、10~1000mPa・sの溶液粘度を持つものが作業性の観点から好ましいが、特に限定されない。なお、上記重合体の溶液粘度(mPa・s)は、当該重合体の良溶媒(例えば、γ-ブチロラクトン、N-メチル-2-ピロリドン等)を用いて調製した濃度10~15質量%の重合体溶液につき、E型回転粘度計を用いて25℃において測定した値である。
<Polymer solution viscosity and molecular weight>
In the present invention, the polymer (P), the polyimide precursor (A), and the polyimide precursor (B) preferably have a solution viscosity of, for example, 10 to 1000 mPa·s when made into a solution of 10 to 15% by mass from the viewpoint of workability, but are not particularly limited thereto. The solution viscosity (mPa·s) of the polymer is a value measured at 25° C. using an E-type rotational viscometer for a polymer solution of 10 to 15% by mass prepared using a good solvent for the polymer (e.g., γ-butyrolactone, N-methyl-2-pyrrolidone, etc.).
上記重合体(P)、ポリイミド前駆体(A)、及びポリイミド前駆体(B)のゲルパーミエーションクロマトグラフィー(GPC)により測定したポリスチレン換算の重量平均分子量(Mw)は、好ましくは1,000~500,000であり、より好ましくは2,000~300,000である。また、Mwと、GPCにより測定したポリスチレン換算の数平均分子量(Mn)との比で表される分子量分布(Mw/Mn)は、好ましくは15以下であり、より好ましくは10以下である。この分子量範囲にあることが、本発明の効果を好適に得る観点から、好ましい。 The weight average molecular weight (Mw) of the polymer (P), polyimide precursor (A), and polyimide precursor (B) measured by gel permeation chromatography (GPC) in terms of polystyrene is preferably 1,000 to 500,000, and more preferably 2,000 to 300,000. The molecular weight distribution (Mw/Mn), which is expressed as the ratio of Mw to the number average molecular weight (Mn) measured by GPC in terms of polystyrene, is preferably 15 or less, and more preferably 10 or less. From the viewpoint of optimally obtaining the effects of the present invention, it is preferable for the molecular weight to be within this range.
<末端封止剤>
本発明における重合体(P)、ポリイミド前駆体(A)、及びポリイミド前駆体(B)を合成するに際して、上記の如きテトラカルボン酸誘導体成分、及びジアミン成分とともに、適当な末端封止剤を用いて末端封止型の重合体としてもよい。末端封止型の重合体は、塗膜によって得られる液晶配向膜の膜硬度の向上や、シール剤と液晶配向膜の密着特性の向上という効果を有する。
<End-capping agent>
In synthesizing the polymer (P), polyimide precursor (A), and polyimide precursor (B) in the present invention, a suitable end-capping agent may be used together with the above-mentioned tetracarboxylic acid derivative component and diamine component to form an end-capping type polymer. The end-capping type polymer has the effect of improving the film hardness of the liquid crystal alignment film obtained by coating and improving the adhesion property between the sealant and the liquid crystal alignment film.
本発明における重合体(P)、ポリイミド前駆体(A)、ポリイミド前駆体(B)の末端の例としては、アミノ基、カルボキシ基、酸無水物基又はこれらの誘導体が挙げられる。アミノ基、カルボキシ基、酸無水物基は通常の縮合反応により得るか、又は以下の末端封止剤を用いて末端を封止することにより得ることができ、例えば、以下の末端封止剤を用いて、同様に得ることができる。 Examples of the terminals of the polymer (P), polyimide precursor (A), and polyimide precursor (B) in the present invention include amino groups, carboxy groups, acid anhydride groups, and derivatives thereof. The amino groups, carboxy groups, and acid anhydride groups can be obtained by a normal condensation reaction, or by blocking the terminals with the following terminal blocking agents, and can be obtained in the same manner, for example, by using the following terminal blocking agents.
末端封止剤としては、例えば、無水酢酸、無水マレイン酸、無水ナジック酸、無水フタル酸、無水イタコン酸、シクロヘキサンジカルボン酸無水物、3-ヒドロキシフタル酸無水物、トリメリット酸無水物、3-(3-トリメトキシシリル)プロピル)-3,4-ジヒドロフラン-2,5-ジオン、4,5,6,7-テトラフルオロイソベンゾフラン-1,3-ジオン、4-エチニルフタル酸無水物等の酸一無水物;二炭酸ジ-tert-ブチル、二炭酸ジアリル等の二炭酸ジエステル化合物;アクリロイルクロリド、メタクリロイルクロリド、ニコチン酸クロリド等のクロロカルボニル化合物;アニリン、2-アミノフェノール、3-アミノフェノール、4-アミノサリチル酸、5-アミノサリチル酸、6-アミノサリチル酸、2-アミノ安息香酸、3-アミノ安息香酸、4-アミノ安息香酸、シクロヘキシルアミン、n-ブチルアミン、n-ペンチルアミン、n-ヘキシルアミン、n-ヘプチルアミン、n-オクチルアミン等のモノアミン化合物;エチルイソシアネート、フェニルイソシアネート、ナフチルイソシアネート、2-アクリロイルオキシエチルイソシアネ-ト及び2-メタクリロイルオキシエチルイソシアネ-ト等の不飽和結合を有するイソシアネート等のモノイソシアネート化合物;エチルイソチオシアネート、アリルイソチオシアネート等のイソチオシアネート化合物等を挙げることができる。 Examples of end-capping agents include acid monoanhydrides such as acetic anhydride, maleic anhydride, nadic anhydride, phthalic anhydride, itaconic anhydride, cyclohexanedicarboxylic anhydride, 3-hydroxyphthalic anhydride, trimellitic anhydride, 3-(3-trimethoxysilyl)propyl)-3,4-dihydrofuran-2,5-dione, 4,5,6,7-tetrafluoroisobenzofuran-1,3-dione, and 4-ethynylphthalic anhydride; dicarbonate diester compounds such as di-tert-butyl dicarbonate and diallyl dicarbonate; chlorocarbonyl compounds such as acryloyl chloride, methacryloyl chloride, and nicotinic acid chloride; aniline, 2-aminophenol, 3-aminophenol, Examples of the monoamine compounds include 4-aminosalicylic acid, 5-aminosalicylic acid, 6-aminosalicylic acid, 2-aminobenzoic acid, 3-aminobenzoic acid, 4-aminobenzoic acid, cyclohexylamine, n-butylamine, n-pentylamine, n-hexylamine, n-heptylamine, and n-octylamine; monoisocyanate compounds such as isocyanates having unsaturated bonds, such as ethyl isocyanate, phenyl isocyanate, naphthyl isocyanate, 2-acryloyloxyethyl isocyanate, and 2-methacryloyloxyethyl isocyanate; and isothiocyanate compounds such as ethyl isothiocyanate and allyl isothiocyanate.
末端封止剤の使用割合は、使用するジアミン成分の合計100モル部に対して、0.01~20モル部が好ましく、0.01~10モル部がより好ましい。 The proportion of the end-capping agent used is preferably 0.01 to 20 molar parts, and more preferably 0.01 to 10 molar parts, per 100 molar parts of the total diamine components used.
<化合物(C)>
本発明の液晶配向剤は、上記式(c)で表される化合物(C)を含有する。尚、化合物(C)は1種類又は2種類以上の化合物を用いてもよい。
上記式(c)におけるRcの1価の有機基の具体例として、炭素数1~6のアルキル基、炭素数2~6のアルケニル基、炭素数2~6のアルキニル基、フッ素原子を含有する炭素数1~6の1価の有機基、又は、炭素数6の芳香族基が挙げられる。
上記Rcにおける炭素数1~6のアルキル基の具体例としては、メチル基、エチル基、プロピル基、イソプロピル基、n-ブチル基、イソブチル基、sec-ブチル基、tert-ブチル基、n-ペンチル基等が挙げられる。上記Rcにおける炭素数2~6のアルケニル基の具体例としては、ビニル基、プロペニル基、ブテニル基等が挙げられ、これらは直鎖状でも分岐状でもよい。上記Rcにおける炭素数2~6のアルキニル基の具体例としては、エチニル基、1-プロピニル基、2-プロピニル基、1-ブチニル基、2-ブチニル基、3-ブチニル基等が挙げられる。上記Rcにおける、フッ素原子を含有する炭素数1~6の1価の有機基としては、フルオロメチル基、トリフルオロメチル基、ペンタフルオロエチル基、ペンタフルオロプロピル基等が挙げられる。炭素数6の芳香族基としては、ハロゲン原子で置換されてもよいフェニル基が挙げられる。
Rcは、好ましくは炭素数1~6のアルキル基であり、より好ましくは炭素数1~4のアルキル基である。
上記化合物(C)のより好ましい具体例として、亜リン酸メチル、亜リン酸エチル、亜リン酸プロピル、亜リン酸ブチル、亜リン酸ヘキシル、亜リン酸フェニル;亜リン酸ジメチル、亜リン酸ジエチル、亜リン酸ジプロピル、亜リン酸ジブチル、亜リン酸ジヘキシル、亜リン酸ジフェニル等が挙げられる。
<Compound (C)>
The liquid crystal aligning agent of the present invention contains the compound (C) represented by the above formula (c). The compound (C) may be one type or two or more types of compounds.
Specific examples of the monovalent organic group for R c in the above formula (c) include an alkyl group having 1 to 6 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, an alkynyl group having 2 to 6 carbon atoms, a monovalent organic group containing a fluorine atom having 1 to 6 carbon atoms, or an aromatic group having 6 carbon atoms.
Specific examples of the alkyl group having 1 to 6 carbon atoms in the above R c include a methyl group, an ethyl group, a propyl group, an isopropyl group, an n-butyl group, an isobutyl group, a sec-butyl group, a tert-butyl group, and an n-pentyl group. Specific examples of the alkenyl group having 2 to 6 carbon atoms in the above R c include a vinyl group, a propenyl group, and a butenyl group, which may be linear or branched. Specific examples of the alkynyl group having 2 to 6 carbon atoms in the above R c include an ethynyl group, a 1-propynyl group, a 2-propynyl group, a 1-butynyl group, a 2-butynyl group, and a 3-butynyl group. Examples of the monovalent organic group having 1 to 6 carbon atoms and containing a fluorine atom in the above R c include a fluoromethyl group, a trifluoromethyl group, a pentafluoroethyl group, and a pentafluoropropyl group. Examples of the aromatic group having 6 carbon atoms include a phenyl group which may be substituted with a halogen atom.
R c is preferably an alkyl group having 1 to 6 carbon atoms, and more preferably an alkyl group having 1 to 4 carbon atoms.
More preferred specific examples of the compound (C) include methyl phosphite, ethyl phosphite, propyl phosphite, butyl phosphite, hexyl phosphite, phenyl phosphite; dimethyl phosphite, diethyl phosphite, dipropyl phosphite, dibutyl phosphite, dihexyl phosphite, diphenyl phosphite, and the like.
化合物(C)の含有量の合計は、液晶配向剤中の全成分を100質量%とした場合、0.1質量%以上が好ましく、0.2質量%以上がより好ましく、0.3質量%以上がさらに好ましい。
また、化合物(C)の含有量の合計は、液晶配向剤中の全成分を100質量%とした場合、本発明の効果を好適に得る観点から、10質量%以下が好ましく、5質量%以下がより好ましく、3質量%以下が更に好ましい。
また、液晶配向剤の(C)成分以外の成分の合計質量が液晶配向剤の全質量に占める割合は、液晶配向剤中の全成分を100質量%とした場合、99.9質量%以下であり、より好ましくは99.8質量%以下であり、さらに好ましくは99.7質量%以下である。さらに、液晶配向剤の(C)成分以外の成分の合計質量が液晶配向剤の全質量に占める割合は、液晶配向剤中の全成分を100質量%とした場合、90質量%以上が好ましい。
The total content of the compound (C) is preferably 0.1 mass % or more, more preferably 0.2 mass % or more, and even more preferably 0.3 mass % or more, when all components in the liquid crystal aligning agent are taken as 100 mass %.
In addition, the total content of the compound (C) is preferably 10% by mass or less, more preferably 5% by mass or less, and even more preferably 3% by mass or less, from the viewpoint of suitably obtaining the effects of the present invention, when all components in the liquid crystal alignment agent are 100% by mass.
In addition, the ratio of the total mass of the components other than the (C) component of the liquid crystal alignment agent to the total mass of the liquid crystal alignment agent is 99.9% by mass or less, more preferably 99.8% by mass or less, and even more preferably 99.7% by mass or less, when all components in the liquid crystal alignment agent are 100% by mass. Furthermore, the ratio of the total mass of the components other than the (C) component of the liquid crystal alignment agent to the total mass of the liquid crystal alignment agent is preferably 90% by mass or more, when all components in the liquid crystal alignment agent are 100% by mass.
本発明の液晶配向剤は、有機溶媒を含有する。有機溶媒の具体例としては、N,N-ジメチルホルムアミド、N,N-ジメチルアセトアミド、N,N-ジメチルラクトアミド、N,N-ジメチルプロピオンアミド、テトラメチル尿素、N,N-ジエチルホルムアミド、N-メチル-2-ピロリドン、N-エチル-2-ピロリドン、ジメチルスルホキシド、γ-ブチロラクトン、γ-バレロラクトン、1,3-ジメチル-2-イミダゾリジノン、メチルエチルケトン、シクロヘキサノン、シクロペンタノン、3-メトキシ-N,N-ジメチルプロパンアミド、3-ブトキシ-N,N-ジメチルプロパンアミド、N-(n-プロピル)-2-ピロリドン、N-イソプロピル-2-ピロリドン、N-(n-ブチル)-2-ピロリドン、N-(tert-ブチル)-2-ピロリドン、N-(n-ペンチル)-2-ピロリドン、N-メトキシプロピル-2-ピロリドン、N-エトキシエチル-2-ピロリドン、N-メトキシブチル-2-ピロリドン、N-シクロヘキシル-2-ピロリドン(これらを総称して「良溶媒」ともいう)が挙げられる。なかでも、N-メチル-2-ピロリドン、N-エチル-2-ピロリドン、3-メトキシ-N,N-ジメチルプロパンアミド、3-ブトキシ-N,N-ジメチルプロパンアミド又はγ-ブチロラクトンが好ましい。良溶媒の含有量は、液晶配向剤中の全成分を100質量%とした場合、20質量%以上が好ましく、30質量%以上が好ましい。 The liquid crystal alignment agent of the present invention contains an organic solvent. Specific examples of organic solvents include N,N-dimethylformamide, N,N-dimethylacetamide, N,N-dimethyllactamide, N,N-dimethylpropionamide, tetramethylurea, N,N-diethylformamide, N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone, dimethylsulfoxide, γ-butyrolactone, γ-valerolactone, 1,3-dimethyl-2-imidazolidinone, methyl ethyl ketone, cyclohexanone, cyclopentanone, 3-methoxy-N ...propionamide, tetramethylurea, N,N-diethylpropionamide, tetramethylurea, N,N-diethylpropionamide, tetramethylurea, N,N-diethylpropionamide, tetramethylurea, N,N-diethylpropionamide, tetramethylurea, N,N-diethylpropionamide, tetramethylurea, N,N-diethylpropionamide, tetramethylurea, N Examples of the good solvent include N-propanamide, 3-butoxy-N,N-dimethylpropanamide, N-(n-propyl)-2-pyrrolidone, N-isopropyl-2-pyrrolidone, N-(n-butyl)-2-pyrrolidone, N-(tert-butyl)-2-pyrrolidone, N-(n-pentyl)-2-pyrrolidone, N-methoxypropyl-2-pyrrolidone, N-ethoxyethyl-2-pyrrolidone, N-methoxybutyl-2-pyrrolidone, and N-cyclohexyl-2-pyrrolidone (collectively referred to as "good solvents"). Among these, N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone, 3-methoxy-N,N-dimethylpropanamide, 3-butoxy-N,N-dimethylpropanamide, and γ-butyrolactone are preferred. The content of the good solvent is preferably 20% by mass or more, and more preferably 30% by mass or more, assuming that the total components in the liquid crystal alignment agent are 100% by mass.
また、液晶配向剤に含有される有機溶媒は、上記溶媒に加えて液晶配向剤を塗布する際の塗布性や塗膜の表面平滑性を向上させる溶媒(貧溶媒ともいう。)を併用した混合溶媒の使用が好ましい。貧溶媒の含有量は、液晶配向剤中の全成分を100質量%とした場合1質量%以上が好ましく、5質量%以上がより好ましく、10質量%以上がさらに好ましい。
また、上記良溶媒及び貧溶媒の含有量の合計は、液晶配向剤中の全成分を100質量%とした場合、99.9質量%以下が好ましく、99.8質量%以下がより好ましく、99.7質量%以下が更に好ましい。
貧溶媒の種類及び含有量は、液晶配向剤の塗布装置、塗布条件、塗布環境等に応じて適宜選択される。上記貧溶媒の具体例を下記するが、これらに限定されない。
In addition, the organic solvent contained in the liquid crystal alignment agent is preferably a mixed solvent containing a solvent (also called a poor solvent) that improves the coatability and surface smoothness of the coating film when applying the liquid crystal alignment agent in addition to the above-mentioned solvent. The content of the poor solvent is preferably 1% by mass or more, more preferably 5% by mass or more, and even more preferably 10% by mass or more, when the total components in the liquid crystal alignment agent are taken as 100% by mass.
The total content of the good solvent and the poor solvent is preferably 99.9% by mass or less, more preferably 99.8% by mass or less, and even more preferably 99.7% by mass or less, when the total amount of all components in the liquid crystal alignment agent is 100% by mass.
The type and content of the poor solvent are appropriately selected depending on the coating device, coating conditions, coating environment, etc. of the liquid crystal alignment agent. Specific examples of the poor solvent are listed below, but are not limited thereto.
ジイソプロピルエーテル、ジイソブチルエーテル、ジイソブチルカルビノール(2,6-ジメチル-4-ヘプタノール)、エチレングリコールジメチルエーテル、エチレングリコールジエチルエーテル、エチレングリコールジブチルエーテル、ジエチレングリコールジメチルエーテル、ジエチレングリコールジエチルエーテル、4-ヒドロキシ-4-メチル-2-ペンタノン、ジエチレングリコールメチルエチルエーテル、ジエチレングリコールジブチルエーテル、3-エトキシブチルアセタート、1-メチルペンチルアセタート、2-エチルブチルアセタート、2-エチルヘキシルアセタート、エチレングリコールジアセタート、プロピレンカーボネート、エチレンカーボネート、エチレングリコールモノブチルエーテル、エチレングリコールモノイソアミルエーテル、エチレングリコールモノヘキシルエーテル、プロピレングリコールモノブチルエーテル、1-(2-ブトキシエトキシ)-2-プロパノール、2-(2-ブトキシエトキシ)-1-プロパノール、プロピレングリコールモノメチルエーテルアセタート、プロピレングリコールジアセテート、ジプロピレングリコールモノメチルエーテル、ジプロピレングリコールモノエチルエーテル、ジプロピレングリコールジメチルエーテル、エチレングリコールモノブチルエーテルアセタート、ジエチレングリコールモノプロピルエーテル、ジエチレングリコールモノエチルエーテルアセタート、ジエチレングリコールモノブチルエーテルアセタート、2-(2-エトキシエトキシ)エチルアセタート、ジエチレングリコールジアセタート、プロピレングリコールジアセテート、酢酸n-ブチル、酢酸プロピレングリコールモノエチルエーテル、酢酸シクロヘキシル、酢酸4-メチル-2-ペンチル、3-メトキシプロピオン酸メチル、3-エトキシプロピオン酸エチル、3-メトキシプロピオン酸エチル、3-メトキシプロピオン酸プロピル、3-メトキシプロピオン酸ブチル、乳酸n-ブチル、乳酸イソアミル、ジエチレングリコールモノエチルエーテル、ジイソブチルケトン(2,6-ジメチル-4-ヘプタノン)等を挙げることができる。 Diisopropyl ether, diisobutyl ether, diisobutyl carbinol (2,6-dimethyl-4-heptanol), ethylene glycol dimethyl ether, ethylene glycol diethyl ether, ethylene glycol dibutyl ether, diethylene glycol dimethyl ether, diethylene glycol diethyl ether, 4-hydroxy-4-methyl-2-pentanone, diethylene glycol methyl ethyl ether, diethylene glycol dibutyl ether, 3-ethoxybutyl acetate, 1-methylpentyl acetate, 2-ethylbutyl acetate, 2-ethylhexyl acetate, ethylene glycol diacetate, propylene carbonate, ethylene carbonate, ethylene glycol monobutyl ether, ethylene glycol monoisoamyl ether, ethylene glycol monohexyl ether, propylene glycol monobutyl ether, 1-(2-butoxyethoxy)-2-propanol, 2-(2-butoxyethoxy)-1-propanol, propylene glycol monomethyl Examples of the ether acetate include propylene glycol diacetate, dipropylene glycol monomethyl ether, dipropylene glycol monoethyl ether, dipropylene glycol dimethyl ether, ethylene glycol monobutyl ether acetate, diethylene glycol monopropyl ether, diethylene glycol monoethyl ether acetate, diethylene glycol monobutyl ether acetate, 2-(2-ethoxyethoxy)ethyl acetate, diethylene glycol diacetate, propylene glycol diacetate, n-butyl acetate, propylene glycol monoethyl ether acetate, cyclohexyl acetate, 4-methyl-2-pentyl acetate, methyl 3-methoxypropionate, ethyl 3-ethoxypropionate, ethyl 3-methoxypropionate, propyl 3-methoxypropionate, butyl 3-methoxypropionate, n-butyl lactate, isoamyl lactate, diethylene glycol monoethyl ether, and diisobutyl ketone (2,6-dimethyl-4-heptanone).
貧溶媒としては、なかでも、ジイソブチルカルビノール、プロピレングリコールモノブチルエーテル、プロピレングリコールジアセテート、ジエチレングリコールジエチルエーテル、ジプロピレングリコールモノメチルエーテル、ジプロピレングリコールジメチルエーテル、4-ヒドロキシ-4-メチル-2-ペンタノン、エチレングリコールモノブチルエーテル、エチレングリコールモノブチルエーテルアセタート、又はジイソブチルケトンが好ましい。 Among the poor solvents, diisobutyl carbinol, propylene glycol monobutyl ether, propylene glycol diacetate, diethylene glycol diethyl ether, dipropylene glycol monomethyl ether, dipropylene glycol dimethyl ether, 4-hydroxy-4-methyl-2-pentanone, ethylene glycol monobutyl ether, ethylene glycol monobutyl ether acetate, and diisobutyl ketone are preferred.
良溶媒と貧溶媒との好ましい溶媒の組み合わせとしては、N-メチル-2-ピロリドンとエチレングリコールモノブチルエーテル、N-メチル-2-ピロリドンとγ-ブチロラクトンとエチレングリコールモノブチルエーテル、N-メチル-2-ピロリドンとγ-ブチロラクトンとプロピレングリコールモノブチルエーテル、N-エチル-2-ピロリドンとプロピレングリコールモノブチルエーテル、N-エチル-2-ピロリドンと4-ヒドロキシ-4-メチル-2-ペンタノン、N-エチル-2-ピロリドンとプロピレングリコールジアセテート、N,N-ジメチルラクトアミドとジイソブチルケトン、N-メチル-2-ピロリドンと3-エトキシプロピオン酸エチル、N-エチル-2-ピロリドンと3-エトキシプロピオン酸エチル、N-エチル-2-ピロリドンと3-エトキシプロピオン酸エチルとプロピレングリコールモノブチルエーテル、N-メチル-2-ピロリドンと3-エトキシプロピオン酸エチルとジエチレングリコールモノプロピルエーテル、N-エチル-2-ピロリドンと3-エトキシプロピオン酸エチルとジエチレングリコールモノプロピルエーテル、N-メチル-2-ピロリドンとエチレングリコールモノブチルエーテルアセタート、N-エチル-2-ピロリドンとジプロピレングリコールジメチルエーテル、N,N-ジメチルラクトアミドとエチレングリコールモノブチルエーテル、N,N-ジメチルラクトアミドとプロピレングリコールジアセテート、N-エチル-2-ピロリドンとジエチレングリコールジエチルエーテル、N-エチル-2-ピロリドンとジエチレングリコールモノエチルエーテルとブチルセロソルブアセテート、N-メチル-2-ピロリドンとジエチレングリコールモノメチルエーテルとブチルセロソルブアセテート、N,N-ジメチルラクトアミドとジエチレングリコールジエチルエーテル、N-メチル-2-ピロリドンとγ-ブチロラクトンと4-ヒドロキシ-4-メチル-2-ペンタノンとジエチレングリコールジエチルエーテル、N-エチル-2-ピロリドンとN-メチル-2-ピロリドンと4-ヒドロキシ-4-メチル-2-ペンタノン、N-エチル-2-ピロリドンと4-ヒドロキシ-4-メチル-2-ペンタノンとプロピレングリコールモノブチルエーテル、N-メチル-2-ピロリドンと4-ヒドロキシ-4-メチル-2-ペンタノンとジイソブチルケトン、N-メチル-2-ピロリドンと4-ヒドロキシ-4-メチル-2-ペンタノンとジプロピレングリコールモノメチルエーテル、N-メチル-2-ピロリドンと4-ヒドロキシ-4-メチル-2-ペンタノンとプロピレングリコールモノブチルエーテル、N-メチル-2-ピロリドンと4-ヒドロキシ-4-メチル-2-ペンタノンとプロピレングリコールジアセテート、N-エチル-2-ピロリドンと4-ヒドロキシ-4-メチル-2-ペンタノンとジプロピレングリコールジメチルエーテル、γ-ブチロラクトンと4-ヒドロキシ-4-メチル-2-ペンタノンとジイソブチルケトン、γ-ブチロラクトンと4-ヒドロキシ-4-メチル-2-ペンタノンとプロピレングリコールジアセテート、N-メチル-2-ピロリドンとγ-ブチロラクトンとプロピレングリコールモノブチルエーテルとジイソブチルケトン、N-メチル-2-ピロリドンとγ-ブチロラクトンとプロピレングリコールモノブチルエーテルとジイソプロピルエーテル、N-メチル-2-ピロリドンとγ-ブチロラクトンとプロピレングリコールモノブチルエーテルとジイソブチルカルビノール、N-メチル-2-ピロリドンとγ-ブチロラクトンとジプロピレングリコールジメチルエーテル、N-メチル-2-ピロリドンとプロピレングリコールモノブチルエーテルとジプロピレングリコールジメチルエーテル、N-エチル-2-ピロリドンとプロピレングリコールモノブチルエーテルとジプロピレングリコールモノメチルエーテル、N-エチル-2-ピロリドンとジエチレングリコールジエチルエーテルとジプロピレングリコールモノメチルエーテル、N-エチル-2-ピロリドンとプロピレングリコールモノブチルエーテルとプロピレングリコールジアセテート、N-エチル-2-ピロリドンとプロピレングリコールモノブチルエーテルとジイソブチルケトン、N-エチル-2-ピロリドンとγ-ブチロラクトンとジイソブチルケトン、N-エチル-2-ピロリドンとN,N-ジメチルラクトアミドとジイソブチルケトン、N-メチル-2-ピロリドンとエチレングリコールモノブチルエーテルとエチレングリコールモノブチルエーテルアセタート、γ-ブチロラクトンとエチレングリコールモノブチルエーテルアセタートとジプロピレングリコールジメチルエーテル、N-エチル-2-ピロリドンとエチレングリコールモノブチルエーテルアセタートとプロピレングリコールジメチルエーテル、N-メチル-2-ピロリドンと酢酸4-メチル-2-ペンチルとエチレングリコールモノブチルエーテル、N-メチル-2-ピロリドンとシクロヘキサノンとプロピレングリコールモノメチルエーテル等を挙げることができる。 Preferred solvent combinations of good and poor solvents include N-methyl-2-pyrrolidone and ethylene glycol monobutyl ether, N-methyl-2-pyrrolidone, γ-butyrolactone and ethylene glycol monobutyl ether, N-methyl-2-pyrrolidone, γ-butyrolactone and propylene glycol monobutyl ether, N-ethyl-2-pyrrolidone and propylene glycol monobutyl ether, N-ethyl-2-pyrrolidone and 4-hydroxy-4-methyl-2-pentanone, N-ethyl-2-pyrrolidone and propylene glycol diacetate, and N,N-dimethyl lactamide and diisopropyl ether. isobutyl ketone, N-methyl-2-pyrrolidone and ethyl 3-ethoxypropionate, N-ethyl-2-pyrrolidone and ethyl 3-ethoxypropionate, N-ethyl-2-pyrrolidone and ethyl 3-ethoxypropionate, N-ethyl-2-pyrrolidone and ethyl 3-ethoxypropionate and propylene glycol monobutyl ether, N-methyl-2-pyrrolidone and ethyl 3-ethoxypropionate and diethylene glycol monopropyl ether, N-ethyl-2-pyrrolidone and ethyl 3-ethoxypropionate and diethylene glycol monopropyl ether, N-methyl-2-pyrrolidone and ethylene glycol monobutyl ether acetate, N-ethyl-2-pyrrolidone and ethylene glycol monobutyl ether acetate Pyrrolidone and dipropylene glycol dimethyl ether, N,N-dimethyl lactamide and ethylene glycol monobutyl ether, N,N-dimethyl lactamide and propylene glycol diacetate, N-ethyl-2-pyrrolidone and diethylene glycol diethyl ether, N-ethyl-2-pyrrolidone, diethylene glycol monoethyl ether and butyl cellosolve acetate, N-methyl-2-pyrrolidone, diethylene glycol monomethyl ether and butyl cellosolve acetate, N,N-dimethyl lactamide and diethylene glycol diethyl ether, N-methyl-2-pyrrolidone N-ethyl-2-pyrrolidone, N-methyl-2-pyrrolidone, 4-hydroxy-4-methyl-2-pentanone, diethylene glycol diethyl ether, N-ethyl-2-pyrrolidone, N-methyl-2-pyrrolidone, 4-hydroxy-4-methyl-2-pentanone, N-ethyl-2-pyrrolidone, 4-hydroxy-4-methyl-2-pentanone, propylene glycol monobutyl ether, N-methyl-2-pyrrolidone, 4-hydroxy-4-methyl-2-pentanone, diisobutyl ketone, N-methyl-2-pyrrolidone, 4-hydroxy-4-methyl-2-pentanone, dipropylene glycol monomethyl ether, N-methyl N-ethyl-2-pyrrolidone, 4-hydroxy-4-methyl-2-pentanone, and propylene glycol monobutyl ether, N-methyl-2-pyrrolidone, 4-hydroxy-4-methyl-2-pentanone, and propylene glycol diacetate, N-ethyl-2-pyrrolidone, 4-hydroxy-4-methyl-2-pentanone, and dipropylene glycol dimethyl ether, γ-butyrolactone, 4-hydroxy-4-methyl-2-pentanone, and diisobutyl ketone, γ-butyrolactone, 4-hydroxy-4-methyl-2-pentanone, and propylene glycol diacetate, N-methyl-2-pyrrolidone, γ-butyrolactone, propylene glycol monobutyl ether, and diisobutyl ketone, N-methyl-2-pyrrolidone, γ-butyrolactone, propylene glycol monobutyl ether, and diisopropyl ether, N-methyl-2-pyrrolidone, γ-butyrolactone, propylene glycol monobutyl ether, and diisobutyl carbinol, N-methyl-2-pyrrolidone, γ-butyrolactone, and dipropylene glycol dimethyl ether, N-methyl-2-pyrrolidone, propylene glycol monobutyl ether, and dipropylene glycol dimethyl ether, N-ethyl-2-pyrrolidone and propylene glycol monobutyl ether. propylene glycol monobutyl ether and dipropylene glycol monomethyl ether, N-ethyl-2-pyrrolidone, diethylene glycol diethyl ether and dipropylene glycol monomethyl ether, N-ethyl-2-pyrrolidone, propylene glycol monobutyl ether and propylene glycol diacetate, N-ethyl-2-pyrrolidone, propylene glycol monobutyl ether and diisobutyl ketone, N-ethyl-2-pyrrolidone, γ-butyrolactone and diisobutyl ketone, N-ethyl-2-pyrrolidone, N,N-dimethyl lactamide and diisobutyl ketone, N-methyl Examples of such compounds include N-ethyl-2-pyrrolidone, ethylene glycol monobutyl ether, and ethylene glycol monobutyl ether acetate, γ-butyrolactone, ethylene glycol monobutyl ether acetate, and dipropylene glycol dimethyl ether, N-ethyl-2-pyrrolidone, ethylene glycol monobutyl ether acetate, and propylene glycol dimethyl ether, N-methyl-2-pyrrolidone, 4-methyl-2-pentyl acetate, and ethylene glycol monobutyl ether, and N-methyl-2-pyrrolidone, cyclohexanone, and propylene glycol monomethyl ether.
液晶配向剤における固形分濃度(液晶配向剤の溶媒以外の成分の合計質量が液晶配向剤の全質量に占める割合)は、粘性、揮発性などを考慮して適宜に選択されるが、好ましくは1~10質量%の範囲である。均一で欠陥のない塗膜を形成させるという点からは、1質量%以上が好ましく、溶液の保存安定性の点からは、10質量%以下が好ましい。特に好ましい固形分濃度は、2~8質量%である。
固形分濃度の範囲は、基板に液晶配向剤を塗布する際に用いる方法によって適宜選択してもよい。例えばスピンコート塗布を行う場合には、固形分濃度が1.5~4.5質量%であることが特に好ましい。印刷法による場合には、固形分濃度を3~9質量%とし、それにより溶液粘度を12~50mPa・sとすることが特に好ましい。インクジェット法による場合には、固形分濃度を1~5質量%とし、それにより、溶液粘度を3~15mPa・sとすることが特に好ましい。液晶配向剤を調製する際の温度は、好ましくは10~50℃であり、より好ましくは20~30℃である。
液晶配向剤中の重合体成分の濃度は、形成させようとする塗膜の厚みの設定によって適宜変更することができる。均一で欠陥のない塗膜を形成させるという点から、液晶配向剤中の重合体成分の濃度(重合体の合計濃度)は、1質量%以上が好ましく、溶液の保存安定性の点からは、10質量%以下が好ましい。特に好ましい重合体の濃度は、2~8質量%である。
液晶配向剤中の重合体成分(P)の含有量(重合体成分(P)を構成する重合体の合計量)は、本開示の効果を好適に得る観点から、液晶配向剤に含まれる重合体成分の合計100質量部に対して、好ましくは10質量部以上であり、より好ましくは20質量部以上であり、更に好ましくは50質量部以上である。
液晶配向剤が後述するその他の重合体を含む場合、重合体成分(P)の含有量は、液晶配向剤に含まれる重合体の合計100質量部に対して、99.9質量部以下が好ましく、99質量部以下がより好ましい。
The solid content concentration in the liquid crystal alignment agent (the ratio of the total mass of the components other than the solvent of the liquid crystal alignment agent to the total mass of the liquid crystal alignment agent) is appropriately selected in consideration of viscosity, volatility, etc., and is preferably in the range of 1 to 10 mass%. From the viewpoint of forming a uniform and defect-free coating film, 1 mass% or more is preferable, and from the viewpoint of storage stability of the solution, 10 mass% or less is preferable. A particularly preferable solid content concentration is 2 to 8 mass%.
The range of the solid content may be appropriately selected depending on the method used when applying the liquid crystal alignment agent to the substrate. For example, when spin-coating is performed, it is particularly preferable that the solid content is 1.5 to 4.5% by mass. When using the printing method, it is particularly preferable that the solid content is 3 to 9% by mass, thereby making the solution viscosity 12 to 50 mPa·s. When using the inkjet method, it is particularly preferable that the solid content is 1 to 5% by mass, thereby making the solution viscosity 3 to 15 mPa·s. The temperature when preparing the liquid crystal alignment agent is preferably 10 to 50°C, more preferably 20 to 30°C.
The concentration of the polymer component in the liquid crystal alignment agent can be appropriately changed depending on the thickness of the coating film to be formed. From the viewpoint of forming a uniform and defect-free coating film, the concentration of the polymer component in the liquid crystal alignment agent (total concentration of polymers) is preferably 1% by mass or more, and from the viewpoint of storage stability of the solution, it is preferably 10% by mass or less. The particularly preferred polymer concentration is 2 to 8% by mass.
The content of the polymer component (P) in the liquid crystal alignment agent (the total amount of polymers constituting the polymer component (P)) is, from the viewpoint of suitably obtaining the effects of the present disclosure, preferably 10 parts by mass or more, more preferably 20 parts by mass or more, and even more preferably 50 parts by mass or more, relative to a total of 100 parts by mass of the polymer components contained in the liquid crystal alignment agent.
When the liquid crystal alignment agent contains other polymers described later, the content of the polymer component (P) is preferably 99.9 parts by mass or less, more preferably 99 parts by mass or less, per 100 parts by mass of the total of the polymers contained in the liquid crystal alignment agent.
本発明の液晶配向剤は、その他、必要に応じて上記以外の成分を含有していてもよい。当該成分としては、例えば、重合体(P)、ポリイミド前駆体(A)及び(B)以外のその他の重合体;エポキシ基、イソシアネート基、オキセタニル基、シクロカーボネート基、ブロックイソシアネート基、ヒドロキシ基及びアルコキシ基から選ばれる少なくとも1種の置換基を有する架橋性化合物(但し、上記化合物(C)を除く。)、並びに重合性不飽和基を有する架橋性化合物からなる群から選ばれる少なくとも1種の化合物;官能性シラン化合物;金属キレート化合物;硬化促進剤;界面活性剤;酸化防止剤;増感剤;防腐剤;液晶配向膜の誘電率や電気抵抗を調整するための化合物;イミド化を促進するための化合物、などが挙げられる。 The liquid crystal alignment agent of the present invention may contain other components as necessary. Examples of such components include other polymers than the polymer (P) and the polyimide precursors (A) and (B); at least one compound selected from the group consisting of crosslinkable compounds having at least one substituent selected from an epoxy group, an isocyanate group, an oxetanyl group, a cyclocarbonate group, a blocked isocyanate group, a hydroxyl group, and an alkoxy group (excluding the above compound (C)), and crosslinkable compounds having a polymerizable unsaturated group; functional silane compounds; metal chelate compounds; curing accelerators; surfactants; antioxidants; sensitizers; preservatives; compounds for adjusting the dielectric constant and electrical resistance of the liquid crystal alignment film; compounds for promoting imidization, and the like.
その他の重合体の具体例を挙げると、ポリシロキサン、ポリエステル、ポリアミド、ポリウレア、ポリウレタン、ポリオルガノシロキサン、セルロース誘導体、ポリアセタール、ポリスチレン誘導体、ポリ(スチレン-マレイン酸無水物)共重合体、ポリ(イソブチレン-マレイン酸無水物)共重合体、ポリ(ビニルエーテル-マレイン酸無水物)共重合体、ポリ(スチレン-フェニルマレイミド)誘導体、ポリ(メタ)アクリレートからなる群から選ばれる重合体等が挙げられる。 Specific examples of other polymers include polymers selected from the group consisting of polysiloxanes, polyesters, polyamides, polyureas, polyurethanes, polyorganosiloxanes, cellulose derivatives, polyacetals, polystyrene derivatives, poly(styrene-maleic anhydride) copolymers, poly(isobutylene-maleic anhydride) copolymers, poly(vinyl ether-maleic anhydride) copolymers, poly(styrene-phenylmaleimide) derivatives, and poly(meth)acrylates.
ポリ(スチレン-マレイン酸無水物)共重合体の具体例としては、SMA1000、2000、3000(Cray Valley社製)、GSM301(岐阜セラツク製造所社製)等が挙げられ、ポリ(イソブチレン-マレイン酸無水物)共重合体の具体例としては、イソバン-600(クラレ社製)が挙げられ、ポリ(ビニルエーテル-マレイン酸無水物)共重合体の具体例としては、Gantrez AN-139(メチルビニルエーテル無水マレイン酸樹脂、アシュランド社製)が挙げられる。その他の重合体は、一種を単独で使用してもよく、また二種以上を組み合わせて使用してもよい。その他の重合体の含有割合は、液晶配向剤中に含まれる重合体の合計100質量部に対して、90質量部以下が好ましく、80質量部以下がより好ましい。また、その他の重合体の含有割合は、液晶配向剤中に含まれる重合体の合計100質量部に対して、0.1質量部以上が好ましく、1質量部以上がより好ましい。 Specific examples of poly(styrene-maleic anhydride) copolymers include SMA1000, 2000, 3000 (Cray Valley) and GSM301 (Gifu Ceramics Manufacturing). Specific examples of poly(isobutylene-maleic anhydride) copolymers include ISOBAM-600 (Kuraray). Specific examples of poly(vinyl ether-maleic anhydride) copolymers include Gantrez AN-139 (methyl vinyl ether maleic anhydride resin, Ashland). The other polymers may be used alone or in combination of two or more. The content of the other polymers is preferably 90 parts by mass or less, more preferably 80 parts by mass or less, relative to a total of 100 parts by mass of the polymers contained in the liquid crystal alignment agent. The content of the other polymers is preferably 0.1 parts by mass or more, more preferably 1 part by mass or more, relative to a total of 100 parts by mass of the polymers contained in the liquid crystal alignment agent.
上記架橋性化合物の好ましい具体例としては、エチレングリコールジグリシジルエーテル、ポリエチレングリコールジグリシジルエーテル、プロピレングリコールジグリシジルエーテル、トリプロピレングリコールジグリシジルエーテル、ポリプロピレングリコールジグリシジルエーテル、ネオペンチルグリコールジグリシジルエーテル、1,6-ヘキサンジオールジグリシジルエーテル、グリセリンジグリシジルエーテル、ジブロモネオペンチルグリコールジグリシジルエーテル、1,3,5,6-テトラグリシジル-2,4-ヘキサンジオール、エピコート828(三菱ケミカル社製)などのビスフェノールA型エポキシ樹脂、エピコート807(三菱ケミカル社製)などのビスフェノールF型エポキシ樹脂、YX-8000(三菱ケミカル社製)などの水添ビスフェノールA型エポキシ樹脂、YX6954BH30(三菱ケミカル社製)などのビフェニル骨格含有エポキシ樹脂、EPPN-201(日本化薬社製)などのフェノールノボラック型エポキシ樹脂、EOCN-102S(日本化薬社製)などの(o,m,p-)クレゾールノボラック型エポキシ樹脂、TEPIC(日産化学社製)などのトリグリシジルイソシアヌレート、セロキサイド2021P(ダイセル社製)などの脂環式エポキシ樹脂、N,N,N’,N’-テトラグリシジル-m-キシリレンジアミン、1,3-ビス(N,N-ジグリシジルアミノメチル)シクロヘキサン、又はN,N,N’,N’-テトラグリシジル-4,4’-ジアミノジフェニルメタンに代表される第三級窒素原子を含有する化合物、テトラキス(グリシジルオキシメチル)メタンなどのオキシラニル基を2つ以上有する化合物;WO2011/132751号公報の段落[0170]~[0175]に記載のオキセタニル基を2つ以上有する化合物;コロネートAPステーブルM、コロネート2503、2515、2507、2513、2555、ミリオネートMS-50(以上、東ソー社製)、タケネートB-830、B-815N、B-820NSU、B-842N、B-846N、B-870N、B-874N、B-882N(以上、三井化学社製)等のブロックイソシアネート基を有する化合物;2,2’-ビス(2-オキサゾリン)、2,2’-ビス(4-メチル-2-オキサゾリン)、2,2’-ビス(5-メチル-2-オキサゾリン)、1,2,4-トリス(2-オキサゾリニル)-ベンゼン、エポクロス(日本触媒社製)のようなオキサゾリン基を有する化合物;WO2011/155577号公報の段落[0025]~[0030]、[0032]に記載のシクロカーボネート基を有する化合物;N,N,N’,N’-テトラキス(2-ヒドロキシエチル)アジポアミド、2,2-ビス(4-ヒドロキシ-3,5-ジヒドロキシメチルフェニル)プロパン、2,2-ビス(4-ヒドロキシ-3,5-ジメトキシフェニル)プロパン、2,2-ビス(4-ヒドロキシ-3,5-ジヒドロキシメチルフェニル)-1,1,1,3,3,3-ヘキサフルオロプロパンなどのヒドロキシ基やアルコキシ基を有する化合物;グリセリンモノ(メタ)アクリレート、グリセリンジ(メタ)アクリレート(1,2-,1,3-体混合物)、グリセリントリス(メタ)アクリレート、グリセリン1,3-ジグリセロラートジ(メタ)アクリレート、ペンタエリストールトリ(メタ)アクリレート、ジエチレングリコールモノ(メタ)アクリレート、トリエチレングリコールモノ(メタ)アクリレート、テトラエチレングリコールモノ(メタ)アクリレート、ペンタエチレングリコールモノ(メタ)アクリレート、ヘキサエチレングリコールモノ(メタ)アクリレートで示される化合物が挙げられる。上記架橋性化合物の含有量は液晶配向剤に含まれる重合体成分100質量部に対して0.1~30質量部であることが好ましく、より好ましくは0.1~20質量部である。 Preferred specific examples of the above crosslinkable compounds include ethylene glycol diglycidyl ether, polyethylene glycol diglycidyl ether, propylene glycol diglycidyl ether, tripropylene glycol diglycidyl ether, polypropylene glycol diglycidyl ether, neopentyl glycol diglycidyl ether, 1,6-hexanediol diglycidyl ether, glycerin diglycidyl ether, dibromoneopentyl glycol diglycidyl ether, 1,3,5,6-tetraglycidyl-2,4-hexanediol, bisphenol A type epoxy resins such as Epicoat 828 (manufactured by Mitsubishi Chemical Corporation), bisphenol F type epoxy resins such as Epicoat 807 (manufactured by Mitsubishi Chemical Corporation), hydrogenated bisphenol A type epoxy resins such as YX-8000 (manufactured by Mitsubishi Chemical Corporation), and biphenyls such as YX6954BH30 (manufactured by Mitsubishi Chemical Corporation). skeleton-containing epoxy resins, phenol novolac type epoxy resins such as EPPN-201 (manufactured by Nippon Kayaku Co., Ltd.), (o, m, p-) cresol novolac type epoxy resins such as EOCN-102S (manufactured by Nippon Kayaku Co., Ltd.), triglycidyl isocyanurates such as TEPIC (manufactured by Nissan Chemical Industries, Ltd.), alicyclic epoxy resins such as Celloxide 2021P (manufactured by Daicel Corporation), N,N,N',N'-tetraglycidyl-m-xylylenediamine, 1,3-bis(2-methyl-2-propanediol), compounds containing a tertiary nitrogen atom, such as tetrakis(glycidyloxymethyl)methane, and compounds having two or more oxiranyl groups, such as tetrakis(N,N-diglycidylaminomethyl)cyclohexane or N,N,N',N'-tetraglycidyl-4,4'-diaminodiphenylmethane; compounds having two or more oxetanyl groups, such as those described in paragraphs [0170] to [0175] of WO2011/132751; Compounds having a blocked isocyanate group, such as Bull M, Coronate 2503, 2515, 2507, 2513, 2555, Millionate MS-50 (all manufactured by Tosoh Corporation), Takenate B-830, B-815N, B-820NSU, B-842N, B-846N, B-870N, B-874N, B-882N (all manufactured by Mitsui Chemicals, Inc.); 2,2'-bis(2-oxazoline), 2,2'-bis(4-methyl-2-oxazoline), 2, Compounds having an oxazoline group, such as 2'-bis(5-methyl-2-oxazoline), 1,2,4-tris(2-oxazolinyl)-benzene, and EPOCROS (manufactured by Nippon Shokubai Co., Ltd.); compounds having a cyclocarbonate group, such as those described in paragraphs [0025] to [0030] and [0032] of WO2011/155577; N,N,N',N'-tetrakis(2-hydroxyethyl)adipamide, 2,2-bis(4-hydroxy-3,5-di hydroxymethylphenyl)propane, 2,2-bis(4-hydroxy-3,5-dimethoxyphenyl)propane, 2,2-bis(4-hydroxy-3,5-dihydroxymethylphenyl)-1,1,1,3,3,3-hexafluoropropane, and other compounds having a hydroxy group or an alkoxy group; and compounds represented by glycerin mono(meth)acrylate, glycerin di(meth)acrylate (1,2-,1,3-mixture), glycerin tris(meth)acrylate, glycerin 1,3-diglycerolate di(meth)acrylate, pentaerythritol tri(meth)acrylate, diethylene glycol mono(meth)acrylate, triethylene glycol mono(meth)acrylate, tetraethylene glycol mono(meth)acrylate, pentaethylene glycol mono(meth)acrylate, and hexaethylene glycol mono(meth)acrylate. The content of the crosslinkable compound is preferably 0.1 to 30 parts by mass, and more preferably 0.1 to 20 parts by mass, per 100 parts by mass of the polymer component contained in the liquid crystal alignment agent.
上記誘電率や電気抵抗を調整するための化合物としては、3-ピコリルアミンなどの窒素原子含有芳香族複素環を有するモノアミンが挙げられる。窒素原子含有芳香族複素環を有するモノアミンの含有量は液晶配向剤に含まれる重合体成分100質量部に対して0.1~30質量部であることが好ましく、より好ましくは0.1~20質量部である。 The compound for adjusting the dielectric constant and electrical resistance is, for example, a monoamine having a nitrogen atom-containing aromatic heterocycle, such as 3-picolylamine. The content of the monoamine having a nitrogen atom-containing aromatic heterocycle is preferably 0.1 to 30 parts by mass, more preferably 0.1 to 20 parts by mass, per 100 parts by mass of the polymer component contained in the liquid crystal alignment agent.
上記官能性シラン化合物の好ましい具体例としては、3-アミノプロピルトリメトキシシラン、3-アミノプロピルトリエトキシシラン、3-アミノプロピルジエトキシメチルシラン、2-アミノプロピルトリメトキシシラン、2-アミノプロピルトリエトキシシラン、N-(2-アミノエチル)-3-アミノプロピルトリメトキシシラン、N-(2-アミノエチル)-3-アミノプロピルメチルジメトキシシラン、3-ウレイドプロピルトリメトキシシラン、3-ウレイドプロピルトリエトキシシラン、ビニルトリメトキシシラン、ビニルトリエトキシシラン、2-(3,4-エポキシシクロヘキシル)エチルトリメトキシシラン、3-グリシドキシプロピルメチルジメトキシシラン、3-グリシドキシプロピルトリメトキシシラン、3-グリシドキシプロピルメチルジエトキシシラン、3-グリシドキシプロピルトリエトキシシラン、p-スチリルトリメトキシシラン、3-メタクリロキシプロピルメチルジメトキシシラン、3-メタクリロキシプロピルトリメトキシシラン、3-メタクリロキシプロピルメチルジエトキシシラン、3-メタクリロキシプロピルトリエトキシシラン、3-アクリロキシプロピルトリメトキシシラン、トリス[3-(トリメトキシシリル)プロピル]イソシアヌレート、3-メルカプトプロピルメチルジメトキシシラン、3-メルカプトプロピルトリメトキシシラン、3-イソシアネートプロピルトリエトキシシラン等が挙げられる。官能性シラン化合物の含有量は、液晶配向剤に含まれる重合体成分100質量部に対して0.1~30質量部であることが好ましく、より好ましくは0.1~20質量部である。 Preferred specific examples of the functional silane compounds include 3-aminopropyltrimethoxysilane, 3-aminopropyltriethoxysilane, 3-aminopropyldiethoxymethylsilane, 2-aminopropyltrimethoxysilane, 2-aminopropyltriethoxysilane, N-(2-aminoethyl)-3-aminopropyltrimethoxysilane, N-(2-aminoethyl)-3-aminopropylmethyldimethoxysilane, 3-ureidopropyltrimethoxysilane, 3-ureidopropyltriethoxysilane, vinyltrimethoxysilane, vinyltriethoxysilane, 2-(3,4-epoxycyclohexyl)ethyltrimethoxysilane, 3-glycidoxypropylmethyldimethoxysilane, Examples of the functional silane include 3-glycidoxypropyl trimethoxysilane, 3-glycidoxypropyl methyl diethoxysilane, 3-glycidoxypropyl triethoxysilane, p-styryl trimethoxysilane, 3-methacryloxypropyl methyl dimethoxysilane, 3-methacryloxypropyl trimethoxysilane, 3-methacryloxypropyl methyl diethoxysilane, 3-methacryloxypropyl triethoxysilane, 3-acryloxypropyl trimethoxysilane, tris[3-(trimethoxysilyl)propyl]isocyanurate, 3-mercaptopropyl methyl dimethoxysilane, 3-mercaptopropyl trimethoxysilane, and 3-isocyanate propyl triethoxysilane. The content of the functional silane compound is preferably 0.1 to 30 parts by mass, more preferably 0.1 to 20 parts by mass, relative to 100 parts by mass of the polymer component contained in the liquid crystal alignment agent.
上記イミド化を促進するための化合物としては、塩基性の部位(例:第一級アミノ基、脂肪族ヘテロ環(例:ピロリジン骨格)、芳香族ヘテロ環(例:イミダゾール環、インドール環)、又はグアニジノ基等)を有する化合物(但し、上記架橋性化合物及び密着助剤は除く。)、又は、焼成時に上記塩基性の部位が発生する化合物が好ましい。より好ましくは、焼成時に上記塩基性の部位が発生する化合物であり、好ましい具体例を挙げると、アミノ酸が有する塩基性の部位の一部又は全てが保護されたアミノ酸が挙げられる。上記アミノ酸が有する塩基性の部位の保護基としては、Boc基などのカルバメート系保護基が挙げられる。上記アミノ酸の具体例としては、グリシン、アラニン、システイン、メチオニン、アスパラギン、グルタミン、バリン、ロイシン、フェニルアラニン、チロシン、トリプトファン、プロリン、ヒドロキシプロリン、アルギニン、ヒスチジン、リシン、オルニチンが挙げられる。イミド化を促進するための化合物のより好ましい具体例を挙げると、N-α-(9-フルオレニルメトキシカルボニル)-N-τ-(tert-ブトキシカルボニル)-L-ヒスチジンが挙げられる。本発明の液晶配向剤に含有される上記イミド化を促進するための化合物の含有量は、液晶配向剤に含まれる重合体成分100質量部に対して、0.1~30質量部が好ましく、より好ましくは0.1~20質量部、さらに好ましくは5~20質量部である。 As the compound for promoting the above-mentioned imidization, a compound having a basic site (e.g., a primary amino group, an aliphatic heterocycle (e.g., a pyrrolidine skeleton), an aromatic heterocycle (e.g., an imidazole ring, an indole ring), or a guanidino group, etc.) (excluding the above-mentioned crosslinking compound and adhesion aid), or a compound which generates the above-mentioned basic site upon baking, is preferred. A compound which generates the above-mentioned basic site upon baking is more preferred, and preferred specific examples include amino acids in which some or all of the basic sites of the amino acid are protected. Examples of protecting groups for the basic sites of the above-mentioned amino acids include carbamate-based protecting groups such as a Boc group. Specific examples of the above-mentioned amino acids include glycine, alanine, cysteine, methionine, asparagine, glutamine, valine, leucine, phenylalanine, tyrosine, tryptophan, proline, hydroxyproline, arginine, histidine, lysine, and ornithine. A more preferred example of the compound for promoting imidization is N-α-(9-fluorenylmethoxycarbonyl)-N-τ-(tert-butoxycarbonyl)-L-histidine. The content of the compound for promoting imidization contained in the liquid crystal alignment agent of the present invention is preferably 0.1 to 30 parts by mass, more preferably 0.1 to 20 parts by mass, and even more preferably 5 to 20 parts by mass, relative to 100 parts by mass of the polymer component contained in the liquid crystal alignment agent.
(液晶配向膜及び液晶表示素子)
本発明に係る液晶表示素子は、上記液晶配向剤を用いて形成した液晶配向膜を具備する。
本発明の液晶配向膜は、例えば、以下の工程(1)~(2)を含む方法、工程(1)~(3)を含む方法により製造することができる。
液晶表示素子の動作モードは特に限定せず、例えば、TN方式、STN方式、垂直配向方式(VA-MVA方式、VA-PVA方式などを含む。)、面内スイッチング方式(IPS方式、FFS方式)、光学補償ベンド方式(OCB方式)など種々の動作モードに適用することができる。
(Liquid crystal alignment film and liquid crystal display element)
The liquid crystal display element according to the present invention comprises a liquid crystal alignment film formed using the liquid crystal aligning agent.
The liquid crystal alignment film of the present invention can be produced, for example, by a method including the following steps (1) to (2) or a method including the following steps (1) to (3).
The operation mode of the liquid crystal display element is not particularly limited, and various operation modes can be applied, such as the TN mode, STN mode, vertical alignment mode (including the VA-MVA mode, VA-PVA mode, etc.), in-plane switching mode (IPS mode, FFS mode), and optical compensation bend mode (OCB mode).
本発明の液晶表示素子は、例えば、以下の工程(1)~(4)を含む方法、工程(1)~(2)及び(4)を含む方法、工程(1)~(3)、(4-2)及び(4-4)を含む方法、又は工程(1)~(3)、(4-3)及び(4-4)を含む方法により製造することができる。
また、本発明の液晶表示素子の一つの態様は、以下の工程(1)~(2)、又は、工程(1)~(3)を含む、液晶配向膜の製造方法により形成された液晶配向膜を具備する液晶表示素子である。
The liquid crystal display element of the present invention can be produced, for example, by a method including the following steps (1) to (4), a method including steps (1) to (2) and (4), a method including steps (1) to (3), (4-2) and (4-4), or a method including steps (1) to (3), (4-3) and (4-4).
Moreover, one embodiment of the liquid crystal display element of the present invention is a liquid crystal display element having a liquid crystal alignment film formed by a method for producing a liquid crystal alignment film, the method including the following steps (1) to (2) or steps (1) to (3):
<工程(1):液晶配向剤を基板上に塗布する工程>
工程(1)は、液晶配向剤を基板上に塗布する工程である。工程(1)の具体例は以下のとおりである。
パターニングされた透明導電膜が設けられている基板の一面に、液晶配向剤を、例えばロールコーター法、スピンコート法、印刷法、インクジェット法などの適宜の塗布方法により塗布する。ここで基板の材質としては、透明性の高い基板であれば特に限定されず、ガラス、窒化珪素とともに、アクリル、ポリカーボネート等のプラスチック等を用いることもできる。また、反射型の液晶表示素子では、片側の基板のみにならば、シリコンウエハー等の不透明な物でも使用でき、この場合の電極にはアルミニウム等の光を反射する材料も使用できる。また、IPS方式又はFFS方式の液晶表示素子を製造する場合には、櫛歯型にパターニングされた透明導電膜又は金属膜からなる電極が設けられている基板と、電極が設けられていない対向基板とを用いる。
IPS方式の液晶表示素子において使用される櫛歯電極基板であるIPS基板は、例えば、基材と、基材上に形成され、櫛歯状に配置された複数の線状電極と、基材上に線状電極を覆うように形成された液晶配向膜とを有する。
なお、FFS方式の液晶表示素子において使用される櫛歯電極基板であるFFS基板は、例えば、基材と、基材上に形成された面電極と、面電極上に形成された絶縁膜と、絶縁膜上に形成され、櫛歯状に配置された複数の線状電極と、絶縁膜上に線状電極を覆うように形成された液晶配向膜とを有する。
<Step (1): Step of applying liquid crystal alignment agent onto substrate>
Step (1) is a step of applying a liquid crystal alignment agent onto a substrate. A specific example of step (1) is as follows.
A liquid crystal alignment agent is applied to one side of a substrate on which a patterned transparent conductive film is provided, for example, by a suitable application method such as a roll coater method, a spin coat method, a printing method, or an inkjet method. The material of the substrate is not particularly limited as long as it is a highly transparent substrate, and plastics such as acrylic and polycarbonate can be used in addition to glass and silicon nitride. In addition, in a reflective liquid crystal display element, an opaque material such as a silicon wafer can be used for only one substrate, and in this case, a material that reflects light such as aluminum can be used for the electrode. In addition, when manufacturing an IPS or FFS liquid crystal display element, a substrate on which an electrode made of a transparent conductive film or a metal film patterned into a comb tooth shape is provided and an opposing substrate on which no electrode is provided are used.
An IPS substrate, which is a comb-tooth electrode substrate used in an IPS-type liquid crystal display element, has, for example, a base material, a plurality of linear electrodes formed on the base material and arranged in a comb-tooth shape, and a liquid crystal alignment film formed on the base material so as to cover the linear electrodes.
An FFS substrate, which is a comb-tooth electrode substrate used in an FFS-type liquid crystal display element, has, for example, a base material, a surface electrode formed on the base material, an insulating film formed on the surface electrode, a plurality of linear electrodes formed on the insulating film and arranged in a comb-tooth shape, and a liquid crystal alignment film formed on the insulating film so as to cover the linear electrodes.
液晶配向剤を基板に塗布し、成膜する方法としては、スクリーン印刷、オフセット印刷、フレキソ印刷、インクジェット法、又はスプレー法等が挙げられる。なかでも、インクジェット法による塗布、成膜法が好適に使用できる。 Methods for applying the liquid crystal alignment agent to a substrate and forming a film include screen printing, offset printing, flexographic printing, the inkjet method, and the spray method. Among these, the inkjet method is the most suitable for application and film formation.
<工程(2):塗布した液晶配向剤を焼成する工程>
工程(2)は、基板上に塗布した液晶配向剤を焼成し、膜を形成する工程である。工程(2)の具体例は以下のとおりである。
工程(1)において液晶配向剤を基板上に塗布した後は、ホットプレート、熱風循環型オーブン又はIR(赤外線)型オーブンなどの加熱手段により、溶媒を蒸発させたり、ポリアミック酸に代表されるポリイミド前駆体の熱イミド化を行ったりすることができる。液晶配向剤を塗布した後の乾燥、焼成工程は、任意の温度と時間を選択することができ、複数回行ってもよい。液晶配向剤を焼成する温度としては、例えば40~180℃で行うことができる。プロセスを短縮する観点で、40~150℃で行ってもよい。焼成時間としては特に限定されないが、1~10分又は、1~5分が挙げられる。ポリアミック酸に代表されるポリイミド前駆体の熱イミド化を行う場合には、上記工程の後、例えば150~300℃、又は150~250℃で焼成する工程を追加してもよい。焼成時間としては特に限定されないが、5~40分、又は、5~30分の焼成時間が挙げられる。
焼成後の膜状物の膜厚は、薄すぎると液晶表示素子の信頼性が低下する場合があるので、5~300nmが好ましく、10~200nmがより好ましい。
<Step (2): Step of baking the applied liquid crystal alignment agent>
In the step (2), the liquid crystal alignment agent applied on the substrate is baked to form a film. Specific examples of the step (2) are as follows.
After the liquid crystal alignment agent is applied to the substrate in step (1), the solvent can be evaporated or the polyimide precursor, typified by polyamic acid, can be thermally imidized by a heating means such as a hot plate, a hot air circulation oven, or an IR (infrared) oven. The drying and baking process after the application of the liquid crystal alignment agent can be performed at any temperature and time, and may be performed multiple times. The temperature for baking the liquid crystal alignment agent can be, for example, 40 to 180°C. From the viewpoint of shortening the process, it may be performed at 40 to 150°C. The baking time is not particularly limited, but may be 1 to 10 minutes or 1 to 5 minutes. When thermally imidizing a polyimide precursor, typified by polyamic acid, a baking process at, for example, 150 to 300°C or 150 to 250°C may be added after the above process. The baking time is not particularly limited, but may be 5 to 40 minutes or 5 to 30 minutes.
If the film-like material after firing is too thin, the reliability of the liquid crystal display device may decrease, so the film thickness is preferably 5 to 300 nm, and more preferably 10 to 200 nm.
<工程(3):工程(2)で得られた膜に配向処理する工程>
工程(3)は、場合により、工程(2)で得られた膜に配向処理する工程である。即ち、IPS方式又はFFS方式等の水平配向方式の液晶表示素子では該塗膜に対し配向能付与処理を行う。一方、VA方式又はPSA方式等の垂直配向方式の液晶表示素子では、形成した塗膜をそのまま液晶配向膜として使用することができるが、該塗膜に対し配向能付与処理を施してもよい。液晶配向膜の配向処理方法としては、ラビング配向処理法、光配向処理法が挙げられる。光配向処理法としては、上記膜状物の表面に、好ましくは一定方向に偏光された放射線を照射し、好ましくは、加熱処理を行い、液晶配向性(液晶配向能ともいう)を付与する方法が挙げられる。放射線としては、100~800nmの波長を有する紫外線又は可視光線を用いることができる。なかでも、好ましくは100~400nm、より好ましくは、200~400nmの波長を有する紫外線である。
<Step (3): Step of subjecting the film obtained in step (2) to an alignment treatment>
Step (3) is a step of subjecting the film obtained in step (2) to an alignment treatment, if necessary. That is, in a horizontal alignment type liquid crystal display element such as an IPS type or FFS type, an alignment ability imparting treatment is performed on the coating film. On the other hand, in a vertical alignment type liquid crystal display element such as a VA type or PSA type, the formed coating film can be used as a liquid crystal alignment film as it is, but the coating film may be subjected to an alignment ability imparting treatment. Examples of the alignment treatment method for the liquid crystal alignment film include a rubbing alignment treatment method and a photo-alignment treatment method. Examples of the photo-alignment treatment method include a method in which the surface of the above-mentioned film-like material is irradiated with radiation, preferably polarized in a certain direction, and preferably heated to impart liquid crystal alignment (also called liquid crystal alignment ability). As the radiation, ultraviolet rays or visible light having a wavelength of 100 to 800 nm can be used. Among them, ultraviolet rays having a wavelength of 100 to 400 nm are preferable, and more preferably, ultraviolet rays having a wavelength of 200 to 400 nm are more preferable.
上記放射線の照射量は、1~10,000mJ/cm2が好ましく、なかでも、100~5,000mJ/cm2がより好ましい。また、放射線を照射する場合、液晶配向性を改善するために、上記膜状物を有する基板を、50~250℃で加熱しながら照射してもよい。このようにして作製した上記液晶配向膜は、液晶分子を一定の方向に安定して配向させることができる。
照射光の光源としては、例えば低圧水銀ランプ、高圧水銀ランプ、Deep UVランプ、重水素ランプ、メタルハライドランプ、アルゴン共鳴ランプ、キセノンランプ、水銀キセノンランプ、エキシマレーザー(例えば、KrFエキシマレーザー)、蛍光ランプ、LEDランプ、ハロゲンランプ(例えば、ナトリウムランプ)、マイクロウェーブ励起無電極ランプなどを使用することができる。
また、照射光として偏光状態の光を用いた場合、偏光光の消光比が高いほどより高い異方性を付与できることから、例えば、紫外線の場合には、偏光紫外線の消光比は10:1以上がより好ましく、20:1以上が更に好ましい。
The radiation dose is preferably 1 to 10,000 mJ/cm 2 , and more preferably 100 to 5,000 mJ/cm 2. When irradiating with radiation, the substrate having the film-like material may be irradiated while being heated at 50 to 250° C. in order to improve the liquid crystal alignment. The liquid crystal alignment film thus produced can stably align liquid crystal molecules in a certain direction.
Examples of light sources for the irradiation light that can be used include low-pressure mercury lamps, high-pressure mercury lamps, deep UV lamps, deuterium lamps, metal halide lamps, argon resonance lamps, xenon lamps, mercury-xenon lamps, excimer lasers (e.g., KrF excimer lasers), fluorescent lamps, LED lamps, halogen lamps (e.g., sodium lamps), and microwave-excited electrodeless lamps.
Furthermore, when polarized light is used as the irradiating light, the higher the extinction ratio of the polarized light, the higher the anisotropy that can be imparted. For example, in the case of ultraviolet light, the extinction ratio of the polarized ultraviolet light is more preferably 10:1 or greater, and even more preferably 20:1 or greater.
更に、上記の方法で、偏光された放射線を照射した塗膜やラビング配向処理を行った塗膜に、水や溶媒を用いて、接触処理してもよい。また、上記配向処理を行った膜は、接触処理を行わず、加熱処理を行っても良い。さらに、上記接触処理を行った膜に更に加熱処理を行ってもよい。 Furthermore, the coating film irradiated with polarized radiation or the coating film that has been subjected to rubbing alignment treatment by the above method may be subjected to a contact treatment using water or a solvent. Also, the film that has been subjected to the above alignment treatment may be subjected to a heat treatment without being subjected to a contact treatment. Furthermore, the film that has been subjected to the above contact treatment may be further subjected to a heat treatment.
上記接触処理に使用する溶媒としては、放射線の照射によって膜状物から生成した分解物を溶解する溶媒であれば、特に限定されるものではない。具体例としては、水、メタノール、エタノール、2-プロパノール、アセトン、メチルエチルケトン、1-メトキシ-2-プロパノール、1-メトキシ-2-プロパノールアセテート、ブチルセロソルブ、乳酸エチル、乳酸メチル、ジアセトンアルコール、3-メトキシプロピオン酸メチル、3-エトキシプロピオン酸エチル、酢酸プロピル、酢酸ブチル、酢酸シクロヘキシル等が挙げられる。溶媒は、1種類でも、2種類以上組み合わせてもよい。 The solvent used in the contact treatment is not particularly limited, so long as it dissolves the decomposition products generated from the film-like material by irradiation with radiation. Specific examples include water, methanol, ethanol, 2-propanol, acetone, methyl ethyl ketone, 1-methoxy-2-propanol, 1-methoxy-2-propanol acetate, butyl cellosolve, ethyl lactate, methyl lactate, diacetone alcohol, methyl 3-methoxypropionate, ethyl 3-ethoxypropionate, propyl acetate, butyl acetate, cyclohexyl acetate, and the like. The solvent may be one type or a combination of two or more types.
上記の放射線を照射した塗膜、又は接触処理を行った膜に対する加熱処理の温度は、50~300℃が好ましく、120~300℃がより好ましく、150~300℃がさらに好ましく、150~250℃が最も好ましい。加熱処理の時間としては、それぞれ1~30分とすることが好ましい。 The temperature for the heat treatment of the coating film irradiated with the above radiation or the film that has been contact-treated is preferably 50 to 300°C, more preferably 120 to 300°C, even more preferably 150 to 300°C, and most preferably 150 to 250°C. The heat treatment time is preferably 1 to 30 minutes, respectively.
<工程(4):液晶セルを作製する工程>
上記のようにして液晶配向膜が形成された基板を2枚準備し、対向配置した2枚の基板間に液晶を配置する。具体的には以下の2つの方法が挙げられる。
第一の方法は、先ず、それぞれの液晶配向膜が対向するように間隙(セルギャップ)を介して2枚の基板を対向配置する。次いで、2枚の基板の周辺部をシール剤を用いて貼り合わせ、基板表面及びシール剤により区画されたセルギャップ内に液晶組成物を注入充填して膜面に接触した後、注入孔を封止する。
<Step (4): Step of Producing a Liquid Crystal Cell>
Two substrates on which the liquid crystal alignment film is formed as described above are prepared, and liquid crystal is disposed between the two substrates arranged opposite to each other. Specifically, the following two methods can be mentioned.
In the first method, first, two substrates are arranged facing each other with a gap (cell gap) between them so that the liquid crystal alignment films face each other, and then the peripheries of the two substrates are bonded together using a sealant, and a liquid crystal composition is injected into the substrate surfaces and the cell gap defined by the sealant so that the liquid crystal composition comes into contact with the film surface, and then the injection hole is sealed.
また、第二の方法は、ODF(One Drop Fill)方式と呼ばれる手法である。液晶配向膜を形成した2枚の基板のうちの一方の基板上の所定の場所に、例えば紫外光硬化性のシール剤を塗布し、更に液晶配向膜面上の所定の数箇所に液晶組成物を滴下する。その後、液晶配向膜が対向するように他方の基板を貼り合わせて液晶組成物を基板の全面に押し広げて膜面に接触させる。次いで、基板の全面に紫外光を照射してシール剤を硬化する。いずれの方法による場合でも、更に、用いた液晶組成物が等方相をとる温度まで加熱した後、室温まで徐冷することにより、液晶充填時の流動配向を除去することが望ましい。
なお、塗膜に対してラビング配向処理を行った場合には、2枚の基板は、各塗膜におけるラビング方向が互いに所定の角度、例えば直交又は逆平行となるように対向配置される。
シール剤としては、例えば硬化剤及びスペーサーとしての酸化アルミニウム球を含有するエポキシ樹脂等を用いることができる。
上記液晶組成物としては、特に制限はなく、少なくとも一種の液晶化合物(液晶分子)を含む組成物であって、ネマチック相を呈する液晶組成物(以下、ネマチック液晶ともいう。)、スメクチック相を呈する液晶、又はコレステリック相を呈する液晶組成物を挙げることができ、そのなかでもネマチック液晶が好ましい。また、誘電率異方性が正または負の各種の液晶組成物を用いることができる。なお、以下では、誘電率異方性が正の液晶組成物を、ポジ型液晶ともいい、誘電率異方性が負の液晶組成物を、ネガ型液晶ともいう。
上記液晶組成物は、フッ素原子、ヒドロキシ基、アミノ基、フッ素原子含有基(例えば、トリフルオロメチル基)、シアノ基、アルキル基、アルコキシ基、アルケニル基、イソチオシアネート基、複素環、シクロアルカン、シクロアルケン、ステロイド骨格、ベンゼン環、又はナフタレン環を有する液晶化合物を含んでもよく、分子内に液晶性を発現する剛直な部位(メソゲン骨格)を2つ以上有する化合物(例えば、剛直な二つのビフェニル構造、又はターフェニル構造がアルキル基で連結されたバイメソゲン化合物)を含んでもよい。
また、上記液晶組成物は、液晶配向性を向上させる観点から、添加物をさらに含有してもよい。このような添加物は、重合性基((メタ)アクリロイル基、等)を有する化合物などの光重合性モノマー;光学活性な化合物(例:メルク(株)社製のS-811など);酸化防止剤;紫外線吸収剤;色素;消泡剤;重合開始剤;又は重合禁止剤などが挙げられる。
ポジ型液晶としては、メルク社製のZLI-2293、ZLI-4792、MLC-2003、MLC-2041、MLC-3019、又はMLC-7081などが挙げられる。
ネガ型液晶としては、例えばメルク社製のMLC-6608、MLC-6609、MLC-6610、MLC-7026、又はMLC-7026-100などが挙げられる。
また、重合性基を有する化合物を含有する液晶として、メルク社製のMLC-3023が挙げられる。
The second method is a method called ODF (One Drop Fill) method. For example, a UV-curable sealant is applied to a predetermined location on one of the two substrates on which a liquid crystal alignment film is formed, and a liquid crystal composition is dropped at several predetermined locations on the liquid crystal alignment film surface. Thereafter, the other substrate is bonded so that the liquid crystal alignment film faces the other substrate, and the liquid crystal composition is spread over the entire surface of the substrate and contacted with the film surface. Next, the entire surface of the substrate is irradiated with UV light to cure the sealant. In either method, it is preferable to remove the flow alignment during liquid crystal filling by heating to a temperature at which the liquid crystal composition used has an isotropic phase and then slowly cooling to room temperature.
When the coating film is subjected to a rubbing alignment treatment, the two substrates are disposed opposite to each other so that the rubbing directions of the coating films are at a predetermined angle, for example, perpendicular or anti-parallel to each other.
As the sealing agent, for example, an epoxy resin containing a hardener and aluminum oxide spheres as spacers can be used.
The liquid crystal composition is not particularly limited, and may be a composition containing at least one liquid crystal compound (liquid crystal molecule), and may be a liquid crystal composition exhibiting a nematic phase (hereinafter also referred to as nematic liquid crystal), a liquid crystal exhibiting a smectic phase, or a liquid crystal composition exhibiting a cholesteric phase, among which nematic liquid crystal is preferred. In addition, various liquid crystal compositions having positive or negative dielectric anisotropy may be used. In the following, a liquid crystal composition having a positive dielectric anisotropy is also referred to as a positive liquid crystal, and a liquid crystal composition having a negative dielectric anisotropy is also referred to as a negative liquid crystal.
The liquid crystal composition may contain a liquid crystal compound having a fluorine atom, a hydroxy group, an amino group, a fluorine atom-containing group (e.g., a trifluoromethyl group), a cyano group, an alkyl group, an alkoxy group, an alkenyl group, an isothiocyanate group, a heterocycle, a cycloalkane, a cycloalkene, a steroid skeleton, a benzene ring, or a naphthalene ring, and may contain a compound having two or more rigid moieties (mesogenic skeletons) that exhibit liquid crystallinity within the molecule (e.g., a bimesogenic compound in which two rigid biphenyl structures or terphenyl structures are linked by an alkyl group).
The liquid crystal composition may further contain an additive from the viewpoint of improving the liquid crystal alignment property. Such additives include a photopolymerizable monomer such as a compound having a polymerizable group (e.g., a (meth)acryloyl group), an optically active compound (e.g., S-811 manufactured by Merck Ltd.), an antioxidant, an ultraviolet absorber, a dye, an antifoaming agent, a polymerization initiator, or a polymerization inhibitor.
Examples of the positive type liquid crystal include ZLI-2293, ZLI-4792, MLC-2003, MLC-2041, MLC-3019, and MLC-7081 manufactured by Merck.
Examples of negative type liquid crystals include MLC-6608, MLC-6609, MLC-6610, MLC-7026, and MLC-7026-100 manufactured by Merck.
Furthermore, an example of a liquid crystal containing a compound having a polymerizable group is MLC-3023 manufactured by Merck.
本発明の液晶配向剤は、電極を備えた一対の基板の間に液晶層を有してなり、一対の基板の間に活性エネルギー線及び熱の少なくとも一方により重合する重合性化合物を含む液晶組成物を配置し、電極間に電圧を印加しつつ、活性エネルギー線の照射及び加熱の少なくとも一方により、重合性化合物を重合させる工程を経て製造される液晶表示素子(PSA方式の液晶表示素子)にも好ましく用いられる。
また、本発明の液晶配向剤は、電極を備えた一対の基板の間に液晶層を有してなり、上記一対の基板の間に活性エネルギー線及び熱の少なくとも一方により重合する重合性基を含む液晶配向膜を配置し、電極間に電圧を印加する工程を経て製造される液晶表示素子(SC-PVA方式の液晶表示素子)にも好ましく用いられる。
The liquid crystal aligning agent of the present invention is also preferably used for a liquid crystal display element (PSA type liquid crystal display element) which has a liquid crystal layer between a pair of substrates provided with electrodes, and is manufactured through a process of disposing a liquid crystal composition containing a polymerizable compound which is polymerized by at least one of active energy rays and heat between the pair of substrates, and polymerizing the polymerizable compound by at least one of irradiation with active energy rays and heating while applying a voltage between the electrodes.
The liquid crystal aligning agent of the present invention is also preferably used for a liquid crystal display element (SC-PVA type liquid crystal display element) which has a liquid crystal layer between a pair of substrates having electrodes, and is manufactured through a process of disposing a liquid crystal alignment film containing a polymerizable group that is polymerized by at least one of active energy rays and heat between the pair of substrates, and applying a voltage between the electrodes.
<工程(4-2):PSA方式の液晶表示素子の場合>
重合性化合物を含有する液晶組成物を注入又は滴下する点以外は上記(4)と同様に実施される。重合性化合物としては、例えばアクリレート基やメタクリレート基などの重合性不飽和基を分子内に1個以上有する重合性化合物を挙げることができる。
<Step (4-2): In the case of a PSA type liquid crystal display element>
The method is carried out in the same manner as in (4) above, except that a liquid crystal composition containing a polymerizable compound is injected or dropped. Examples of the polymerizable compound include polymerizable compounds having one or more polymerizable unsaturated groups in the molecule, such as an acrylate group or a methacrylate group.
<工程(4-3):SC-PVA方式の液晶表示素子の場合>
上記(4)と同様にした後、後述する紫外線を照射する工程を経て液晶表示素子を製造する方法を採用してもよい。この方法によれば、上記PSA方式の液晶表示素子を製造する場合と同様に、少ない光照射量で応答速度に優れた液晶表示素子を得ることができる。重合性基を有する化合物は、上記重合性不飽和基を分子内に1個以上有する化合物であってもよく、その含有量は、液晶配向剤に含有される重合体成分100質量部に対して0.1~30質量部であることが好ましく、より好ましくは1~20質量部である。また、上記重合性基は液晶配向剤に用いる重合体が有していてもよく、このような重合体としては、例えば上記光重合性基を末端に有するジアミンを含むジアミン成分を反応に用いて得られる重合体が挙げられる。
<Step (4-3): In the case of an SC-PVA type liquid crystal display element>
A method of manufacturing a liquid crystal display element through a step of irradiating ultraviolet light described later after the same procedure as in (4) above may be adopted. According to this method, a liquid crystal display element having excellent response speed can be obtained with a small amount of light irradiation, as in the case of manufacturing the PSA type liquid crystal display element. The compound having a polymerizable group may be a compound having one or more of the above-mentioned polymerizable unsaturated groups in the molecule, and the content thereof is preferably 0.1 to 30 parts by mass, more preferably 1 to 20 parts by mass, relative to 100 parts by mass of the polymer component contained in the liquid crystal alignment agent. The polymerizable group may be contained in the polymer used in the liquid crystal alignment agent, and an example of such a polymer includes a polymer obtained by using a diamine component containing a diamine having the above-mentioned photopolymerizable group at its terminal in a reaction.
<工程(4-4):紫外線を照射する工程>
上記(4-2)又は(4-3)で得られた一対の基板の有する導電膜間に電圧を印加した状態で液晶セルに光照射する。ここで印加する電圧は、例えば5~50Vの直流又は交流とすることができる。また、照射する光としては、例えば150~800nmの波長の光を含む紫外線及び可視光線を用いることができるが、300~400nmの波長の光を含む紫外線が好ましい。照射光の光源としては、例えば低圧水銀ランプ、高圧水銀ランプ、重水素ランプ、メタルハライドランプ、アルゴン共鳴ランプ、キセノンランプ、エキシマレーザーなどを使用することができる。光の照射量は、好ましくは1,000~200,000J/m2であり、より好ましくは1,000~100,000J/m2である。
<Step (4-4): Step of irradiating with ultraviolet light>
The liquid crystal cell is irradiated with light while a voltage is applied between the conductive films of the pair of substrates obtained in (4-2) or (4-3) above. The voltage applied here can be, for example, 5 to 50 V DC or AC. The light to be irradiated can be, for example, ultraviolet light and visible light containing light with a wavelength of 150 to 800 nm, but ultraviolet light containing light with a wavelength of 300 to 400 nm is preferred. The light source for the irradiation light can be, for example, a low-pressure mercury lamp, a high-pressure mercury lamp, a deuterium lamp, a metal halide lamp, an argon resonance lamp, a xenon lamp, an excimer laser, or the like. The amount of light irradiation is preferably 1,000 to 200,000 J/m 2 , more preferably 1,000 to 100,000 J/m 2 .
そして、必要に応じて液晶セルの外側表面に偏光板を貼り合わせることにより液晶表示素子を得ることができる。液晶セルの外表面に貼り合わされる偏光板としては、ポリビニルアルコールを延伸配向させながらヨウ素を吸収させた「H膜」と称される偏光フィルムを酢酸セルロース保護膜で挟んだ偏光板又はH膜そのものからなる偏光板を挙げることができる。 Then, if necessary, a polarizing plate can be attached to the outer surface of the liquid crystal cell to obtain a liquid crystal display element. Examples of polarizing plates that can be attached to the outer surface of the liquid crystal cell include a polarizing film called an "H film" made by absorbing iodine while stretching and aligning polyvinyl alcohol, sandwiched between cellulose acetate protective films, and a polarizing plate made of the H film itself.
以下に実施例を挙げて、本発明を更に具体的に説明するが、本発明は、これらの実施例に限定されるものではない。なお、化合物、溶媒の略号は、以下のとおりである。 The present invention will be explained in more detail below with reference to examples, but the present invention is not limited to these examples. The abbreviations for compounds and solvents are as follows:
(有機溶媒)
NMP:N-メチル-2-ピロリドン
GBL:γ-ブチロラクトン
BCS:エチレングリコールモノブチルエーテル
(Organic solvent)
NMP: N-methyl-2-pyrrolidone GBL: γ-butyrolactone BCS: Ethylene glycol monobutyl ether
(ジアミン)
DA-1~DA12:それぞれ、下記構造式(DA-1)~(DA-12)で表される化合物
DA-1 to DA12: Compounds represented by the following structural formulas (DA-1) to (DA-12), respectively.
(テトラカルボン酸誘導体)
CA-1~CA-5:それぞれ、下記構造式(CA-1)~(CA-5)で表される化合物
CA-1 to CA-5: Compounds represented by the following structural formulas (CA-1) to (CA-5), respectively.
(化合物(C))
化合物(c):亜リン酸ジブチル
(Compound (C))
Compound (c): dibutyl phosphite
(添加剤)
AD-1:下記構造式(AD-1)で表される化合物
AD-2:3-グリシドキシプロピルトリエトキシシラン
AD-3:3-アミノプロピルトリエトキシシラン
AD-4:N-α-(9-フルオレニルメトキシカルボニル)-N-τ-(tert-ブトキシカルボニル)-L-ヒスチジン
AD-1: Compound represented by the following structural formula (AD-1) AD-2: 3-glycidoxypropyltriethoxysilane AD-3: 3-aminopropyltriethoxysilane AD-4: N-α-(9-fluorenylmethoxycarbonyl)-N-τ-(tert-butoxycarbonyl)-L-histidine
<粘度>
合成例において、重合体溶液の粘度は、E型粘度計TVE-22H(東機産業社製)を用い、サンプル量1.1mL、コーンロータTE-1(1°34’、R24)、温度25℃で測定した。
<Viscosity>
In the synthesis examples, the viscosity of the polymer solution was measured using an E-type viscometer TVE-22H (manufactured by Toki Sangyo Co., Ltd.) with a sample amount of 1.1 mL, a cone rotor TE-1 (1°34′, R24), and a temperature of 25°C.
<ポリイミドのイミド化率の測定>
合成例におけるポリイミドのイミド化率は次のようにして測定した。ポリイミド粉末30mgをNMR(核磁気共鳴)サンプル管(NMRサンプリングチューブスタンダード,φ5(草野科学社製))に入れ、重水素化ジメチルスルホキシド(DMSO-d6,0.05質量%TMS(テトラメチルシラン)混合品)(0.53mL)を添加し、超音波をかけて完全に溶解させた。この溶液をNMR測定機(JNW-ECA500)(日本電子データム社製)にて500MHzのプロトンNMRを測定した。イミド化率は、イミド化前後で変化しない構造に由来するプロトンを基準プロトンとして決め、このプロトンのピーク積算値と、9.5ppm~10.0ppm付近に現れるアミド酸のNH基に由来するプロトンピーク積算値とを用い以下の式によって求めた。
イミド化率(%)=(1-α・x/y)×100
<Measurement of imidization rate of polyimide>
The imidization rate of the polyimide in the synthesis example was measured as follows. 30 mg of polyimide powder was placed in an NMR (nuclear magnetic resonance) sample tube (NMR sampling tube standard, φ5 (Kusano Scientific Co., Ltd.)), deuterated dimethyl sulfoxide (DMSO-d6, 0.05 mass % TMS (tetramethylsilane) mixture) (0.53 mL) was added, and the mixture was completely dissolved by applying ultrasonic waves. This solution was measured for proton NMR at 500 MHz using an NMR measurement device (JNW-ECA500) (JEOL Datum Co., Ltd.). The imidization rate was calculated by the following formula, using a proton derived from a structure that does not change before and after imidization as a reference proton, and the peak integrated value of this proton and the proton peak integrated value derived from the NH group of the amic acid that appears around 9.5 ppm to 10.0 ppm.
Imidization rate (%)=(1−α·x/y)×100
上記式において、xはアミック酸のNH基由来のプロトンピーク積算値、yは基準プロトンのピーク積算値、αはポリアミック酸(イミド化率が0%)の場合におけるアミド酸のNH基プロトン1個に対する基準プロトンの個数割合である。 In the above formula, x is the integrated value of the proton peak derived from the NH group of the amic acid, y is the integrated value of the peak of the reference proton, and α is the ratio of the number of reference protons to one NH group proton of the amic acid in the case of polyamic acid (imidization rate 0%).
[重合体の合成]
(合成例1)
撹拌装置付き及び窒素導入管付きの500mL四つ口フラスコに、DA-5を2.16g(20.0mmol)、DA-2を7.33g(30.0mmol)、DA-6を9.61g(30.0mmol)、DA-10を7.97g(20.0mmol)を取り、NMPを311.3g加えて、窒素を送りながら撹拌し溶解させた。このジアミン溶液を撹拌しながらCA-2を20.85g(93.0mmol)添加し、更に固形分濃度が12質量%になるようにNMPを40.1g加え、40℃下で24時間撹拌してポリマー溶液(重合体-1)を得た(粘度:405mPa・s)。
[Polymer synthesis]
(Synthesis Example 1)
In a 500 mL four-neck flask equipped with a stirrer and a nitrogen inlet tube, 2.16 g (20.0 mmol) of DA-5, 7.33 g (30.0 mmol) of DA-2, 9.61 g (30.0 mmol) of DA-6, and 7.97 g (20.0 mmol) of DA-10 were taken, and 311.3 g of NMP was added, and the mixture was stirred and dissolved while feeding nitrogen. While stirring this diamine solution, 20.85 g (93.0 mmol) of CA-2 was added, and 40.1 g of NMP was added so that the solid content concentration was 12% by mass, and the mixture was stirred at 40 ° C. for 24 hours to obtain a polymer solution (polymer-1) (viscosity: 405 mPa s).
(合成例2)
撹拌装置付き及び窒素導入管付きの100mL四つ口フラスコに、DA-8を4.14g(20.8mmol)、DA-9を0.79g(5.20mmol)を取り、NMPを44.4g加えて、窒素を送りながら撹拌し溶解させた。このジアミン溶液を撹拌しながら、CA-4を7.27g(24.7mmol)添加し、更に固形分濃度が12質量%になるようにNMPを45.1g加え、窒素雰囲気下、60度で加熱しながら24時間撹拌してポリマーの溶液(重合体-2)を得た(粘度:398mPa・s)。
(Synthesis Example 2)
In a 100 mL four-neck flask equipped with a stirrer and a nitrogen inlet tube, 4.14 g (20.8 mmol) of DA-8 and 0.79 g (5.20 mmol) of DA-9 were placed, and 44.4 g of NMP was added, and the mixture was stirred and dissolved while feeding nitrogen. While stirring this diamine solution, 7.27 g (24.7 mmol) of CA-4 was added, and 45.1 g of NMP was further added so that the solid content concentration became 12 mass%, and the mixture was stirred for 24 hours while heating at 60°C under a nitrogen atmosphere to obtain a polymer solution (polymer-2) (viscosity: 398 mPa s).
(合成例3)
撹拌装置付きおよび窒素導入管付きの100ml四つ口フラスコにDA-1を7.45g(26.0mmol)入れ、NMPを67.0g加え、窒素を送りながら撹拌し溶解させた。このジアミン溶液を水冷下で撹拌しながらCA-3を4.86g(24.8mmol)加え、更に固形分濃度が12質量%になるようにNMPを23.3g加え、窒素雰囲気下、50度で加熱しながら20時間撹拌してポリマーの溶液(重合体-3)を得た(粘度:530mPa・s)。
(Synthesis Example 3)
7.45 g (26.0 mmol) of DA-1 was placed in a 100 ml four-neck flask equipped with a stirrer and a nitrogen inlet tube, 67.0 g of NMP was added, and the mixture was stirred and dissolved while feeding nitrogen. 4.86 g (24.8 mmol) of CA-3 was added to this diamine solution while stirring under water cooling, and 23.3 g of NMP was further added so that the solid content concentration became 12 mass%, and the mixture was stirred for 20 hours while heating at 50°C under a nitrogen atmosphere to obtain a polymer solution (polymer-3) (viscosity: 530 mPa s).
(合成例4)
撹拌装置付きおよび窒素導入管付きの100ml四つ口フラスコにDA-3を0.99g(5.00mmol)、DA-8を3.99g(20.0mmol)入れ、NMPを57.2g加え、窒素を送りながら撹拌し溶解させた。このジアミン溶液を水冷下で撹拌しながらCA-5を1.50g(5.00mmol)とNMPを1.07g加えて、窒素雰囲気下、水冷下で3時間攪拌した。その後、CA-1を3.53g(18.0mmol)添加し、更に固形分濃度が10質量%になるようにNMPを31.8g加えて、再び窒素雰囲気下、水冷下で3時間攪拌してポリマーの溶液(重合体-4)を得た(粘度:165mPa・s)。
(Synthesis Example 4)
DA-3 0.99g (5.00mmol) and DA-8 3.99g (20.0mmol) were put into a 100ml four-neck flask equipped with a stirrer and a nitrogen inlet tube, and 57.2g of NMP was added, and the mixture was stirred and dissolved while feeding nitrogen. This diamine solution was stirred under water cooling while adding 1.50g (5.00mmol) of CA-5 and 1.07g of NMP, and stirred for 3 hours under a nitrogen atmosphere and water cooling. Thereafter, 3.53g (18.0mmol) of CA-1 was added, and 31.8g of NMP was added so that the solid content concentration was 10% by mass, and the mixture was stirred again under a nitrogen atmosphere and water cooling for 3 hours to obtain a polymer solution (polymer-4) (viscosity: 165mPa·s).
(合成例5)
撹拌装置付き及び窒素導入管付きの500mL四つ口フラスコに、DA-5を3.24g(30.0mmol)、DA-2を7.33g(30.0mmol)、DA-11を3.00g(20.0mmol)、DA-7を6.83g(20.0mmol)を取り、NMPを234.7g加えて、窒素を送りながら撹拌し溶解させた。このジアミン溶液を撹拌しながらCA-2を20.85g(93.0mmol)添加し、更に固形分濃度が12質量%になるようにNMPを67.9g加え、40℃下で24時間撹拌してポリマー溶液(重合体-5)を得た(粘度:451mPa・s)。
(Synthesis Example 5)
In a 500 mL four-neck flask equipped with a stirrer and a nitrogen inlet tube, 3.24 g (30.0 mmol) of DA-5, 7.33 g (30.0 mmol) of DA-2, 3.00 g (20.0 mmol) of DA-11, and 6.83 g (20.0 mmol) of DA-7 were taken, and 234.7 g of NMP was added, and the mixture was stirred and dissolved while feeding nitrogen. While stirring this diamine solution, 20.85 g (93.0 mmol) of CA-2 was added, and 67.9 g of NMP was added so that the solid content concentration was 12% by mass, and the mixture was stirred at 40 ° C. for 24 hours to obtain a polymer solution (polymer-5) (viscosity: 451 mPa s).
(合成例6)
撹拌装置付き及び窒素導入管付きの500mL四つ口フラスコに、DA-4を17.90g(60.0mmol)、DA-11を6.01g(40.0mmol)を取り、NMPを275g加えて、窒素を送りながら撹拌し溶解させた。このジアミン溶液を撹拌しながらCA-1を18.43g(94.0mmol)添加し、更に固形分濃度が12質量%になるようにNMPを35.5g加え、室温で24時間撹拌してポリマー溶液(重合体-6)を得た(粘度:503mPa・s)。
(Synthesis Example 6)
In a 500 mL four-neck flask equipped with a stirrer and a nitrogen inlet tube, 17.90 g (60.0 mmol) of DA-4 and 6.01 g (40.0 mmol) of DA-11 were placed, 275 g of NMP was added, and the mixture was stirred and dissolved while feeding nitrogen. While stirring this diamine solution, 18.43 g (94.0 mmol) of CA-1 was added, and 35.5 g of NMP was further added so that the solid content concentration became 12 mass%, and the mixture was stirred at room temperature for 24 hours to obtain a polymer solution (polymer-6) (viscosity: 503 mPa s).
(合成例7)
撹拌装置及び窒素導入管付きの500mL四つ口フラスコに、DA-1を2.60g(24.0mmol)、DA-2を5.86g(24.0mmol)、DA-12を4.13g(16.0mmol)及びDA-7を5.46g(16.0mmol)量り取り、NMPを233.38g加えて、窒素を送りながら撹拌し溶解させた。このジアミン溶液を撹拌しながら、CA-2を17.31g(77.2mmol)添加し、更に、固形分濃度が12質量%になるようにNMPを加え、40℃で4時間撹拌して、ポリマー溶液(重合体-7)を得た(粘度:431mPa・s)。
(Synthesis Example 7)
In a 500 mL four-neck flask equipped with a stirrer and a nitrogen inlet tube, 2.60 g (24.0 mmol) of DA-1, 5.86 g (24.0 mmol) of DA-2, 4.13 g (16.0 mmol) of DA-12, and 5.46 g (16.0 mmol) of DA-7 were weighed out, 233.38 g of NMP was added, and the mixture was stirred and dissolved while feeding nitrogen. While stirring this diamine solution, 17.31 g (77.2 mmol) of CA-2 was added, and further, NMP was added so that the solid concentration became 12% by mass, and the mixture was stirred at 40 ° C. for 4 hours to obtain a polymer solution (polymer-7) (viscosity: 431 mPa s).
(合成例8)
撹拌装置及び窒素導入管付きの100mL四つ口フラスコに、合成例7で得られたポリマー溶液(重合体-7)を50g量り取り、NMPを25g加え、30分撹拌した。得られたポリアミック酸溶液に、無水酢酸を4.16g、ピリジンを1.07g加えて、55℃で2時間30分加熱し、化学イミド化を行った。得られた反応液を、300mLのメタノールに撹拌しながら投入し、析出した沈殿物をろ取した。続いて、沈殿物を300mLのメタノールで3回洗浄した。次いで、得られた樹脂粉末を、60℃で12時間乾燥することで、ポリイミド樹脂粉末を得た。このポリイミド樹脂粉末のイミド化率は70%であった。
撹拌子を入れた100mL三角フラスコに、得られたポリイミド樹脂粉末4.80gを量り取り、NMPを35.20g加え、70℃で12時間撹拌して溶解させ、固形分濃度が12質量%のポリマー溶液(重合体-8)を得た。
(Synthesis Example 8)
50 g of the polymer solution (Polymer-7) obtained in Synthesis Example 7 was weighed out into a 100 mL four-neck flask equipped with a stirrer and a nitrogen inlet tube, and 25 g of NMP was added and stirred for 30 minutes. 4.16 g of acetic anhydride and 1.07 g of pyridine were added to the obtained polyamic acid solution, and the mixture was heated at 55° C. for 2 hours and 30 minutes to perform chemical imidization. The obtained reaction solution was poured into 300 mL of methanol while stirring, and the precipitate was filtered out. Subsequently, the precipitate was washed three times with 300 mL of methanol. Next, the obtained resin powder was dried at 60° C. for 12 hours to obtain a polyimide resin powder. The imidization rate of this polyimide resin powder was 70%.
4.80 g of the obtained polyimide resin powder was weighed out into a 100 mL Erlenmeyer flask containing a stirrer, 35.20 g of NMP was added, and the mixture was stirred at 70° C. for 12 hours to dissolve the polyimide resin powder, thereby obtaining a polymer solution (polymer-8) having a solid content of 12% by mass.
上記合成例で得られた重合体の仕様を表1に示す。表中、テトラカルボン酸成分の括弧内の数値は、重合に使用したテトラカルボン酸成分の総量100モル部に対して、使用した各テトラカルボン酸二無水物の量(モル部)を表す。ジアミン成分の括弧内の数値は、重合に使用したジアミン成分の総量100モル部に対して、使用した各ジアミンの量(モル部)を表す。 The specifications of the polymer obtained in the above synthesis example are shown in Table 1. In the table, the numbers in parentheses for the tetracarboxylic acid components indicate the amount (parts by mole) of each tetracarboxylic dianhydride used per 100 parts by mole of the total amount of tetracarboxylic acid components used in the polymerization. The numbers in parentheses for the diamine components indicate the amount (parts by mole) of each diamine used per 100 parts by mole of the total amount of diamine components used in the polymerization.
[液晶配向剤の調製]
(実施例1)
撹拌子の入った30mL三角フラスコに、合成例1で得られたポリマー(重合体-1)の溶液(9.17g)を量り取り、NMP(2.83g)、BCS(6.00g)及びAD-1の10質量%NMP溶液(0.56g)、AD-2の1質量%NMP溶液(1.10g)、AD-4(0.15g)、化合物(c)(0.20g)を加え、室温で2時間撹拌することで、液晶配向剤(1)を得た。
[Preparation of liquid crystal alignment agent]
Example 1
In a 30 mL Erlenmeyer flask containing a stirrer, the solution (9.17 g) of the polymer (polymer-1) obtained in Synthesis Example 1 was weighed out, and NMP (2.83 g), BCS (6.00 g), a 10 mass% NMP solution of AD-1 (0.56 g), a 1 mass% NMP solution of AD-2 (1.10 g), AD-4 (0.15 g), and compound (c) (0.20 g) were added, and the mixture was stirred at room temperature for 2 hours to obtain a liquid crystal alignment agent (1).
(実施例2)
撹拌子の入った30mL三角フラスコに、合成例1で得られたポリマー(重合体-1)の溶液(3.67g)、合成例2で得られたポリマー(重合体-2)の溶液(5.50g)を量り取り、NMP(2.83g)、BCS(6.00g)及びAD-1の10質量%NMP溶液(0.56g)、AD-2の1質量%NMP溶液(1.10g)、AD-4(0.15g)、化合物(c)(0.20g)を加え、室温で2時間撹拌することで、液晶配向剤(2)を得た。
Example 2
In a 30 mL Erlenmeyer flask containing a stirrer, the solution (3.67 g) of the polymer (polymer-1) obtained in Synthesis Example 1 and the solution (5.50 g) of the polymer (polymer-2) obtained in Synthesis Example 2 were weighed out, and NMP (2.83 g), BCS (6.00 g), 10 mass% NMP solution (0.56 g) of AD-1, 1 mass% NMP solution (1.10 g) of AD-2, AD-4 (0.15 g), and compound (c) (0.20 g) were added, and the mixture was stirred at room temperature for 2 hours to obtain a liquid crystal alignment agent (2).
(実施例3)
撹拌子の入った30mL三角フラスコに、合成例5で得られたポリマー(重合体-5)の溶液(3.67g)、合成例6で得られたポリマー(重合体-6)の溶液(5.50g)を量り取り、NMP(2.83g)、BCS(6.00g)及びAD-1の10質量%NMP溶液(0.56g)、AD-2の1質量%NMP溶液(1.10g)、化合物(c)(0.20g)を加え、室温で2時間撹拌することで、液晶配向剤(3)を得た。
Example 3
In a 30 mL Erlenmeyer flask containing a stirrer, the solution (3.67 g) of the polymer (polymer-5) obtained in Synthesis Example 5 and the solution (5.50 g) of the polymer (polymer-6) obtained in Synthesis Example 6 were weighed out, and NMP (2.83 g), BCS (6.00 g), 10 mass% NMP solution of AD-1 (0.56 g), 1 mass% NMP solution of AD-2 (1.10 g), and compound (c) (0.20 g) were added, and the mixture was stirred at room temperature for 2 hours to obtain a liquid crystal alignment agent (3).
(実施例4)
撹拌子の入った30mL三角フラスコに、合成例8で得られたポリマー(重合体-8)の溶液(3.00g)、合成例2で得られたポリマー(重合体-2)の溶液(4.50g)を量り取り、NMP(0.86g)、GBL(6.00g)、BCS(4.00g)及びAD-1の10質量%NMP溶液(0.45g)、AD-2の1質量%NMP溶液(0.90g)、AD-4(0.09g)、化合物(c)(0.20g)を加え、室温で2時間撹拌することで、液晶配向剤(4)を得た。
Example 4
In a 30 mL Erlenmeyer flask containing a stirrer, the solution (3.00 g) of the polymer (polymer-8) obtained in Synthesis Example 8 and the solution (4.50 g) of the polymer (polymer-2) obtained in Synthesis Example 2 were weighed out, and NMP (0.86 g), GBL (6.00 g), BCS (4.00 g), 10 mass% NMP solution of AD-1 (0.45 g), 1 mass% NMP solution of AD-2 (0.90 g), AD-4 (0.09 g), and compound (c) (0.20 g) were added, and the mixture was stirred at room temperature for 2 hours to obtain a liquid crystal alignment agent (4).
(実施例5)
撹拌子の入った30mL三角フラスコに、合成例3で得られたポリマー(重合体-3)の溶液(2.00g)、合成例4で得られたポリマー(重合体-4)の溶液(9.60g)を量り取り、NMP(3.24g)、BCS(4.00g)及びAD-3の1質量%NMP溶液(0.96g)、化合物(c)(0.20g)を加え、室温で2時間撹拌することで、液晶配向剤(5)を得た。
Example 5
In a 30 mL Erlenmeyer flask containing a stirrer, the solution (2.00 g) of the polymer (polymer-3) obtained in Synthesis Example 3 and the solution (9.60 g) of the polymer (polymer-4) obtained in Synthesis Example 4 were weighed out, and NMP (3.24 g), BCS (4.00 g), a 1 mass % NMP solution of AD-3 (0.96 g), and compound (c) (0.20 g) were added, and the mixture was stirred at room temperature for 2 hours to obtain a liquid crystal alignment agent (5).
(実施例6)
撹拌子の入った30mL三角フラスコに、合成例6で得られたポリマー(重合体-6)の溶液(9.17g)を量り取り、NMP(4.63g)、BCS(6.00g)、化合物(c)(0.20g)を加え、室温で2時間撹拌することで、液晶配向剤(6)を得た。
Example 6
The solution (9.17 g) of the polymer (polymer-6) obtained in Synthesis Example 6 was weighed out into a 30 mL Erlenmeyer flask containing a stirrer, and NMP (4.63 g), BCS (6.00 g), and compound (c) (0.20 g) were added thereto, followed by stirring at room temperature for 2 hours to obtain a liquid crystal alignment agent (6).
(比較例1)
撹拌子の入った30mL三角フラスコに、合成例1で得られたポリマー(重合体-1)の溶液(9.17g)を量り取り、NMP(3.03g)、BCS(6.00g)及びAD-1の10質量%NMP溶液(0.56g)、AD-2の1質量%NMP溶液(1.10g)、AD-4(0.15g)を加え、室温で2時間撹拌することで、液晶配向剤(7)を得た。
(Comparative Example 1)
In a 30 mL Erlenmeyer flask containing a stirrer, the solution (9.17 g) of the polymer (polymer-1) obtained in Synthesis Example 1 was weighed out, and NMP (3.03 g), BCS (6.00 g), a 10 mass% NMP solution of AD-1 (0.56 g), a 1 mass% NMP solution of AD-2 (1.10 g), and AD-4 (0.15 g) were added, and the mixture was stirred at room temperature for 2 hours to obtain a liquid crystal alignment agent (7).
(比較例2)
撹拌子の入った30mL三角フラスコに、合成例1で得られたポリマー(重合体-1)の溶液(3.67g)、合成例2で得られたポリマー(重合体-2)の溶液(5.50g)を量り取り、NMP(3.03g)、BCS(6.00g)及びAD-1の10質量%NMP溶液(0.56g)、AD-2の1質量%NMP溶液(1.10g)、AD-4(0.15g)を加え、室温で2時間撹拌することで、液晶配向剤(8)を得た。
(Comparative Example 2)
In a 30 mL Erlenmeyer flask containing a stirrer, the solution (3.67 g) of the polymer (polymer-1) obtained in Synthesis Example 1 and the solution (5.50 g) of the polymer (polymer-2) obtained in Synthesis Example 2 were weighed out, and NMP (3.03 g), BCS (6.00 g), 10 mass% NMP solution of AD-1 (0.56 g), 1 mass% NMP solution of AD-2 (1.10 g), and AD-4 (0.15 g) were added, and the mixture was stirred at room temperature for 2 hours to obtain a liquid crystal alignment agent (8).
(比較例3)
撹拌子の入った30mL三角フラスコに、合成例5で得られたポリマー(重合体-5)の溶液(3.67g)、合成例6で得られたポリマー(重合体-6)の溶液(5.50g)を量り取り、NMP(3.03g)、BCS(6.00g)及びAD-1の10質量%NMP溶液(0.56g)、AD-2の1質量%NMP溶液(1.10g)を加え、室温で2時間撹拌することで、液晶配向剤(9)を得た。
(Comparative Example 3)
In a 30 mL Erlenmeyer flask containing a stirrer, the solution (3.67 g) of the polymer (polymer-5) obtained in Synthesis Example 5 and the solution (5.50 g) of the polymer (polymer-6) obtained in Synthesis Example 6 were weighed out, and NMP (3.03 g), BCS (6.00 g), a 10 mass% NMP solution (0.56 g) of AD-1, and a 1 mass% NMP solution (1.10 g) of AD-2 were added, and the mixture was stirred at room temperature for 2 hours to obtain a liquid crystal alignment agent (9).
(比較例4)
撹拌子の入った30mL三角フラスコに、合成例8で得られたポリマー(重合体-8)の溶液(3.00g)、合成例2で得られたポリマー(重合体-2)の溶液(4.50g)を量り取り、NMP(1.06g)、GBL(6.00g)、BCS(4.00g)及びAD-1の10質量%NMP溶液(0.45g)、AD-2の1質量%NMP溶液(0.90g)、AD-4(0.09g)を加え、室温で2時間撹拌することで、液晶配向剤(4)を得た。
(Comparative Example 4)
In a 30 mL Erlenmeyer flask containing a stirrer, the solution (3.00 g) of the polymer (polymer-8) obtained in Synthesis Example 8 and the solution (4.50 g) of the polymer (polymer-2) obtained in Synthesis Example 2 were weighed out, and NMP (1.06 g), GBL (6.00 g), BCS (4.00 g), 10 mass% NMP solution of AD-1 (0.45 g), 1 mass% NMP solution of AD-2 (0.90 g), and AD-4 (0.09 g) were added, and the mixture was stirred at room temperature for 2 hours to obtain a liquid crystal alignment agent (4).
(比較例5)
撹拌子の入った30mL三角フラスコに、合成例3で得られたポリマー(重合体-3)の溶液(2.00g)、合成例4で得られたポリマー(重合体-4)の溶液(9.60g)を量り取り、NMP(3.44g)、BCS(4.00g)及びAD-3の1質量%NMP溶液(0.96g)を加え、室温で2時間撹拌することで、液晶配向剤(11)を得た。
(Comparative Example 5)
In a 30 mL Erlenmeyer flask containing a stirrer, the solution (2.00 g) of the polymer (polymer-3) obtained in Synthesis Example 3 and the solution (9.60 g) of the polymer (polymer-4) obtained in Synthesis Example 4 were weighed out, and NMP (3.44 g), BCS (4.00 g) and a 1 mass % NMP solution (0.96 g) of AD-3 were added, and the mixture was stirred at room temperature for 2 hours to obtain a liquid crystal alignment agent (11).
(比較例6)
撹拌子の入った30mL三角フラスコに、合成例6で得られたポリマー(重合体-6)の溶液(9.37g)を量り取り、NMP(4.63g)、BCS(6.00g)を加え、室温で2時間撹拌することで、液晶配向剤(12)を得た。
(Comparative Example 6)
A solution (9.37 g) of the polymer (polymer-6) obtained in Synthesis Example 6 was weighed out into a 30 mL Erlenmeyer flask containing a stirrer, and NMP (4.63 g) and BCS (6.00 g) were added thereto, followed by stirring at room temperature for 2 hours to obtain a liquid crystal alignment agent (12).
実施例1~6及び比較例1~6で得られた液晶配向剤の重合体、本発明に記載の亜リン酸エステルの種類及び比率は、下記表2のとおりである。
表中、化合物(C)の括弧内の数値は、各液晶配向剤の総量100質量部に対する、各化合物の含有量(質量部)を表す。
The polymers of the liquid crystal aligning agents obtained in Examples 1 to 6 and Comparative Examples 1 to 6, and the types and ratios of the phosphite esters described in the present invention are as shown in Table 2 below.
In the table, the numerical values in parentheses for compound (C) indicate the content (parts by mass) of each compound relative to 100 parts by mass of the total amount of each liquid crystal aligning agent.
[FFS駆動方式の液晶セルの作製(光配向処理)]
(実施例7~10及び比較例7~10)
FFS駆動方式の液晶表示素子の構成を備えた液晶セルを作製した。
初めに電極付きの基板を準備した。基板は、30mm×50mmの大きさで、厚さが0.7mmのガラス基板を用いた。基板上には第1層目として対向電極を構成する、ベタ状のパターンを備えたITO電極が形成されている。第1層目の対向電極の上には第2層目として、CVD法により成膜されたSiN(窒化珪素)膜が形成されていた。第2層目のSiN膜は、層間絶縁膜として機能する、膜厚が500nmのものを用いた。第2層目のSiN膜の上には、第3層目としてITO膜をパターニングして形成された櫛歯状の画素電極が配置され、第1画素および第2画素の2つの画素が形成されていた。各画素のサイズは、縦10mmで横約5mmであった。このとき、第1層目の対向電極と第3層目の画素電極とは、第2層目のSiN膜の作用により電気的に絶縁されていた。
[Fabrication of FFS driving type liquid crystal cell (photo-alignment treatment)]
(Examples 7 to 10 and Comparative Examples 7 to 10)
A liquid crystal cell having the configuration of a liquid crystal display element of an FFS driving method was fabricated.
First, a substrate with electrodes was prepared. The substrate was a glass substrate with a size of 30 mm x 50 mm and a thickness of 0.7 mm. An ITO electrode with a solid pattern was formed on the substrate, which constituted the counter electrode as the first layer. A SiN (silicon nitride) film formed by a CVD method was formed as the second layer on the first layer of the counter electrode. The second layer of the SiN film was a 500 nm thick film that functioned as an interlayer insulating film. A comb-shaped pixel electrode formed by patterning an ITO film as the third layer was arranged on the second layer of the SiN film, and two pixels, a first pixel and a second pixel, were formed. The size of each pixel was 10 mm long and about 5 mm wide. At this time, the first layer of the counter electrode and the third layer of the pixel electrode were electrically insulated by the action of the second layer of the SiN film.
第3層目の画素電極は、中央部分が内角160°で屈曲した幅3μmの電極要素が6μmの間隔を開けて平行になるように複数配列された櫛歯形状を有しており、1つの画素は、複数の電極要素の屈曲部を結ぶ線を境に第1領域と第2領域を有していた。
各画素の第1領域と第2領域とを比較すると、それらを構成する画素電極の電極要素の形成方向が異なるものとなっていた。すなわち、上記複数の電極要素の屈曲部を結ぶ方向を基準とした場合、画素の第1領域では画素電極の電極要素が時計回りに80°の角度をなすように形成され、画素の第2領域では画素電極の電極要素が反時計回りに80°の角度をなすように形成されていた。すなわち、各画素の第1領域と第2領域とでは、画素電極と対向電極との間の電圧印加によって誘起される液晶分子の、基板面内での回転動作(インプレーン・スイッチング)の方向が互いに逆方向となるように構成されていた。
The pixel electrode of the third layer had a comb-tooth shape in which multiple electrode elements, each 3 μm wide and bent at an interior angle of 160° in the center, were arranged in parallel at intervals of 6 μm, and each pixel had a first region and a second region separated by a line connecting the bent portions of the multiple electrode elements.
When comparing the first and second regions of each pixel, the electrode elements of the pixel electrodes constituting them were formed in different directions. That is, when the direction connecting the bent portions of the above-mentioned multiple electrode elements was taken as a reference, the electrode elements of the pixel electrodes in the first region of the pixel were formed to form an angle of 80° clockwise, and the electrode elements of the pixel electrodes in the second region of the pixel were formed to form an angle of 80° counterclockwise. That is, in the first and second regions of each pixel, the directions of rotational movement (in-plane switching) of liquid crystal molecules in the substrate plane induced by application of a voltage between the pixel electrode and the counter electrode were configured to be opposite to each other.
次に、上記液晶配向剤の実施例1~4及び比較例1~4で得られた液晶配向剤(1)~(4)及び液晶配向剤(7)~(10)を1.0μmのフィルターで濾過した後、上記電極付き基板と裏面にITO膜が成膜されている高さ4μmの柱状スペーサーを有するガラス基板に、それぞれスピンコート塗布にて塗布した。80℃のホットプレート上で5分間乾燥させた後、230℃の熱風循環式オーブンで30分間焼成を行い、膜厚100nmの塗膜を形成させた。次に、光配向処理を行った。具体的には、この塗膜面に偏光板を介して消光比10:1以上の直線偏光した波長254nmの紫外線を照射した。なお、照射した紫外線の照射量は、下記の表3に記載の条件で行った。次に、上記の塗膜付き基板を230℃のホットプレート上で30分間加熱する加熱工程を行い、液晶配向膜付き基板を得た。 Next, the liquid crystal alignment agents (1) to (4) and the liquid crystal alignment agents (7) to (10) obtained in Examples 1 to 4 and Comparative Examples 1 to 4 of the liquid crystal alignment agent were filtered through a 1.0 μm filter, and then applied by spin coating to the above-mentioned electrode-attached substrate and a glass substrate having a columnar spacer with a height of 4 μm and an ITO film formed on the back surface. After drying for 5 minutes on a hot plate at 80°C, it was baked for 30 minutes in a hot air circulation oven at 230°C to form a coating film with a thickness of 100 nm. Next, a photoalignment treatment was performed. Specifically, the coating surface was irradiated with linearly polarized ultraviolet light with a wavelength of 254 nm and an extinction ratio of 10:1 or more through a polarizing plate. The irradiation amount of the ultraviolet light was performed under the conditions shown in Table 3 below. Next, a heating process was performed in which the above-mentioned coating-attached substrate was heated on a hot plate at 230°C for 30 minutes, and a substrate with a liquid crystal alignment film was obtained.
上記の液晶配向膜付き基板を2枚用意し、液晶注入口を残して周囲にシール剤(三井化学社製 XN-1500T)を印刷し、液晶配向膜面が向き合い配向方向が0°になるようにして張り合わせた。その後、120℃で90分間の加熱処理を行い、シール剤を硬化させて空セルを作製した。この空セルにネガ型液晶MLC-7026-100(メルク社製)を常温で真空注入した後、注入口を封止してアンチパラレル配向の液晶セルとした。得られたFFS駆動方式の液晶セルを120℃で1時間加熱し、23℃で一晩放置してから下記する各評価に用いた。 Two of the above substrates with liquid crystal alignment film were prepared, and a sealant (Mitsui Chemicals XN-1500T) was printed around the periphery, leaving a liquid crystal injection port, and then they were bonded together so that the liquid crystal alignment film surfaces faced each other and the alignment direction was 0°. They were then heated at 120°C for 90 minutes to harden the sealant and create an empty cell. Negative liquid crystal MLC-7026-100 (Merck) was vacuum injected into this empty cell at room temperature, and the injection port was then sealed to create a liquid crystal cell with anti-parallel alignment. The resulting FFS drive type liquid crystal cell was heated at 120°C for 1 hour, left to stand overnight at 23°C, and then used for the various evaluations described below.
[FFS駆動方式の液晶セルの作製(ラビング配向処理)]
(実施例11~12及び比較例11~12)
上記と同様の電極付き基板、及び柱状スペーサーを有するガラス基板を準備した。そして、上記液晶配向剤の実施例5~6及び比較例11~12で得られた液晶配向剤(5)~(6)及び液晶配向剤(11)~(12)を用いた以外は、上記実施例7~10と同様の手順で膜厚100nmの塗膜を形成させた。次に、上記光配向処理を以下に記載のラビング配向処理に変更して、配向処理を行った。具体的には、塗膜が形成された基板を、レーヨン布でラビング(ローラー直径:140mm、ローラー回転数:1000rpm、移動速度:30mm/sec、押し込み長:0.3mm)した。その後、純水中にて1分間超音波照射をして洗浄を行い、エアブローにて水滴を除去した後、80℃で10分間乾燥して液晶配向膜付き基板を得た。
このようにして得られた上記液晶配向膜付きの基板を2枚用意し、上記と同様の手順でFFS駆動方式の液晶セルを作製し、下記する各評価に用いた。
[Fabrication of FFS driving type liquid crystal cell (rubbing alignment treatment)]
(Examples 11 to 12 and Comparative Examples 11 to 12)
A substrate with electrodes similar to those described above and a glass substrate with columnar spacers were prepared. Then, a coating film with a thickness of 100 nm was formed in the same manner as in Examples 7 to 10, except that the liquid crystal alignment agents (5) to (6) and (11) to (12) obtained in Examples 5 to 6 and Comparative Examples 11 to 12 of the liquid crystal alignment agent were used. Next, the photo-alignment treatment was changed to the rubbing alignment treatment described below, and an alignment treatment was performed. Specifically, the substrate on which the coating film was formed was rubbed with a rayon cloth (roller diameter: 140 mm, roller rotation speed: 1000 rpm, moving speed: 30 mm/sec, indentation length: 0.3 mm). Thereafter, the substrate was cleaned by irradiating ultrasonic waves in pure water for 1 minute, water droplets were removed by air blowing, and then dried at 80°C for 10 minutes to obtain a substrate with a liquid crystal alignment film.
Two substrates with the liquid crystal alignment film thus obtained were prepared, and a liquid crystal cell of the FFS driving system was fabricated in the same manner as above, and used for the following evaluations.
[コントラストの面内均一性の評価]
AXOMETRICS社製AxoStepを用いて液晶セルのツイスト角のばらつきの評価を行った。上記で作製した液晶セルを測定ステージに設置し、電圧無印加の状態で、画素面内のCircular Retardanceの分布を測定して標準偏差σの3倍である3σを算出した。面内均一性は、この3σの値が小さいほど良好であると言える。
[Evaluation of in-plane uniformity of contrast]
The variation in the twist angle of the liquid crystal cell was evaluated using AxoStep manufactured by AXOMETRICS. The liquid crystal cell prepared above was placed on a measurement stage, and the distribution of circular retardance in the pixel plane was measured without applying voltage, and 3σ, which is three times the standard deviation σ, was calculated. It can be said that the smaller the value of 3σ, the better the in-plane uniformity.
[長期交流駆動による残像特性評価]
上記で作成したFFS駆動液晶セルに対し、60℃の恒温環境下、周波数60Hzで±5.8Vの交流電圧を120時間印加した。その後、液晶セルの画素電極と対向電極との間をショートさせた状態にし、そのまま室温に一日放置した。
上記の処理を行った液晶セルに関して、電圧無印加状態における、画素の第1領域の液晶の配向方向と第2領域の液晶の配向方向とのずれを角度Δθとして算出した。
具体的には、偏光軸が直交するように配置された2枚の偏光板の間に液晶セルを設置し、バックライトを点灯させ、画素の第1領域の透過光強度が最も小さくなるように液晶セルの配置角度を調整した。次に、画素の第2領域の透過光強度が最も小さくなるように液晶セルを回転させたときに要する回転角度(Δθ)を求めた。長期交流駆動による残像特性は、この回転角度の値が小さいほど良好であると言える。
[Evaluation of image retention characteristics using long-term AC driving]
An AC voltage of ±5.8 V at a frequency of 60 Hz was applied to the FFS driving liquid crystal cell prepared above for 120 hours in a constant temperature environment of 60° C. Thereafter, the pixel electrode and the counter electrode of the liquid crystal cell were shorted, and the cell was left at room temperature for one day.
For the liquid crystal cell that had been subjected to the above-mentioned treatment, the deviation between the alignment direction of the liquid crystal in the first region of the pixel and the alignment direction of the liquid crystal in the second region in the absence of applied voltage was calculated as an angle Δθ.
Specifically, a liquid crystal cell was placed between two polarizing plates arranged so that the polarization axes were perpendicular to each other, and the backlight was turned on to adjust the arrangement angle of the liquid crystal cell so that the transmitted light intensity of the first region of the pixel was minimized. Next, the rotation angle (Δθ) required when the liquid crystal cell was rotated so that the transmitted light intensity of the second region of the pixel was minimized was calculated. It can be said that the smaller the value of this rotation angle, the better the afterimage characteristics due to long-term AC driving.
[電圧保持率の評価]
上記で作製した液晶セルの電圧保持率の評価を行った。具体的には、上記の手法で得られた液晶セルに、60℃の温度下で2VPPの交流電圧を60μ秒間印加し、1秒後の電圧を測定し、電圧がどのくらい保持できているかを電圧保持率(VHRともいう)として計算した。なお、測定は、電圧保持率測定装置(VHR-1、東陽テクニカ社製)を使用し、Voltage:±1V、Pulse Width:60μs、Flame Period:1000msの設定で行った。
[Evaluation of voltage holding ratio]
The voltage holding ratio of the liquid crystal cell prepared above was evaluated. Specifically, an AC voltage of 2 VPP was applied to the liquid crystal cell obtained by the above method for 60 μs at a temperature of 60° C., the voltage after 1 second was measured, and the voltage that could be held was calculated as the voltage holding ratio (also referred to as VHR). The measurement was performed using a voltage holding ratio measuring device (VHR-1, manufactured by Toyo Corporation) with the settings of Voltage: ±1 V, Pulse Width: 60 μs, and Flame Period: 1000 ms.
上記、コントラストの面内均一性評価、長期交流駆動時の残像特性評価、電圧保持率の評価結果を下記表5に示す。 The results of the evaluation of the above-mentioned in-plane contrast uniformity, afterimage characteristics during long-term AC operation, and voltage retention rate are shown in Table 5 below.
上記実施例7~12及び比較例7~12の結果を比較すると、化合物(c)を添加した液晶配向膜を用いたテストセルは、添加していない液晶配向膜を用いたテストセルよりも、コントラストの面内均一性評価が良好であることが確認された。また、実施例7~10及び比較例7~10の結果を比較すると、化合物(c)を添加した液晶配向膜を用いた場合、長期交流駆動による残像特性も良化することが確認された。更に、実施例8及び実施例11と比較例8及び比較例11の結果を比較すると、化合物(c)を添加した配向膜を用いた場合、電圧保持率が良化することが確認された。
つまり、本発明の液晶配向剤を用いた液晶表示素子は、高いコントラスト、優れた残像特性、及び優れた信頼性を有することが確認された。
Comparing the results of Examples 7 to 12 and Comparative Examples 7 to 12, it was confirmed that the test cells using the liquid crystal alignment film to which the compound (c) was added had a better in-plane uniformity evaluation of contrast than the test cells using the liquid crystal alignment film to which the compound (c) was not added. In addition, comparing the results of Examples 7 to 10 and Comparative Examples 7 to 10, it was confirmed that when the liquid crystal alignment film to which the compound (c) was added was used, the afterimage characteristics due to long-term AC driving were also improved. Furthermore, comparing the results of Examples 8 and 11 with the results of Comparative Examples 8 and 11, it was confirmed that when the alignment film to which the compound (c) was added was used, the voltage holding ratio was improved.
In other words, it was confirmed that the liquid crystal display device using the liquid crystal aligning agent of the present invention has high contrast, excellent afterimage characteristics, and excellent reliability.
本発明の構成を備える液晶表示素子を用いることにより、液晶配向膜面内での液晶のツイスト角度のバラツキ(不均一性)が小さく、且つ、AC残像を抑制できる液晶表示素子が得られる。更に、高い電圧保持率の液晶表示素子が得られるため、高い表示品位が求められる液晶表示素子における利用が期待できる。そして、これらの素子は、表示を目的とする液晶ディスプレイ、さらには、光の透過と遮断を制御する調光窓や光シャッターなどにおいても有用である。 By using a liquid crystal display element having the configuration of the present invention, it is possible to obtain a liquid crystal display element in which the variation (non-uniformity) in the twist angle of the liquid crystal within the liquid crystal alignment film plane is small and AC afterimages can be suppressed. Furthermore, since a liquid crystal display element with a high voltage retention rate is obtained, it is expected that it will be used in liquid crystal display elements that require high display quality. These elements are also useful in liquid crystal displays for display purposes, and in light control windows and optical shutters that control the transmission and blocking of light.
Claims (17)
前記重合体成分(P)が、ポリイミド前駆体、及び該ポリイミド前駆体のイミド化物であるポリイミドからなる群から選ばれる少なくとも1種の重合体(P)を含有する、液晶配向剤。
(RcO)nP(=O)(OH)2-nH (c)
(式(c)中、Rcは、互いに独立に、炭素数1~6の1価の有機基を表す。nは、1又は2の整数である。) A liquid crystal aligning agent comprising a polymer component (P) containing one or more polymers, and a compound (C) represented by the following formula (c):
The liquid crystal aligning agent, wherein the polymer component (P) contains at least one polymer (P) selected from the group consisting of polyimide precursors and polyimides which are imidized products of the polyimide precursors.
(R c O) n P(=O)(OH) 2-n H (c)
(In formula (c), R c 's each independently represent a monovalent organic group having 1 to 6 carbon atoms, and n is an integer of 1 or 2.)
A4は、エステル結合、アミド結合、チオエステル結合、又は炭素数2~20の2価の有機基を表す。但し、1,4-フェニレン基、該フェニレン基上の水素原子の1~4つがR4、及びR4’で置換されている2価の有機基、又はこれらの2価の有機基同士が連結した2価の有機基を除く。
a3、a4、及びa4’は、それぞれ独立して0~4の整数である。
aは、1~4の整数である。b及びcはそれぞれ独立して1~2の整数である。R3、R4、R4’が複数存在する場合、R3、R4、及びR4’の構造は同一でも異なってもよい。a3、a4、及びa4’が複数存在する場合、それぞれ同一でも異なっていてもよい。*は結合手を表す。) The liquid crystal aligning agent according to claim 4, wherein the divalent organic group of Y in the formula (P0) is a divalent organic group represented by the following formulas (3) to (4):
A4 represents an ester bond, an amide bond, a thioester bond, or a divalent organic group having 2 to 20 carbon atoms, except for a 1,4-phenylene group, a divalent organic group in which 1 to 4 hydrogen atoms on the phenylene group are substituted with R4 and R4 ' , or a divalent organic group in which these divalent organic groups are linked to each other.
a3, a4, and a4' each independently represents an integer of 0 to 4.
a is an integer of 1 to 4. b and c are each independently an integer of 1 to 2. When a plurality of R 3 , R 4 , and R 4' are present, the structures of R 3 , R 4 , and R 4' may be the same or different. When a plurality of a3, a4, and a4' are present, they may be the same or different. * represents a bond.
前記重合体成分(P)が、以下の条件(i)~(iii)の少なくとも一つを満たす、液晶配向剤。
(i)1種以上の構造単位を有し、下記式(A1)で表される構造単位(a1)を有するポリイミド前駆体(A)及び該ポリイミド前駆体のイミド化物であるポリイミドからなる群から選ばれる少なくとも1種の重合体を2種類以上含む、重合体成分(P1)。
(ii)前記ポリイミド前駆体(A)と異なる重合体であって、1種以上の構造単位を有し、下記式(B1)で表される構造単位(b1)を有するポリイミド前駆体(B)を2種類以上含む、重合体成分(P2)。
(iii)前記ポリイミド前駆体(A)及び該ポリイミド前駆体のイミド化物であるポリイミドからなる群から選ばれる少なくとも1種の重合体と、前記ポリイミド前駆体(B)と、を含む、重合体成分(P3)。
The liquid crystal aligning agent, wherein the polymer component (P) satisfies at least one of the following conditions (i) to (iii):
(i) A polymer component (P1) having one or more types of structural units and including two or more types of at least one polymer selected from the group consisting of a polyimide precursor (A) having a structural unit (a1) represented by the following formula (A1) and a polyimide which is an imidized product of the polyimide precursor:
(ii) A polymer component (P2) which is a polymer different from the polyimide precursor (A), has one or more types of structural units, and contains two or more types of polyimide precursors (B) having a structural unit (b1) represented by the following formula (B1):
(iii) A polymer component (P3) containing at least one polymer selected from the group consisting of the polyimide precursor (A) and a polyimide which is an imidization product of the polyimide precursor (A), and the polyimide precursor (B).
工程(1):請求項1又は7に記載の液晶配向剤を基板上に塗布する工程
工程(2):塗布した前記液晶配向剤を焼成する工程
工程(3):工程(2)で得られた膜に配向処理する工程 A method for producing a liquid crystal alignment film, comprising the following steps (1) to (3):
Step (1): A step of applying the liquid crystal alignment agent according to claim 1 or 7 onto a substrate; Step (2): A step of baking the applied liquid crystal alignment agent; Step (3): A step of performing an alignment treatment on the film obtained in step (2).
焼成工程:150℃~300℃で焼成する工程。 The method for producing a liquid crystal alignment film according to claim 11, further comprising the following baking step after the step (3):
Firing step: A step of firing at 150°C to 300°C.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310342698.4A CN118725877A (en) | 2023-03-31 | 2023-03-31 | Liquid crystal alignment agent, liquid crystal alignment film, liquid crystal display element, and method for producing the same |
CN2023103426984 | 2023-03-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2024204521A1 true WO2024204521A1 (en) | 2024-10-03 |
Family
ID=92850181
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2024/012607 WO2024204521A1 (en) | 2023-03-31 | 2024-03-28 | Liquid crystal aligning agent, liquid crystal alignment film, liquid crystal display element, and methods for manufacturing same |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN118725877A (en) |
WO (1) | WO2024204521A1 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016006738A1 (en) * | 2014-07-10 | 2016-01-14 | 전북대학교산학협력단 | Inducer for vertically aligning liquid crystals and liquid crystal display device manufactured using same |
WO2019230091A1 (en) * | 2018-05-29 | 2019-12-05 | Jsr株式会社 | Liquid crystal orientation agent, liquid crystal orientation film, and liquid crystal element |
JP2022071804A (en) * | 2020-10-28 | 2022-05-16 | Jsr株式会社 | Liquid crystal alignment agent, liquid crystal orientation membrane, liquid crystal element, and method for manufacturing liquid crystal element |
-
2023
- 2023-03-31 CN CN202310342698.4A patent/CN118725877A/en active Pending
-
2024
- 2024-03-28 WO PCT/JP2024/012607 patent/WO2024204521A1/en unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016006738A1 (en) * | 2014-07-10 | 2016-01-14 | 전북대학교산학협력단 | Inducer for vertically aligning liquid crystals and liquid crystal display device manufactured using same |
WO2019230091A1 (en) * | 2018-05-29 | 2019-12-05 | Jsr株式会社 | Liquid crystal orientation agent, liquid crystal orientation film, and liquid crystal element |
JP2022071804A (en) * | 2020-10-28 | 2022-05-16 | Jsr株式会社 | Liquid crystal alignment agent, liquid crystal orientation membrane, liquid crystal element, and method for manufacturing liquid crystal element |
Also Published As
Publication number | Publication date |
---|---|
CN118725877A (en) | 2024-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2022176680A1 (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
WO2022270287A1 (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
WO2023286735A1 (en) | Liquid crystal alignment agent, liquid crystal alignment film, liquid crystal display element production method, and liquid crystal display element | |
WO2023286733A1 (en) | Liquid crystal aligning agent, liquid crystal alignment film, method for producing liquid crystal display element, and liquid crystal display element | |
KR20250009419A (en) | Novel diamine compound, polymer obtained by using the diamine, liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
WO2023068085A1 (en) | Liquid crystal alignment agent, liquid crystal alignment film, liquid crystal display element, and compound | |
JP7517208B2 (en) | Liquid crystal alignment agent, liquid crystal alignment film, liquid crystal element, and method for producing liquid crystal element | |
WO2022234820A1 (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
JP7428177B2 (en) | Liquid crystal alignment agent, liquid crystal alignment film, liquid crystal display element and diamine | |
WO2018124166A1 (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
WO2024142964A1 (en) | Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element | |
WO2024204521A1 (en) | Liquid crystal aligning agent, liquid crystal alignment film, liquid crystal display element, and methods for manufacturing same | |
WO2024154728A1 (en) | Liquid crystal display element and method for manufacturing same | |
WO2024111498A1 (en) | Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element | |
WO2024162336A1 (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
TW202037716A (en) | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element | |
JP7505643B2 (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
JP7497782B2 (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
JP2024091548A (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
TW202503029A (en) | Liquid crystal alignment agent, liquid crystal alignment film, liquid crystal display element and manufacturing method thereof | |
WO2024157869A1 (en) | Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element | |
WO2022190896A1 (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element | |
WO2024122359A1 (en) | Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element | |
WO2023032753A1 (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
JP2024070838A (en) | Liquid crystal orientation agent, liquid crystal orientation film, and liquid crystal display element |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 24780621 Country of ref document: EP Kind code of ref document: A1 |